Bipin N. Savani, M.B.B.S.

Professor

bipin.savani@vumc.org
Faculty Appointments
Professor of Medicine
Education
M.B.B.S., B.J. Medical College, Ahmedabad, India
Office Address
Hematology, Stem Cell Transplantation and Cellular Therapy Section
3927 TVC
Nashville, TN 37232
Research Description
Dr Savani’s area of specialization is in the treatment of hematological malignancies, stem cell transplantation/ cellular therapy, and his primary field of research is in the long-term follow-up after transplantation/ cellular therapy, including regimen-related toxicity/ supportive care, and outcomes analysis of hematological malignancies, transplant and cellular therapy recipients. Dr Savani has published over 500 peer-reviewed articles, reviews, book chapters, editorials, perspectives and commentaries in the field of hematological malignancies, stem cell transplantation and cellular therapy. He is Co-Editor-in-Chief of journals Bone Marrow Transplantation (EBMT journal) and Clinical Hematology International (IACH journal) and associate editor of British Journal of Haematology (BSH), Transplantation and Cellular Therapy (ASTCT journal, formerly BBMT), eJHaem (sister journal BJH); and also serves as an editorial advisory board member for several journals in the field. Dr Savani is currently leader of the Conditioning Regimen Subcommittee of the Acute Leukemia Working Party of the EBMT. He also serves as Co-Chair Regimen-Related Toxicity and Supportive Care-CIBMTR and medical monitor for Blood and Marrow Transplant Clinical Trial Network (BMT-CTN). Dr Savani is a member of the ASH Committee on Practice (COP) and a liaison member from the COP to the ASH Task Force on Immunotherapies subcommittee. He has recently edited several special issues for Seminars in Hematology, Hematology/ Oncology Clinics of North America and edited Wiley books entitled "Blood and Marrow Transplantation Long Term Management: Prevention and Complications" (first ed 2014, second ed May 2021) and "Clinical guide to transplantation in lymphomas" (first ed 2015). Co-authored handbook on Leukemia (FAST FACTS: Leukemia, first ed 2019). He has served as a Foundation for the Accreditation of Cellular Therapy (FACT) adults program clinical/ marrow collection facilities and Immune Effector Cell (IEC) inspector role since 2011.

Board Certifications: Internal Medicine (Exp 2025), Hematology (Exp 2027), Medical Oncology (Ext 2028)
Clinical Research Keywords
Hematopoietic cell transplantation; Cellular therapy
Publications
Nagler A, Labopin M, Dholaria B, Ciceri F, Fraccaroli A, Blaise D, Fanin R, Bruno B, Forcade E, Vydra J, Chevallier P, Bulabois CE, Jindra P, Bornhäuser M, Canaani J, Sanz J, Savani BN, Spyridonidis A, Giebel S, Brissot E, Bazarbachi A, Esteve J, Mohty M. Impact of Cytogenetic Risk on Outcomes of Non-T Cell Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia. Transplant Cell Ther [print-electronic]. 2022 Aug 8/25/2022; PMID: 36031079, PII: S2666-6367(22)01556-1, DOI: 10.1016/j.jtct.2022.08.018, ISSN: 2666-6367.

Kharfan-Dabaja MA, Reljic T, Yassine F, Nishihori T, Kumar A, Tawk MM, Keller K, Ayala E, Savani B, Mohty M, Aljurf M, Saber W. Efficacy of a second allogeneic hematopoietic cell transplant in relapsed acute myeloid leukemia: results of a systematic review and meta-analysis. Transplant Cell Ther [print-electronic]. 2022 Aug 8/12/2022; PMID: 35970301, PII: S2666-6367(22)01547-0, DOI: 10.1016/j.jtct.2022.08.008, ISSN: 2666-6367.

Rotz SJ, Yi JC, Hamilton BK, Wei W, Preussler JM, Cerny J, Deol A, Jim H, Khera N, Hahn T, Hashmi SK, Holtan S, Jaglowski SM, Loren AW, McGuirk J, Reynolds J, Saber W, Savani BN, Stiff P, Uberti J, Wingard JR, Wood WA, Baker KS, Majhail NS, Syrjala KL. Health Related Quality of Life in Young Adults Survivors of Hematopoietic Cell Transplantation. Transplant Cell Ther [print-electronic]. 2022 Jul 7/21/2022; PMID: 35872304, PII: S2666-6367(22)01480-4, DOI: 10.1016/j.jtct.2022.07.018, ISSN: 2666-6367.

Saliba RM, Majid AA, Pidala J, Arora M, Spellman SR, Hemmer MT, Wang T, Abboud C, Ahmed S, Antin JH, Beitinjaneh A, Buchbinder D, Byrne M, Cahn JY, Choe H, Hanna R, Hematti P, Kamble RT, Kitko CL, Laughlin M, Lekakis L, MacMillan ML, Martino R, Mehta PA, Nishihori T, Patel SS, Perales MA, Rangarajan HG, Ringdén O, Rosenthal J, Savani BN, Schultz KR, Seo S, Teshima T, van der Poel M, Verdonck LF, Weisdorf D, Wirk B, Yared JA, Schriber J, Champlin R, Ciurea S. Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis. Transplant Cell Ther [print-electronic]. 2022 Jul 7/16/2022; PMID: 35853610, PII: S2666-6367(22)01476-2, DOI: 10.1016/j.jtct.2022.07.013, ISSN: 2666-6367.

Dholaria B, Mehraban N, Baer B, Long N, Jayani RV, Byrne MT, Kassim AA, Engelhardt BG, Savani BN, Oluwole OO. Feasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience [letter]. Br J Haematol [print-electronic]. 2022 Jun 6/28/2022; PMID: 35765247, DOI: 10.1111/bjh.18339, ISSN: 1365-2141.

Devillier R, Galimard JE, Labopin M, Blaise D, Raiola AM, Pavlu J, Castagna L, Socié G, Chalandon Y, Martino M, Stölzel F, Bug G, Bruno B, Vrhovac R, Charbonnier A, Olivieri A, Bay JO, Arroyo H, Yakoub-Agha I, Avenoso D, Neubauer A, Nguyen S, Forcade E, Brissot E, Savani B, Nagler A, Mohty M. Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT. Bone Marrow Transplant [print-electronic]. 2022 Jun 6/25/2022; PMID: 35752739, PII: 10.1038/s41409-022-01674-x, DOI: 10.1038/s41409-022-01674-x, ISSN: 1476-5365.

Nagler A, Ngoya M, Galimard JE, Labopin M, Bornhäuser M, Stelljes M, Finke J, Ganser A, Einsele H, Kröger N, Brecht A, Bethge W, Edinger M, Kulagin A, Passweg J, Blau IW, Elmaagacli A, Schäfer-Eckart K, Platzbecker U, Schroeder T, Bunjes D, Tischer J, Martin S, Spyridonidis A, Giebel S, Savani B, Mohty M. Longitudinal outcome over two decades of unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: an ALWP/EBMT analysis. Clin Cancer Res [print-electronic]. 2022 Jun 6/7/2022; PMID: 35670780, PII: 699405, DOI: 10.1158/1078-0432.CCR-22-0809, ISSN: 1557-3265.

Dholaria B, Radujkovic A, Estrada-Merly N, Sirait T, Kim S, Hernández-Boluda JC, Czerw T, Hayden PJ, Kansagra A, Ho VT, Nishihori T, Shaughnessy P, Scott B, Nakamura R, Oran B, Kharfan-Dabaja M, Savani BN, McLornan D, Yakoub-Agha I, Saber W. Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis [letter]. Br J Haematol [print-electronic]. 2022 Jun 6/3/2022; PMID: 35658101, DOI: 10.1111/bjh.18297, ISSN: 1365-2141.

Ohmoto A, Fuji S, Shultes KC, Savani BN, Einsele H. Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia. Bone Marrow Transplant [print-electronic]. 2022 Jun; 57(6): 874-80. PMID: 35440805, PMCID: PMC9017083, PII: 10.1038/s41409-022-01680-z, DOI: 10.1038/s41409-022-01680-z, ISSN: 1476-5365.

Rodríguez-Arbolí E, Labopin M, Eder M, Brecht A, Blau IW, Huynh A, Forcade E, Tischer J, Bethge W, Bondarenko S, Verbeek M, Bulabois CE, Einsele H, Stölzel F, Savani B, Spyridonidis A, Bazarbachi A, Giebel S, Brissot E, Schmid C, Nagler A, Mohty M. Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysis. Bone Marrow Transplant [print-electronic]. 2022 Jun; 57(6): 934-41. PMID: 35393528, PII: 10.1038/s41409-022-01611-y, DOI: 10.1038/s41409-022-01611-y, ISSN: 1476-5365.

Maakaron JE, Zhang MJ, Chen K, Abhyankar S, Bhatt VR, Chhabra S, El Jurdi N, Farag SS, He F, Juckett M, de Lima M, Majhail N, van der Poel M, Saad A, Savani B, Ustun C, Waller EK, Litzow M, Kebriaei P, Hourigan CS, Saber W, Weisdorf D. Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis. Bone Marrow Transplant [print-electronic]. 2022 Jun; 57(6): 911-7. PMID: 35368040, PII: 10.1038/s41409-022-01650-5, DOI: 10.1038/s41409-022-01650-5, ISSN: 1476-5365.

Broglie L, Friend BD, Chhabra S, Bupp C, Schiller GJ, Logan B, Pasquini MC, Savani B, Stadtmauer EA, Thakar MS, Sorror M. Differential use of the hematopoietic cell transplantation-comorbidity index among adult and pediatric transplant physicians [letter]. Leuk Lymphoma [print-electronic]. 2022 May 5/18/2022; 1-4. PMID: 35583292, DOI: 10.1080/10428194.2022.2076848, ISSN: 1029-2403.

Duque-Afonso J, Finke J, Labopin M, Craddock C, Protheroe R, Kottaridis P, Tholouli E, Byrne JL, Orchard K, Salmenniemi U, Hilgendorf I, Hunter H, Nicholson E, Bloor A, Snowden JA, Verbeek M, Clark A, Savani BN, Spyridonidis A, Nagler A, Mohty M. Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone Marrow Transplant [print-electronic]. 2022 May 5/14/2022; PMID: 35568756, PII: 10.1038/s41409-022-01646-1, DOI: 10.1038/s41409-022-01646-1, ISSN: 1476-5365.

Danylesko I, Peczynski C, Labopin M, Polge E, Tischer J, Blaise D, Koc Y, Gülbas Z, Ciceri F, Arat M, Castagna L, Bruno B, Raiola AM, Botella-Garcia C, Savani BN, Piemontese S, Ruggeri A, Nagler A, Mohty M. Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT. Bone Marrow Transplant [print-electronic]. 2022 May 5/13/2022; PMID: 35562547, PII: 10.1038/s41409-022-01695-6, DOI: 10.1038/s41409-022-01695-6, ISSN: 1476-5365.

Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, Burns L, Eissa H, Murthy HS, Prasad P, Sharma A, Suelzer E, Agrawal V, Aljurf M, Baker K, Basak GW, Buchbinder D, DeFilipp Z, Grkovic LD, Dias A, Einsele H, Eisenberg ML, Epperla N, Farhadfar N, Flatau A, Gale RP, Greinix H, Hamilton BK, Hashmi S, Hematti P, Jamani K, Maharaj D, Murray J, Naik S, Nathan S, Pavletic S, Peric Z, Pulanic D, Ross R, Salonia A, Sanchez-Ortega I, Savani BN, Schechter T, Shah AJ, Smith SM, Snowden JA, Steinberg A, Tremblay D, Vij SC, Walker L, Wolff D, Yared JA, Schoemans H, Tichelli A. Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Bone Marrow Transplant [print-electronic]. 2022 May 5/6/2022; PMID: 35523848, PII: 10.1038/s41409-022-01591-z, DOI: 10.1038/s41409-022-01591-z, ISSN: 1476-5365.

Kansagra A, Dispenzieri A, Fraser R, Estrada-Merly N, Sidana S, Nishihori T, Hansen DK, Anderson LD, Banerjee R, Bumma N, Dhakal B, Khouri J, Landau H, Lee CH, Mian H, Nathan S, Savani BN, Kumar SK, Qazilbash MH, Shah N, D'Souza A. Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma. Blood Adv [print-electronic]. 2022 May 5/4/2022; PMID: 35507742, PII: 485149, DOI: 10.1182/bloodadvances.2022007218, ISSN: 2473-9537.

Nagler A, Peczynski C, Dholaria B, Labopin M, Valerius T, Dreger P, Kröger N, Reinhardt HC, Finke J, Franke GN, Ciceri F, Verbeek M, Blau IW, Bornhäuser M, Spyridonidis A, Bug G, Bazarbachi A, Schmid C, Yakoub-Agha I, Savani BN, Mohty M. Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia. Bone Marrow Transplant [print-electronic]. 2022 Apr 4/30/2022; PMID: 35501565, PII: 10.1038/s41409-022-01693-8, DOI: 10.1038/s41409-022-01693-8, ISSN: 1476-5365.

Alseraihy A, McGrath E, Niederwieser D, Chabannon C, Szer J, Mohty M, Kharfan-Dabaja MA, Orchard K, Schwartz J, Rasheed W, Koh M, Kröger N, Kodera Y, Fakih RE, Worel N, Manson L, Rintala T, Tabakhi A, Savani B, Gergis U, Sureda A, Eldridge PW, Yakoub-Agha I, Hamadani M, Weisdorf D, Greinix H, Aljurf M. Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy. Transplant Cell Ther [print-electronic]. 2022 Apr 4/10/2022; PMID: 35413459, PII: S2666-6367(22)01198-8, DOI: 10.1016/j.jtct.2022.04.003, ISSN: 2666-6367.

Murthy HS, Ahn KW, Estrada-Merly N, Alkhateeb HB, Bal S, Kharfan-Dabaja MA, Dholaria B, Foss F, Gowda L, Jagadeesh D, Sauter C, Abid MB, Aljurf M, Awan FT, Bacher U, Badawy SM, Battiwalla M, Bredeson C, Cerny J, Chhabra S, Deol A, Diaz MA, Farhadfar N, Freytes C, Gajewski J, Gandhi MJ, Ganguly S, Grunwald MR, Halter J, Hashmi S, Hildebrandt GC, Inamoto Y, Jimenez-Jimenez AM, Kalaycio M, Kamble R, Krem MM, Lazarus HM, Lazaryan A, Maakaron J, Munshi PN, Munker R, Nazha A, Nishihori T, Oluwole OO, Ortí G, Pan DC, Patel SS, Pawarode A, Rizzieri D, Saba NS, Savani B, Seo S, Ustun C, van der Poel M, Verdonck LF, Wagner JL, Wirk B, Oran B, Nakamura R, Scott B, Saber W. Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research. Transplant Cell Ther [print-electronic]. 2022 Apr; 28(4): 187.e1-187.e10. PMID: 35081472, PII: S2666-6367(22)00036-7, DOI: 10.1016/j.jtct.2022.01.017, ISSN: 2666-6367.

Dhakal B, Chhabra S, Savani BN, Hamadani M. Promise and pitfalls of allogeneic chimeric antigen receptor therapy in plasma cell and lymphoid malignancies. Br J Haematol [print-electronic]. 2022 Apr; 197(1): 28-40. PMID: 34671973, DOI: 10.1111/bjh.17904, ISSN: 1365-2141.

Booth GS, Jacobs JW, Stephens LD, Chooljian DM, Savani BN, Gehrie EA. When should we tell patients there may be no blood? Evaluating the 'informed' consent process [letter]. Br J Haematol [print-electronic]. 2022 Mar 3/22/2022; PMID: 35315509, DOI: 10.1111/bjh.18156, ISSN: 1365-2141.

Patel SS, Ahn KW, Khanal M, Bupp C, Allbee-Johnson M, Majhail NS, Hamilton BK, Rotz SJ, Hashem H, Beitinjaneh A, Lazarus HM, Krem MM, Prestidge T, Bhatt NS, Sharma A, Gadalla SM, Murthy HS, Broglie L, Nishihori T, Freytes CO, Hildebrandt GC, Gergis U, Seo S, Wirk B, Pasquini MC, Savani BN, Sorror ML, Stadtmauer EA, Chhabra S. Non-infectious pulmonary toxicity after allogeneic hematopoietic cell transplantation. Transplant Cell Ther [print-electronic]. 2022 Mar 3/18/2022; PMID: 35314376, PII: S2666-6367(22)01163-0, DOI: 10.1016/j.jtct.2022.03.015, ISSN: 2666-6367.

Abou-Ismail MY, Fraser R, Allbee-Johnson M, Metheny L, Ravi G, Ahn KW, Bhatt NS, Lazarus HM, de Lima M, El Jurdy N, Hematti P, Beitinjaneh AM, Nishihori T, Badawy SM, Sharma A, Pasquini MC, Savani BN, Sorror ML, Stadtmauer EA, Chhabra S. Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?. Br J Haematol [print-electronic]. 2022 Mar 3/14/2022; PMID: 35286719, DOI: 10.1111/bjh.18108, ISSN: 1365-2141.

Swoboda R, Labopin M, Giebel S, Angelucci E, Arat M, Aljurf M, Sica S, Pavlu J, Socié G, Bernasconi P, Rigacci L, Tischer J, Risitano A, Rovira M, Saccardi R, Pioltelli P, Van Gorkom G, Vitek A, Savani BN, Spyridonidis A, Peric Z, Nagler A, Mohty M. Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplant [print-electronic]. 2022 Mar; 57(3): 399-406. PMID: 35031709, PII: 10.1038/s41409-021-01550-0, DOI: 10.1038/s41409-021-01550-0, ISSN: 1476-5365.

Guru Murthy GS, Kim S, Hu ZH, Estrada-Merly N, Abid MB, Aljurf M, Bacher U, Badawy SM, Beitinjaneh A, Bredeson C, Cahn JY, Cerny J, Diaz Perez MA, Farhadfar N, Gale RP, Ganguly S, Gergis U, Hildebrandt GC, Grunwald MR, Hashmi S, Hossain NM, Kalaycio M, Kamble RT, Kharfan-Dabaja MA, Hamilton BK, Lazarus HM, Liesveld J, Litzow M, Marks DI, Murthy HS, Nathan S, Nazha A, Nishihori T, Patel SS, Pawarode A, Rizzieri D, Savani B, Seo S, Solh M, Ustun C, van der Poel M, Verdonck LF, Vij R, Wirk B, Oran B, Nakamura R, Scott B, Saber W. Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors. JAMA Oncol. 2022 Mar 3/1/2022; 8(3): 404-11. PMID: 35024768, PMCID: PMC8759031, PII: 2788054, DOI: 10.1001/jamaoncol.2021.6846, ISSN: 2374-2445.

Patel A, Wilkerson K, Chen H, Sharma D, Byrne M, Green J, Sengsayadeth S, Dholaria B, Savani B, Chinratanalab W, Jayani R, Gatwood K, Engelhardt BG, Kitko C, Connelly J, Kassim A. Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation. Transplant Cell Ther [print-electronic]. 2022 Feb 2/15/2022; PMID: 35181561, PII: S2666-6367(22)00089-6, DOI: 10.1016/j.jtct.2022.02.010, ISSN: 2666-6367.

Nagler A, Labopin M, Dholaria B, Wu D, Choi G, Aljurf M, Ciceri F, Gedde-Dahl T, Meijer E, Niittyvuopio R, Bondarenko S, Bourhis JH, Cornelissen JJ, Socié G, Koc Y, Canaani J, Savani B, Bug G, Spyridonidis A, Giebel S, Brissot E, Bazarbachi A, Esteve J, Mohty M. Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation. Transplant Cell Ther [print-electronic]. 2022 Feb; 28(2): 86.e1-86.e8. PMID: 34856420, PII: S2666-6367(21)01360-9, DOI: 10.1016/j.jtct.2021.11.013, ISSN: 2666-6367.

Jacobs JW, Bibb LA, Savani BN, Booth GS. Refusing blood transfusions from COVID-19-vaccinated donors: are we repeating history? [letter]. Br J Haematol [print-electronic]. 2022 Feb; 196(3): 585-8. PMID: 34523736, PMCID: PMC8653055, DOI: 10.1111/bjh.17842, ISSN: 1365-2141.

Marvin-Peek J, Savani BN, Olalekan OO, Dholaria B. Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia. Cancers (Basel). 2022 Jan 1/19/2022; 14(3): PMID: 35158765, PMCID: PMC8833567, PII: cancers14030497, DOI: 10.3390/cancers14030497, ISSN: 2072-6694.

Wieduwilt MJ, Metheny L, Zhang MJ, Wang HL, Estrada-Merly N, Marks DI, Al-Homsi AS, Muffly L, Chao N, Rizzieri D, Gale RP, Gadalla SM, Cairo M, Mussetti A, Gore S, Bhatt VR, Patel SS, Michelis FV, Inamoto Y, Badawy SM, Copelan E, Palmisiano N, Kharfan-Dabaja MA, Lazarus HM, Ganguly S, Bredeson C, Diaz Perez MA, Cassaday R, Savani BN, Ballen K, Martino R, Wirk B, Bacher U, Aljurf M, Bashey A, Murthy HS, Yared JA, Aldoss I, Farhadfar N, Liu H, Abdel-Azim H, Waller EK, Solh M, Seftel MD, van der Poel M, Grunwald MR, Liesveld JL, Kamble RT, McGuirk J, Munker R, Cahn JY, Lee JW, Freytes CO, Krem MM, Winestone LE, Gergis U, Nathan S, Olsson RF, Verdonck LF, Sharma A, Ringdén O, Friend BD, Cerny J, Choe H, Chhabra S, Nishihori T, Seo S, George B, Baxter-Lowe LA, Hildebrandt GC, de Lima M, Litzow M, Kebriaei P, Hourigan CS, Abid MB, Weisdorf DJ, Saber W. Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia. Blood Adv. 2022 Jan 1/11/2022; 6(1): 339-57. PMID: 34547770, PMCID: PMC8753217, PII: 476983, DOI: 10.1182/bloodadvances.2021004916, ISSN: 2473-9537.

Menghrajani K, Gomez-Arteaga A, Madero-Marroquin R, Zhang MJ, Bo-Subait K, Sanchez J, Wang HL, Aljurf M, Assal A, Bacher VU, Badawy SM, Bejanyan N, Bhatt VR, Bredeson C, Byrne M, Castillo P, Cerny J, Chhabra S, Ciurea SO, DeFilipp Z, Farhadfar N, Gadalla S, Gale RP, Ganguly S, Gowda L, Grunwald MR, Hashmi S, Hildebrandt G, Kanakry CG, Kansagra A, Khimani F, Krem M, Lazarus H, Liu H, Martino R, Michelis FV, Nathan S, Nishihori T, Olsson R, Reshef R, Rizzieri D, Rowe JM, Savani BN, Seo S, Sharma A, Solh M, Ustun C, Verdonck LF, Hourigan C, Sandmaier B, Litzow M, Kebriaei P, Weisdorf D, Zhang Y, Tallman MS, Saber W. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Adv. 2022 Jan 1/8/2022; 6(3): 828-47. PMID: 34551064, PMCID: PMC8945306, PII: 476993, DOI: 10.1182/bloodadvances.2021004881, ISSN: 2473-9537.

Iqbal M, Savani BN, Hamadani M. New Indications and platforms for CAR-T therapy in lymphomas beyond DLBCL. EJHaem [print-electronic]. 2022 Jan; 3(Suppl 1): 11-23. PMID: 34988550, PMCID: PMC8725814, DOI: 10.1002/jha2.323, ISSN: 2688-6146.

Connelly JA, Savani BN. Finding the best haematopoietic stem cell transplant regimen for GATA2 haploinsufficiency: how close are we?. Br J Haematol [print-electronic]. 2022 Jan; 196(1): 13-4. PMID: 34580866, DOI: 10.1111/bjh.17859, ISSN: 1365-2141.

Iqbal M, Savani BN, Hamadani M. New Indications and platforms for CAR-T therapy in lymphomas beyond DLBCL. EJHaem [print-electronic]. 2022 Jan; 3(Suppl 1): 11-23. PMID: 34988550, PMCID: PMC8725814, DOI: 10.1002/jha2.323, ISSN: 2688-6146.

Patel U, Abernathy J, Savani BN, Oluwole O, Sengsayadeth S, Dholaria B. CAR T cell therapy in solid tumors: A review of current clinical trials. EJHaem. 2022 Jan; 3(Suppl 1): 24-31. PMID: 35844304, PMCID: PMC9175685, PII: JHA2356, DOI: 10.1002/jha2.356, ISSN: 2688-6146.

Bhaskar ST, Dholaria BR, Sengsayadeth SM, Savani BN, Oluwole OO. Role of bridging therapy during chimeric antigen receptor T cell therapy. EJHaem. 2022 Jan; 3(Suppl 1): 39-45. PMID: 35844303, PMCID: PMC9175845, PII: JHA2335, DOI: 10.1002/jha2.335, ISSN: 2688-6146.

Sengsayadeth SM, Dholaria BR, Savani BN, Oluwole OO. Chimeric antigen receptor-T cell therapies: The changing landscape [editorial]. EJHaem. 2022 Jan; 3(Suppl 1): 3-5. PMID: 35844302, PMCID: PMC9176045, PII: JHA2340, DOI: 10.1002/jha2.340, ISSN: 2688-6146.

Gatwood KS, Dholaria BR, Lucena M, Baer B, Savani BN, Oluwole OO. Chimeric antigen receptor T-cell therapy: Challenges and framework of outpatient administration. EJHaem. 2022 Jan; 3(Suppl 1): 54-60. PMID: 35844300, PMCID: PMC9176074, PII: JHA2333, DOI: 10.1002/jha2.333, ISSN: 2688-6146.

Sengsayadeth S, Savani BN, Oluwole O, Dholaria B. Overview of approved CAR-T therapies, ongoing clinical trials, and its impact on clinical practice. EJHaem. 2022 Jan; 3(Suppl 1): 6-10. PMID: 35844299, PMCID: PMC9175669, PII: JHA2338, DOI: 10.1002/jha2.338, ISSN: 2688-6146.

Sengsayadeth S, Broglie L, Savani BN. Effectiveness of COVID-19 vaccination in patients after allogeneic haematopoietic cell transplant: how much protection are we getting?. Br J Haematol [print-electronic]. 2021 Dec 12/1/2021; PMID: 34850381, DOI: 10.1111/bjh.17955, ISSN: 1365-2141.

Schmid C, Labopin M, Schaap N, Veelken H, Brecht A, Stadler M, Finke J, Baron F, Collin M, Bug G, Ljungman P, Blaise D, Tischer J, Bloor A, Kulagin A, Giebel S, Gorin NC, Esteve J, Ciceri F, Savani B, Nagler A, Mohty M. Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia. Bone Marrow Transplant [print-electronic]. 2021 Nov 11/8/2021; PMID: 34750562, PII: 10.1038/s41409-021-01515-3, DOI: 10.1038/s41409-021-01515-3, ISSN: 1476-5365.

Metheny L, Callander NS, Hall AC, Zhang MJ, Bo-Subait K, Wang HL, Agrawal V, Al-Homsi AS, Assal A, Bacher U, Beitinjaneh A, Bejanyan N, Bhatt VR, Bredeson C, Byrne M, Cairo M, Cerny J, DeFilipp Z, Perez MAD, Freytes CO, Ganguly S, Grunwald MR, Hashmi S, Hildebrandt GC, Inamoto Y, Kanakry CG, Kharfan-Dabaja MA, Lazarus HM, Lee JW, Nathan S, Nishihori T, Olsson RF, Ringdén O, Rizzieri D, Savani BN, Savoie ML, Seo S, van der Poel M, Verdonck LF, Wagner JL, Yared JA, Hourigan CS, Kebriaei P, Litzow M, Sandmaier BM, Saber W, Weisdorf D, de Lima M. Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults. Transplant Cell Ther [print-electronic]. 2021 Nov; 27(11): 923.e1-923.e12. PMID: 34428556, PII: S2666-6367(21)01146-5, DOI: 10.1016/j.jtct.2021.08.010, ISSN: 2666-6367.

Oran B, Ahn KW, Fretham C, Beitinjaneh A, Bashey A, Pawarode A, Wirk B, Scott BL, Savani BN, Bredeson C, Weisdorf D, Marks DI, Rizzieri D, Copelan E, Hildebrandt GC, Hale GA, Murthy HS, Lazarus HM, Cerny J, Liesveld JL, Yared JA, Yves-Cahn J, Szer J, Verdonck LF, Aljurf M, van der Poel M, Litzow M, Kalaycio M, Grunwald MR, Diaz MA, Sabloff M, Kharfan-Dabaja MA, Majhail NS, Farhadfar N, Reshef R, Olsson RF, Gale RP, Nakamura R, Seo S, Chhabra S, Hashmi S, Farhan S, Ganguly S, Nathan S, Nishihori T, Jain T, Agrawal V, Bacher U, Popat U, Saber W. Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes. Transplant Cell Ther [print-electronic]. 2021 Nov; 27(11): 921.e1-921.e10. PMID: 34403791, PII: S2666-6367(21)01143-X, DOI: 10.1016/j.jtct.2021.08.007, ISSN: 2666-6367.

Lee CJ, Pusic I, Savani BN. Beyond ruxolitinib in steroid-refractory acute graft-versus-host disease. Br J Haematol [print-electronic]. 2021 Nov; 195(3): 306-7. PMID: 34402041, DOI: 10.1111/bjh.17735, ISSN: 1365-2141.

Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, Burns L, Eissa H, Murthy HS, Prasad P, Sharma A, Suelzer E, Agrawal V, Aljurf M, Baker K, Basak GW, Buchbinder D, DeFilipp Z, Grkovic LD, Dias A, Einsele H, Eisenberg ML, Epperla N, Farhadfar N, Flatau A, Gale RP, Greinix H, Hamilton BK, Hashmi S, Hematti P, Jamani K, Maharaj D, Murray J, Naik S, Nathan S, Pavletic S, Peric Z, Pulanic D, Ross R, Salonia A, Sanchez-Ortega I, Savani BN, Schechter T, Shah AJ, Smith SM, Snowden JA, Steinberg A, Tremblay D, Vij SC, Walker L, Wolff D, Yared JA, Schoemans H, Tichelli A. Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Transplant Cell Ther [print-electronic]. 2021 Oct 10/29/2021; PMID: 34757220, PII: S2666-6367(21)01329-4, DOI: 10.1016/j.jtct.2021.10.013, ISSN: 2666-6367.

Dhakal B, Chhabra S, Savani BN, Hamadani M. Promise and pitfalls of allogeneic chimeric antigen receptor therapy in plasma cell and lymphoid malignancies. Br J Haematol [print-electronic]. 2021 Oct 10/21/2021; PMID: 34671973, DOI: 10.1111/bjh.17904, ISSN: 1365-2141.

Waidhauser J, Labopin M, Esteve J, Kröger N, Cornelissen J, Gedde-Dahl T, Van Gorkom G, Finke J, Rovira M, Schaap N, Petersen E, Beelen D, Bunjes D, Savani B, Schmid C, Nagler A, Mohty M, . Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT. Bone Marrow Transplant [print-electronic]. 2021 Oct; 56(10): 2445-53. PMID: 34059800, PMCID: PMC8486660, PII: 10.1038/s41409-021-01322-w, DOI: 10.1038/s41409-021-01322-w, ISSN: 1476-5365.

Connelly JA, Savani BN. Finding the best haematopoietic stem cell transplant regimen for GATA2 haploinsufficiency: how close are we?. Br J Haematol [print-electronic]. 2021 Sep 9/27/2021; PMID: 34580866, DOI: 10.1111/bjh.17859, ISSN: 1365-2141.

Menghrajani K, Gomez-Arteaga A, Madero-Marroquin R, Zhang MJ, Bo-Subait K, Sanchez J, Wang HL, Aljurf M, Assal A, Bacher U, Badawy SM, Bejanyan N, Bhatt VR, Bredeson CN, Byrne M, Castillo P, Cerny J, Chhabra S, Ciurea SO, DeFilipp Z, Farhadfar N, Gadalla SM, Gale RP, Ganguly S, Gowda L, Grunwald MR, Hashmi S, Hildebrandt GC, Kanakry CG, Kansagra A, Khimani F, Krem M, Lazarus HM, Liu H, Martino R, Michelis FV, Nathan S, Nishihori T, Olsson RF, Reshef R, Rizzieri D, Rowe JM, Savani BN, Seo S, Sharma A, Solh M, Ustun C, Verdonck LF, Hourigan CS, Sandmaier BM, Litzow MR, Kebriaei P, Weisdorf DJ, Zhang Y, Tallman MS, Saber W. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Adv [print-electronic]. 2021 Sep 9/22/2021; PMID: 34551064, PII: S2473-9529(21)00604-2, DOI: 10.1182/bloodadvances.2021004881, ISSN: 2473-9537.

Wieduwilt MJ, Metheny L, Zhang MJ, Wang HL, Estrada-Merly N, Marks DI, Al-Homsi AS, Muffly L, Chao NJ, Rizzieri D, Gale RP, Gadalla SM, Cairo MS, Mussetti A, Gore SD, Bhatt VR, Patel SS, Michelis FV, Inamoto Y, Badawy SM, Copelan E, Palmisiano N, Kharfan-Dabaja MA, Lazarus HM, Ganguly S, Bredeson CN, Diaz Perez MA, Cassaday R, Savani BN, Ballen KK, Martino R, Wirk B, Bacher U, Aljurf M, Bashey A, Murthy HS, Yared JA, Aldoss I, Farhadfar N, Liu H, Abdel-Azim H, Waller EK, Solh M, Seftel M, van der Poel MWM, Grunwald MR, Liesveld JL, Kamble RT, McGuirk JP, Munker R, Cahn JY, Lee JW, Freytes CO, Krem M, Winestone LE, Gergis U, Nathan S, Olsson RF, Verdonck LF, Sharma A, Ringden O, Friend BD, Cerny J, Choe HK, Chhabra S, Nishihori T, Seo S, George B, Baxter-Lowe LA, Hildebrandt GC, de Lima M, Litzow MR, Kebriaei P, Hourigan CS, Abid MB, Weisdorf DJ, Saber W. Haploidentical vs. sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia. Blood Adv [print-electronic]. 2021 Sep 9/21/2021; PMID: 34547770, PII: 476983, DOI: 10.1182/bloodadvances.2021004916, ISSN: 2473-9537.

Jacobs JW, Bibb LA, Savani BN, Booth GS. Refusing blood transfusions from COVID-19-vaccinated donors: are we repeating history? [letter]. Br J Haematol [print-electronic]. 2021 Sep 9/15/2021; PMID: 34523736, DOI: 10.1111/bjh.17842, ISSN: 1365-2141.

Patel P, Savani B, Byrne M. Treosulphan versus busulphan: pros and cons. Br J Haematol [print-electronic]. 2021 Sep 9/12/2021; PMID: 34514593, DOI: 10.1111/bjh.17816, ISSN: 1365-2141.

Munshi PN, Hamadani M, Kumar A, Dreger P, Friedberg JW, Dreyling M, Kahl B, Jerkeman M, Kharfan-Dabaja MA, Locke FL, Shadman M, Hill BT, Ahmed S, Herrera AF, Sauter CS, Bachanova V, Ghosh N, Lunning M, Kenkre VP, Aljurf M, Wang M, Maddocks KJ, Leonard JP, Kamdar M, Phillips T, Cashen AF, Inwards DJ, Sureda A, Cohen JB, Smith SM, Carlo-Stella C, Savani B, Robinson SP, Fenske TS. American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma. Transplant Cell Ther. 2021 Sep; 27(9): 720-8. PMID: 34452722, PMCID: PMC8447221, PII: S2666-6367(21)00744-2, DOI: 10.1016/j.jtct.2021.03.001.

Kharfan-Dabaja MA, Labopin M, Bazarbachi A, Ciceri F, Finke J, Bruno B, Bornhäuser M, Gedde-Dahl T, Labussière-Wallet H, Niittyvuopio R, Valerius T, Angelucci E, Brecht A, Caballero D, Kuball J, Potter V, Schmid C, Tischer J, Zuckerman T, Benedetti F, Blaise D, Diez-Martin JL, Sanz J, Ruggeri A, Brissot E, Savani BN, Giebel S, Nagler A, Mohty M. Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT. Bone Marrow Transplant [print-electronic]. 2021 Sep; 56(9): 2194-202. PMID: 33931757, PII: 10.1038/s41409-021-01317-7, DOI: 10.1038/s41409-021-01317-7, ISSN: 1476-5365.

Metheny L, Callander NS, Hall AC, Zhang MJ, Bo-Subait K, Wang HL, Agrawal V, Al-Homsi AS, Assal A, Bacher U, Beitinjaneh A, Bejanyan N, Bhatt VR, Bredeson C, Byrne M, Cairo M, Cerny J, DeFilipp Z, Perez MAD, Freytes CO, Ganguly S, Grunwald MR, Hashmi S, Hildebrandt GC, Inamoto Y, Kanakry CG, Kharfan-Dabaja MA, Lazarus HM, Lee JW, Nathan S, Nishihori T, Olsson RF, Ringdén O, Rizzieri D, Savani BN, Savoie ML, Seo S, van der Poel M, Verdonck LF, Wagner JL, Yared JA, Hourigan CS, Kebriaei P, Litzow M, Sandmaier BM, Saber W, Weisdorf D, de Lima M. Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults. Transplant Cell Ther [print-electronic]. 2021 Aug 8/21/2021; PMID: 34428556, PII: S2666-6367(21)01146-5, DOI: 10.1016/j.jtct.2021.08.010, ISSN: 2666-6367.

Munshi PN, Hamadani M, Kumar A, Dreger P, Friedberg JW, Dreyling M, Kahl B, Jerkeman M, Kharfan-Dabaja MA, Locke FL, Shadman M, Hill BT, Ahmed S, Herrera AF, Sauter CS, Bachanova V, Ghosh N, Lunning M, Kenkre VP, Aljurf M, Wang M, Maddocks KJ, Leonard JP, Kamdar M, Phillips T, Cashen AF, Inwards DJ, Sureda A, Cohen JB, Smith SM, Carlo-Stella C, Savani B, Robinson SP, Fenske TS. ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma. Bone Marrow Transplant [print-electronic]. 2021 Aug 8/20/2021; PMID: 34413469, PII: 10.1038/s41409-021-01288-9, DOI: 10.1038/s41409-021-01288-9, ISSN: 1476-5365.

Lee CJ, Pusic I, Savani BN. Beyond ruxolitinib in steroid-refractory acute graft-versus-host disease. Br J Haematol [print-electronic]. 2021 Aug 8/16/2021; PMID: 34402041, DOI: 10.1111/bjh.17735, ISSN: 1365-2141.

Oran B, Ahn KW, Fretham C, Beitinjaneh A, Bashey A, Pawarode A, Wirk B, Scott BL, Savani BN, Bredeson C, Weisdorf D, Marks DI, Rizzieri D, Copelan E, Hildebrandt GC, Hale GA, Murthy HS, Lazarus HM, Cerny J, Liesveld JL, Yared JA, Yves-Cahn J, Szer J, Verdonck LF, Aljurf M, van der Poel M, Litzow M, Kalaycio M, Grunwald MR, Diaz MA, Sabloff M, Kharfan-Dabaja MA, Majhail NS, Farhadfar N, Reshef R, Olsson RF, Gale RP, Nakamura R, Seo S, Chhabra S, Hashmi S, Farhan S, Ganguly S, Nathan S, Nishihori T, Jain T, Agrawal V, Bacher U, Popat U, Saber W. Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes. Transplant Cell Ther [print-electronic]. 2021 Aug 8/14/2021; PMID: 34403791, PII: S2666-6367(21)01143-X, DOI: 10.1016/j.jtct.2021.08.007, ISSN: 2666-6367.

Lazaryan A, Dolan M, Zhang MJ, Wang HL, Kharfan-Dabaja MA, Marks DI, Bejanyan N, Copelan E, Majhail NS, Waller EK, Chao N, Prestidge T, Nishihori T, Kebriaei P, Inamoto Y, Hamilton B, Hashmi SK, Kamble RT, Bacher U, Hildebrandt GC, Stiff PJ, McGuirk J, Aldoss I, Beitinjaneh AM, Muffly L, Vij R, Olsson RF, Byrne M, Schultz KR, Aljurf M, Seftel M, Savoie ML, Savani BN, Verdonck LF, Cairo MS, Hossain N, Bhatt VR, Frangoul HA, Abdel-Azim H, Al Malki M, Munker R, Rizzieri D, Khera N, Nakamura R, Ringdén O, Van der Poel M, Murthy HS, Liu H, Mori S, De Oliveira S, Bolaños-Meade J, Elsawy M, Barba P, Nathan S, George B, Pawarode A, Grunwald M, Agrawal V, Wang Y, Assal A, Caro PC, Kuwatsuka Y, Seo S, Ustun C, Politikos I, Lazarus HM, Saber W, Sandmaier BM, De Lima M, Litzow M, Bachanova V, Weisdorf D. Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Haematologica. 2021 Aug 8/1/2021; 106(8): 2295-6. PMID: 34333962, PMCID: PMC8327734, DOI: 10.3324/haematol.2021.279046, ISSN: 1592-8721.

Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, Burroughs LM, Majhail N, Al-Homsi AS, Al-Kadhimi ZS, Bar M, Bertaina A, Boelens JJ, Champlin R, Chaudhury S, DeFilipp Z, Dholaria B, El-Jawahri A, Fanning S, Fraint E, Gergis U, Giralt S, Hamilton BK, Hashmi SK, Horn B, Inamoto Y, Jacobsohn DA, Jain T, Johnston L, Kanate AS, Kansagra A, Kassim A, Kean LS, Kitko CL, Knight-Perry J, Kurtzberg J, Liu H, MacMillan ML, Mahmoudjafari Z, Mielcarek M, Mohty M, Nagler A, Nemecek E, Olson TS, Oran B, Perales MA, Prockop SE, Pulsipher MA, Pusic I, Riches ML, Rodriguez C, Romee R, Rondon G, Saad A, Shah N, Shaw PJ, Shenoy S, Sierra J, Talano J, Verneris MR, Veys P, Wagner JE, Savani BN, Hamadani M, Carpenter PA. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther. 2021 Aug; 27(8): 642-9. PMID: 34304802, PII: S2666-6367(21)00831-9, DOI: 10.1016/j.jtct.2021.04.007.

Bhatt NS, Brazauskas R, Salit RB, Syrjala K, Bo-Subait S, Tecca H, Badawy SM, Baker KS, Beitinjaneh A, Bejanyan N, Byrne M, Dias A, Farhadfar N, Freytes CO, Ganguly S, Hashmi S, Hayashi RJ, Hong S, Inamoto Y, Jamani K, Kasow KA, Khera N, Krem MM, Lazarus HM, Lee CJ, Lee S, Majhail NS, Malone AK, Marks DI, Mau LW, Mayo SJ, Muffly LS, Nathan S, Nishihori T, Page KM, Preussler J, Rangarajan HG, Rotz SJ, Salooja N, Savani BN, Schears R, Schechter-Finkelstein T, Schiller G, Shah AJ, Sharma A, Wang T, Wirk B, Battiwalla M, Schoemans H, Hamilton B, Buchbinder D, Phelan R, Shaw B. Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States. Transplant Cell Ther [print-electronic]. 2021 Aug; 27(8): 679.e1-679.e8. PMID: 33895402, PMCID: PMC8425287, PII: S2666-6367(21)00860-5, DOI: 10.1016/j.jtct.2021.04.013, ISSN: 2666-6367.

Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, Burroughs LM, Majhail N, Al-Homsi AS, Al-Kadhimi ZS, Bar M, Bertaina A, Boelens JJ, Champlin R, Chaudhury S, DeFilipp Z, Dholaria B, El-Jawahri A, Fanning S, Fraint E, Gergis U, Giralt S, Hamilton BK, Hashmi SK, Horn B, Inamoto Y, Jacobsohn DA, Jain T, Johnston L, Kanate AS, Kansagra A, Kassim A, Kean LS, Kitko CL, Knight-Perry J, Kurtzberg J, Liu H, MacMillan ML, Mahmoudjafari Z, Mielcarek M, Mohty M, Nagler A, Nemecek E, Olson TS, Oran B, Perales MA, Prockop SE, Pulsipher MA, Pusic I, Riches ML, Rodriguez C, Romee R, Rondon G, Saad A, Shah N, Shaw PJ, Shenoy S, Sierra J, Talano J, Verneris MR, Veys P, Wagner JE, Savani BN, Hamadani M, Carpenter PA. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther. 2021 Aug; 27(8): 642-9. PMID: 34304802, PII: S2666-6367(21)00831-9, DOI: 10.1016/j.jtct.2021.04.007.

Hochman MJ, Savani BN, Jain T. Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasms. EJHaem. 2021 Aug; 2(3): 607-15. PMID: 35844680, PMCID: PMC9175746, PII: JHA2264, DOI: 10.1002/jha2.264, ISSN: 2688-6146.

Bazarbachi AH, Labopin M, Kröger N, Brecht A, Blaise D, Clausen J, Fanin R, Einsele H, Cavanna L, Itäla-Remes M, Bulabois CE, Kündgen L, Martin H, Schmid C, Wagner-Drouet EM, Alakel N, Bazarbachi A, Savani B, Nagler A, Mohty M. Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk [print-electronic]. 2021 Jul 7/17/2021; PMID: 34373225, PII: S2152-2650(21)00280-9, DOI: 10.1016/j.clml.2021.07.010, ISSN: 2152-2669.

Patel A, Oluwole O, Savani B, Dholaria B. Taking a BiTE out of the CAR T space race [letter]. Br J Haematol [print-electronic]. 2021 Jun 6/15/2021; PMID: 34131894, DOI: 10.1111/bjh.17622, ISSN: 1365-2141.

Blaise D, Savani BN. Alternative donor transplantation for severe aplastic anaemia in 2021: haplo donor, cord blood or both?. Br J Haematol [print-electronic]. 2021 Jun; 193(5): 863-4. PMID: 33993468, DOI: 10.1111/bjh.17401, ISSN: 1365-2141.

Dholaria B, Savani BN, Huang XJ, Nagler A, Perales MA, Mohty M. The evolving role of allogeneic haematopoietic cell transplantation in the era of chimaeric antigen receptor T-cell therapy. Br J Haematol [print-electronic]. 2021 Jun; 193(6): 1060-75. PMID: 33928630, DOI: 10.1111/bjh.17460, ISSN: 1365-2141.

Panch SR, Logan B, Sees JA, Bo-Subait S, Savani B, Shah NN, Hsu JW, Switzer G, Lazarus HM, Anderlini P, Hematti P, Confer D, Pulsipher MA, Shaw BE, Stroncek DF. Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations. Transplant Cell Ther [print-electronic]. 2021 Jun; 27(6): 503.e1-503.e8. PMID: 33823169, PMCID: PMC8217152, PII: S2666-6367(21)00751-X, DOI: 10.1016/j.jtct.2021.03.008, ISSN: 2666-6367.

Fuji S, Byrne M, Nagler A, Mohty M, Savani BN. How we can mitigate the side effects associated with systemic glucocorticoid after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant [print-electronic]. 2021 Jun; 56(6): 1248-56. PMID: 33514922, PII: 10.1038/s41409-020-01205-6, DOI: 10.1038/s41409-020-01205-6, ISSN: 1476-5365.

Dholaria B, Savani BN, Huang XJ, Nagler A, Perales MA, Mohty M. The evolving role of allogeneic haematopoietic cell transplantation in the era of chimaeric antigen receptor T-cell therapy. Br J Haematol [print-electronic]. 2021 Jun; 193(6): 1060-75. PMID: 33928630, DOI: 10.1111/bjh.17460, ISSN: 1365-2141.

Blaise D, Savani BN. Alternative donor transplantation for severe aplastic anaemia in 2021: haplo donor, cord blood or both?. Br J Haematol [print-electronic]. 2021 Jun; 193(5): 863-4. PMID: 33993468, DOI: 10.1111/bjh.17401, ISSN: 1365-2141.

Sanz J, Galimard JE, Labopin M, Afanasyev B, Sergeevich MI, Angelucci E, Kröger N, Koc Y, Ciceri F, Diez-Martin JL, Arat M, Sica S, Rovira M, Aljurf M, Tischer J, Savani B, Ruggeri A, Nagler A, Mohty M. Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT. J Hematol Oncol. 2021 May 5/28/2021; 14(1): 84. PMID: 34049582, PMCID: PMC8161915, PII: 10.1186/s13045-021-01094-2, DOI: 10.1186/s13045-021-01094-2, ISSN: 1756-8722.

Sanber K, Savani B, Jain T. Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cells. Br J Haematol [print-electronic]. 2021 May 5/25/2021; PMID: 34036558, DOI: 10.1111/bjh.17544, ISSN: 1365-2141.

Lapointe G, Skepper CK, Holder LM, Armstrong D, Bellamacina C, Blais J, Bussiere D, Bian J, Cepura C, Chan H, Dean CR, De Pascale G, Dhumale B, Fisher LM, Fulsunder M, Kantariya B, Kim J, King S, Kossy L, Kulkarni U, Lakshman J, Leeds JA, Ling X, Lvov A, Ma S, Malekar S, McKenney D, Mergo W, Metzger L, Mhaske K, Moser HE, Mostafavi M, Namballa S, Noeske J, Osborne C, Patel A, Patel D, Patel T, Piechon P, Polyakov V, Prajapati K, Prosen KR, Reck F, Richie DL, Sanderson MR, Satasia S, Savani B, Selvarajah J, Sethuraman V, Shu W, Tashiro K, Thompson KV, Vaarla K, Vala L, Veselkov DA, Vo J, Vora B, Wagner T, Wedel L, Williams SL, Yendluri S, Yue Q, Yifru A, Zhang Y, Rivkin A. Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria. J Med Chem [print-electronic]. 2021 May 5/13/2021; 64(9): 6329-57. PMID: 33929852, DOI: 10.1021/acs.jmedchem.1c00375, ISSN: 1520-4804.

Dholaria B, Labopin M, Sanz J, Ruggeri A, Cornelissen J, Labussière-Wallet H, Blaise D, Forcade E, Chevallier P, Grassi A, Zubarovskaya L, Kuball J, Ceballos P, Ciceri F, Baron F, Savani BN, Nagler A, Mohty M. Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia. J Hematol Oncol. 2021 May 5/3/2021; 14(1): 76. PMID: 33941226, PMCID: PMC8094558, PII: 10.1186/s13045-021-01086-2, DOI: 10.1186/s13045-021-01086-2, ISSN: 1756-8722.

Booth GS, Savani BN, Langston AA. Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematopoietic cell transplantation. Br J Haematol [print-electronic]. 2021 May; 193(4): 701-2. PMID: 33844846, DOI: 10.1111/bjh.17465, ISSN: 1365-2141.

Kharfan-Dabaja MA, Labopin M, Brissot E, Kroger N, Finke J, Ciceri F, Deconinck E, Blaise D, Chevallier P, Gramatzki M, Ganser A, Stelljes M, Edinger M, Savani B, Ruggeri A, Sanz J, Nagler A, Mohty M. Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia. Br J Haematol [print-electronic]. 2021 May; 193(3): 592-601. PMID: 33838047, DOI: 10.1111/bjh.17426, ISSN: 1365-2141.

Farhadfar N, Dias A, Wang T, Fretham C, Chhabra S, Murthy HS, Broglie L, D'Souza A, Gadalla SM, Gale RP, Hashmi S, Al-Homsi AS, Hildebrandt GC, Hematti P, Rizzieri D, Chee L, Lazarus HM, Bredeson C, Jaimes EA, Beitinjaneh A, Bashey A, Prestidge T, Krem MM, Marks DI, Benoit S, Yared JA, Nishihori T, Olsson RF, Freytes CO, Stadtmauer E, Savani BN, Sorror ML, Ganguly S, Wingard JR, Pasquini M. Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther [print-electronic]. 2021 May; 27(5): 410-22. PMID: 33775617, PMCID: PMC8168834, PII: S2666-6367(21)00717-X, DOI: 10.1016/j.jtct.2021.02.030, ISSN: 2666-6367.

Booth GS, Savani BN, Langston AA. Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematopoietic cell transplantation. Br J Haematol [print-electronic]. 2021 May; 193(4): 701-2. PMID: 33844846, DOI: 10.1111/bjh.17465, ISSN: 1365-2141.

Bazarbachi AH, Al Hamed R, Labopin M, Halaburda K, Labussiere H, Bernasconi P, Schroyens W, Gandemer V, Schaap NPM, Loschi M, Jindra P, Snowden J, Wu D, Guffroy B, Rovira M, Chantepie SP, Poiré X, Lopez-Corral L, Nikolousis M, Pelosini M, Ciceri F, Baron F, Bazarbachi A, Corbacioglu S, Savani BN, Peric Z, Nagler A, Carreras E, Mohty M. Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party. Bone Marrow Transplant [print-electronic]. 2021 Apr; 56(4): 917-27. PMID: 33208915, PII: 10.1038/s41409-020-01135-3, DOI: 10.1038/s41409-020-01135-3, ISSN: 1476-5365.

Shouval R, Fein JA, Labopin M, Cho C, Bazarbachi A, Baron F, Bug G, Ciceri F, Corbacioglu S, Galimard JE, Giebel S, Gilleece MH, Giralt S, Jakubowski A, Montoto S, O'Reilly RJ, Papadopoulos EB, Peric Z, Ruggeri A, Sanz J, Sauter CS, Savani BN, Schmid C, Spyridonidis A, Tamari R, Versluis J, Yakoub-Agha I, Perales MA, Mohty M, Nagler A. Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry. Lancet Haematol. 2021 Mar; 8(3): e205-e215. PMID: 33636142, PII: S2352-3026(20)30394-X, DOI: 10.1016/S2352-3026(20)30394-X, ISSN: 2352-3026.

El Fakih R, Greinix H, Koh M, Shaw B, Mohty M, Al Nahedh M, Saber W, Kharfan-Dabaja MA, Perales MA, Savani BN, Majhail NS, Passweg JR, Sureda A, Ahmed SO, Gluckman E, Riches M, El-Jawahri A, Rondelli D, Srivastava A, Faulkner L, Atsuta Y, Ballen KK, Rasheed W, Okamoto S, Seber A, Chao N, Kröger N, Kodera Y, Szer J, Hashmi SK, Horowitz MM, Weisdorf D, Niederwieser D, Aljurf M. Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program. Transplant Cell Ther [print-electronic]. 2021 Mar; 27(3): 267.e1-267.e5. PMID: 33781535, PII: S2666-6367(20)30062-2, DOI: 10.1016/j.jtct.2020.12.015, ISSN: 2666-6367.

Booth GS, Savani BN. The Intersection of Photopheresis and COVID-19 Vaccination. Transplant Cell Ther [print-electronic]. 2021 Mar; 27(3): 278. PMID: 33462569, PMCID: PMC7807169, PII: S2666-6367(21)00009-9, DOI: 10.1016/j.jtct.2021.01.008, ISSN: 2666-6367.

Shouval R, Fein JA, Labopin M, Cho C, Bazarbachi A, Baron F, Bug G, Ciceri F, Corbacioglu S, Galimard JE, Giebel S, Gilleece MH, Giralt S, Jakubowski A, Montoto S, O'Reilly RJ, Papadopoulos EB, Peric Z, Ruggeri A, Sanz J, Sauter CS, Savani BN, Schmid C, Spyridonidis A, Tamari R, Versluis J, Yakoub-Agha I, Perales MA, Mohty M, Nagler A. Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry. Lancet Haematol. 2021 Mar; 8(3): e205-e215. PMID: 33636142, PII: S2352-3026(20)30394-X, DOI: 10.1016/S2352-3026(20)30394-X, ISSN: 2352-3026.

Hong S, Brazauskas R, Hebert KM, Ganguly S, Abdel-Azim H, Diaz MA, Beattie S, Ciurea SO, Szwajcer D, Badawy SM, Gratwohl AA, LeMaistre C, Aljurf MDSM, Olsson RF, Bhatt NS, Farhadfar N, Yared JA, Yoshimi A, Seo S, Gergis U, Beitinjaneh AM, Sharma A, Lazarus H, Law J, Ulrickson M, Hashem H, Schoemans H, Cerny J, Rizzieri D, Savani BN, Kamble RT, Shaw BE, Khera N, Wood WA, Hashmi S, Hahn T, Lee SJ, Rizzo JD, Majhail NS, Saber W. Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States. Cancer [print-electronic]. 2021 Feb 2/15/2021; 127(4): 609-18. PMID: 33085090, DOI: 10.1002/cncr.33232, ISSN: 1097-0142.

Patel DA, Mendoza KA, Chen H, Engelhardt BG, Savani BN, Goodman SA, Warner J, Kassim AA, Byrne M, Chinratanalab W, Greer JP, Hunt C, Jagasia M. Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplant. J Hematol [print-electronic]. 2021 Feb; 10(1): 35-9. PMID: 33643509, PMCID: PMC7891906, DOI: 10.14740/jh761, ISSN: 1927-1220.

Dholaria B, Labopin M, Angelucci E, Tischer J, Arat M, Ciceri F, Gülbas Z, Ozdogu H, Sica S, Diez-Martin JL, Koc Y, Pavlu J, Socié G, Giebel S, Savani BN, Nagler A, Mohty M. Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia. Transplant Cell Ther [print-electronic]. 2021 Feb; 27(2): 171.e1-171.e8. PMID: 33830029, PII: S2666-6367(20)30017-8, DOI: 10.1016/j.jtct.2020.10.008, ISSN: 2666-6367.

Carpenter PA, Papanicolaou G, Chemaly RF, Boeckh M, Savani BN. American Society for Transplantation and Cellular Therapy Infectious Disease Guidelines: Preface to the Series [editorial]. Transplant Cell Ther [print-electronic]. 2021 Feb; 27(2): 103-4. PMID: 33830021, PII: S2666-6367(20)30004-X, DOI: 10.1016/j.jtct.2020.10.004, ISSN: 2666-6367.

Giebel S, Labopin M, Sobczyk-Kruszelnicka M, Stelljes M, Byrne JL, Fegueux N, Beelen DW, Rovira M, Spyridonidis A, Blaise D, Bornhäuser M, Karadogan I, Savani BN, Nagler A, Mohty M, . Total body irradiation + fludarabine compared to busulfan + fludarabine as "reduced-toxicity conditioning" for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplant [print-electronic]. 2021 Feb; 56(2): 481-91. PMID: 32892216, PII: 10.1038/s41409-020-01050-7, DOI: 10.1038/s41409-020-01050-7, ISSN: 1476-5365.

Heinicke T, Labopin M, Polge E, Stelljes M, Ganser A, Tischer J, Brecht A, Kröger N, Beelen DW, Scheid C, Bethge W, Dreger P, Bunjes D, Wagner E, Platzbecker U, Savani BN, Nagler A, Mohty M. Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia - a study of the Acute Leukemia Working Party of the EBMT. Leuk Lymphoma [print-electronic]. 2021 Feb; 62(2): 399-409. PMID: 33040622, DOI: 10.1080/10428194.2020.1827248, ISSN: 1029-2403.

Nagler A, Labopin M, Dholaria B, Angelucci E, Afanasyev B, Cornelissen JJ, Sica S, Meijer E, Ciceri F, Van Gorkom G, Kröger N, Martin H, Pioltelli P, Risitano A, Canaani J, Savani BN, Sanz J, Mohty M. Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia. Clin Cancer Res [print-electronic]. 2021 Feb 2/1/2021; 27(3): 843-51. PMID: 33148668, PII: 1078-0432.CCR-20-2809, DOI: 10.1158/1078-0432.CCR-20-2809, ISSN: 1557-3265.

Cairo MS, Savani BN. Haematopoietic progenitor cell transplantation in adults with symptomatic sickle cell disease: the time has arrived. Br J Haematol [print-electronic]. 2021 Feb; 192(4): 678-80. PMID: 33482009, DOI: 10.1111/bjh.17309, ISSN: 1365-2141.

Patel DA, Mendoza KA, Chen H, Engelhardt BG, Savani BN, Goodman SA, Warner J, Kassim AA, Byrne M, Chinratanalab W, Greer JP, Hunt C, Jagasia M. Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplant. J Hematol [print-electronic]. 2021 Feb; 10(1): 35-9. PMID: 33643509, PMCID: PMC7891906, DOI: 10.14740/jh761, ISSN: 1927-1220.

Carpenter PA, Papanicolaou G, Chemaly RF, Boeckh M, Savani BN. American Society for Transplantation and Cellular Therapy Infectious Disease Guidelines: Preface to the Series [editorial]. Transplant Cell Ther [print-electronic]. 2021 Feb; 27(2): 103-4. PMID: 33830021, PII: S2666-6367(20)30004-X, DOI: 10.1016/j.jtct.2020.10.004, ISSN: 2666-6367.

Fuji S, Byrne M, Nagler A, Mohty M, Savani BN. How we can mitigate the side effects associated with systemic glucocorticoid after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant [print-electronic]. 2021 Jan 1/29/2021; PMID: 33514922, PII: 10.1038/s41409-020-01205-6, DOI: 10.1038/s41409-020-01205-6, ISSN: 1476-5365.

Bona K, Brazauskas R, He N, Lehmann L, Abdel-Azim H, Ahmed IA, Al-Homsi AS, Aljurf M, Arnold SD, Badawy SM, Battiwalla M, Beattie S, Bhatt NS, Dalal J, Dandoy CE, Diaz MA, Frangoul HA, Freytes CO, Ganguly S, George B, Gomez-Almaguer D, Hahn T, Kamble RT, Knight JM, LeMaistre CF, Law J, Lazarus HM, Majhail NS, Olsson RF, Preussler J, Savani BN, Schears R, Seo S, Sharma A, Srivastava A, Steinberg A, Szwajcer D, Wirk B, Yoshimi A, Khera N, Wood WA, Hashmi S, Duncan CN, Saber W. Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis. Blood. 2021 Jan 1/28/2021; 137(4): 556-68. PMID: 33104215, PMCID: PMC7845011, PII: S0006-4971(21)00157-9, DOI: 10.1182/blood.2020006252, ISSN: 1528-0020.

Cairo MS, Savani BN. Haematopoietic progenitor cell transplantation in adults with symptomatic sickle cell disease: the time has arrived. Br J Haematol [print-electronic]. 2021 Jan 1/22/2021; PMID: 33482009, DOI: 10.1111/bjh.17309, ISSN: 1365-2141.

Battipaglia G, Labopin M, Hamladji RM, Blaise D, Chevallier P, Brissot E, Gerbitz A, Socié G, Afanasyev B, Ciceri F, Meijer E, Koc Y, Cornelissen JJ, Huynh A, Ozdogu H, Maertens J, Paul F, Labussière-Wallet H, Ruggeri A, Aljurf M, Bazarbachi A, Savani B, Nagler A, Mohty M. Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Cancer [print-electronic]. 2021 Jan 1/15/2021; 127(2): 209-18. PMID: 33119152, DOI: 10.1002/cncr.33255, ISSN: 1097-0142.

Booth GS, Savani BN. The Intersection of Photopheresis and COVID-19 Vaccination. Transplant Cell Ther [print-electronic]. 2021 Jan 1/14/2021; PMID: 33462569, PMCID: PMC7807169, PII: S2666-6367(21)00009-9, DOI: 10.1016/j.jtct.2021.01.008, ISSN: 2666-6367.

Saraceni F, Labopin M, Forcade E, Kröger N, Socié G, Niittyvuopio R, Cornelissen JJ, Labussière-Wallet H, Blaise D, Choi G, Byrne JL, Guillerm G, Marchand T, Esteve J, Bazarbachi A, Savani B, Olivieri A, Nagler A, Mohty M. Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT). Cancer Med [print-electronic]. 2021 Jan; 10(1): 23-33. PMID: 33242374, DOI: 10.1002/cam4.3593, ISSN: 2045-7634.

Nagler A, Baron F, Labopin M, Polge E, Esteve J, Bazarbachi A, Brissot E, Bug G, Ciceri F, Giebel S, Gilleece MH, Gorin NC, Lanza F, Peric Z, Ruggeri A, Sanz J, Savani BN, Schmid C, Shouval R, Spyridonidis A, Versluis J, Mohty M. Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT. Bone Marrow Transplant [print-electronic]. 2021 Jan; 56(1): 218-24. PMID: 32724200, PII: 10.1038/s41409-020-01005-y, DOI: 10.1038/s41409-020-01005-y, ISSN: 1476-5365.

Dholaria B, Savani BN, Hamilton BK, Oran B, Liu HD, Tallman MS, Ciurea SO, Holtzman NG, Ii GLP, Devine SM, Mannis G, Grunwald MR, Appelbaum F, Rodriguez C, El Chaer F, Shah N, Hashmi SK, Kharfan-Dabaja MA, DeFilipp Z, Aljurf M, AlShaibani A, Inamoto Y, Jain T, Majhail N, Perales MA, Mohty M, Hamadani M, Carpenter PA, Nagler A. Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy. Transplant Cell Ther [print-electronic]. 2021 Jan; 27(1): 6-20. PMID: 32966881, PII: S1083-8791(20)30584-X, DOI: 10.1016/j.bbmt.2020.09.020.

Bazarbachi A, Schmid C, Labopin M, Beelen D, Wolfgang Blau I, Potter V, Niittyvuopio R, Socié G, Blaise D, Sanz J, Ciceri F, Abou Dalle I, Spyridonidis A, Bug G, Esteve J, Savani BN, Nagler A, Mohty M. Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years. Clin Cancer Res [print-electronic]. 2020 Dec 12/15/2020; 26(24): 6475-82. PMID: 32988970, PII: 1078-0432.CCR-20-3134, DOI: 10.1158/1078-0432.CCR-20-3134, ISSN: 1557-3265.

Bazarbachi AH, Al Hamed R, Labopin M, Halaburda K, Labussiere H, Bernasconi P, Schroyens W, Gandemer V, Schaap NPM, Loschi M, Jindra P, Snowden J, Wu D, Guffroy B, Rovira M, Chantepie SP, Poiré X, Lopez-Corral L, Nikolousis M, Pelosini M, Ciceri F, Baron F, Bazarbachi A, Corbacioglu S, Savani BN, Peric Z, Nagler A, Carreras E, Mohty M. Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party. Bone Marrow Transplant [print-electronic]. 2020 Nov 11/18/2020; PMID: 33208915, PII: 10.1038/s41409-020-01135-3, DOI: 10.1038/s41409-020-01135-3, ISSN: 1476-5365.

Nagler A, Labopin M, Dholaria B, Angelucci E, Afanasyev B, Cornelissen JJ, Sica S, Meijer E, Ciceri F, Van Gorkom G, Kröger N, Martin H, Pioltelli P, Risitano A, Canaani J, Savani BN, Sanz J, Mohty M. Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia. Clin Cancer Res [print-electronic]. 2020 Nov 11/4/2020; PMID: 33148668, PII: 1078-0432.CCR-20-2809, DOI: 10.1158/1078-0432.CCR-20-2809, ISSN: 1557-3265.

Nazha A, Hu ZH, Wang T, Lindsley RC, Abdel-Azim H, Aljurf M, Bacher U, Bashey A, Cahn JY, Cerny J, Copelan E, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla SM, Gale RP, George B, Gergis U, Grunwald MR, Hamilton B, Hashmi S, Hildebrandt GC, Inamoto Y, Kalaycio M, Kamble RT, Kharfan-Dabaja MA, Lazarus HM, Liesveld JL, Litzow MR, Majhail NS, Murthy HS, Nathan S, Nishihori T, Pawarode A, Rizzieri D, Sabloff M, Savani BN, Schachter L, Schouten HC, Seo S, Shah NN, Solh M, Valcárcel D, Vij R, Warlick E, Wirk B, Wood WA, Yared JA, Alyea E, Popat U, Sobecks RM, Scott BL, Nakamura R, Saber W. A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes. Biol Blood Marrow Transplant [print-electronic]. 2020 Nov; 26(11): 2139-46. PMID: 32781289, PMCID: PMC7609542, PII: S1083-8791(20)30471-7, DOI: 10.1016/j.bbmt.2020.08.003, ISSN: 1523-6536.

Bona K, Brazauskas R, He N, Lehmann LE, Abdel-Azim H, Ahmed I, Al-Homsi AS, Aljurf M, Arnold SD, Badawy SM, Battiwalla M, Beattie S, Bhatt NS, Dalal J, Dandoy CE, Diaz MA, Frangoul H, Freytes CO, Ganguly S, George B, Gomez-Almaguer D, Hahn T, Kamble R, Knight JM, LeMaistre CF, Law J, Lazarus HM, Majhail NS, Olsson RF, Preussler JM, Savani BN, Schears R, Seo S, Sharma A, Srivastava A, Steinberg A, Szwajcer D, Wirk B, Yoshimi A, Khera N, Wood WA, Hashmi S, Duncan C, Saber W. Neighborhood-Poverty and Pediatric Allogeneic Hematopoietic Cell Transplantation Outcomes: A CIBMTR Analysis. Blood [print-electronic]. 2020 Oct 10/26/2020; PMID: 33104215, PII: 469714, DOI: 10.1182/blood.2020006252, ISSN: 1528-0020.

Gupta V, Kim S, Hu ZH, Liu Y, Aljurf M, Bacher U, Beitinjaneh A, Cahn JY, Cerny J, Copelan E, Gadalla SM, Gale RP, Ganguly S, George B, Gerds AT, Gergis U, Hamilton BK, Hashmi S, Hildebrandt GC, Kamble RT, Kindwall-Keller T, Lazarus HM, Liesveld JL, Litzow M, Maziarz RT, Nishihori T, Olsson RF, Rizzieri D, Savani BN, Seo S, Solh M, Szer J, Verdonck LF, Wirk B, Woolfrey A, Yared JA, Alyea EP, Popat UR, Sobecks RM, Scott BL, Nakamura R, Saber W. Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS. Blood Adv. 2020 Oct 10/13/2020; 4(19): 4748-57. PMID: 33007075, PMCID: PMC7556156, PII: 463999, DOI: 10.1182/bloodadvances.2020002621, ISSN: 2473-9537.

Heinicke T, Labopin M, Polge E, Stelljes M, Ganser A, Tischer J, Brecht A, Kröger N, Beelen DW, Scheid C, Bethge W, Dreger P, Bunjes D, Wagner E, Platzbecker U, Savani BN, Nagler A, Mohty M. Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia - a study of the Acute Leukemia Working Party of the EBMT. Leuk Lymphoma [print-electronic]. 2020 Oct 10/11/2020; 1-11. PMID: 33040622, DOI: 10.1080/10428194.2020.1827248, ISSN: 1029-2403.

Bazarbachi A, Labopin M, Blaise D, Forcade E, Socié G, Berceanu A, Angelucci E, Bulabois CE, Kröger N, Rambaldi A, Ceballos P, Mielke S, El Cheikh J, Yakoub-Agha I, Savani B, Spyridonidis A, Nagler A, Mohty M. Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia. Bone Marrow Transplant [print-electronic]. 2020 Oct 10/6/2020; PMID: 33020591, PII: 10.1038/s41409-020-01074-z, DOI: 10.1038/s41409-020-01074-z, ISSN: 1476-5365.

Loke J, Labopin M, Craddock C, Niederwieser D, Cornelissen J, Afansayev B, Jindra P, Maertens J, Blaise D, Boriskina K, Gramatzki M, Ganser A, Savani B, Mohty M, Nagler A. Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT. Bone Marrow Transplant [print-electronic]. 2020 Oct 10/2/2020; PMID: 33009514, PII: 10.1038/s41409-020-01072-1, DOI: 10.1038/s41409-020-01072-1, ISSN: 1476-5365.

Bejanyan N, Zhang M, Bo-Subait K, Brunstein C, Wang H, Warlick ED, Giralt S, Nishihori T, Martino R, Passweg J, Dias A, Copelan E, Hale G, Gale RP, Solh M, Kharfan-Dabaja MA, Diaz MA, Ganguly S, Gore S, Verdonck LF, Hossain NM, Kekre N, Savani B, Byrne M, Kanakry C, Cairo MS, Ciurea S, Schouten HC, Bredeson C, Munker R, Lazarus H, Cahn JY, van Der Poel M, Rizzieri D, Yared JA, Freytes C, Cerny J, Aljurf M, Palmisiano ND, Pawarode A, Bacher VU, Grunwald MR, Nathan S, Wirk B, Hildebrandt GC, Seo S, Olsson RF, George B, de Lima M, Hourigan CS, Sandmaier BM, Litzow M, Kebriaei P, Saber W, Weisdorf D. Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study. Biol Blood Marrow Transplant [print-electronic]. 2020 Oct 10/1/2020; PMID: 33010430, PII: S1083-8791(20)30618-2, DOI: 10.1016/j.bbmt.2020.09.026, ISSN: 1523-6536.

Dholaria B, Savani BN, Hamilton BK, Oran B, Liu HD, Tallman MS, Ciurea SO, Holtzman NG, Ii GLP, Devine SM, Mannis G, Grunwald MR, Appelbaum F, Rodriguez C, El Chaer F, Shah N, Hashmi SK, Kharfan-Dabaja MA, DeFilipp Z, Aljurf M, AlShaibani A, Inamoto Y, Jain T, Majhail N, Perales MA, Mohty M, Hamadani M, Carpenter PA, Nagler A. Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy. Biol Blood Marrow Transplant [print-electronic]. 2020 Sep 9/20/2020; PMID: 32966881, PII: S1083-8791(20)30584-X, DOI: 10.1016/j.bbmt.2020.09.020.

Giebel S, Labopin M, Sobczyk-Kruszelnicka M, Stelljes M, Byrne JL, Fegueux N, Beelen DW, Rovira M, Spyridonidis A, Blaise D, Bornhäuser M, Karadogan I, Savani BN, Nagler A, Mohty M, . Total body irradiation + fludarabine compared to busulfan + fludarabine as "reduced-toxicity conditioning" for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplant [print-electronic]. 2020 Sep 9/5/2020; PMID: 32892216, PII: 10.1038/s41409-020-01050-7, DOI: 10.1038/s41409-020-01050-7, ISSN: 1476-5365.

Beksac M, Savani BN. Prognostic scoring system after transplantation in myeloma: predicting early relapse. Br. J. Haematol [print-electronic]. 2020 Jul 7/26/2020; PMID: 32712969, DOI: 10.1111/bjh.16986, ISSN: 1365-2141.

Rodríguez-Arboli E, Labopin M, Tischer J, Brecht A, Ganser A, Finke J, Blau IW, Kröger N, Kalhs P, Forcade E, Bunjes D, Spyridonidis A, Savani B, Nagler A, Mohty M. FLAMSA-based reduced intensity conditioning versus myeloablative conditioning in younger patients with relapsed/refractory acute myeloid leukemia with active disease at the time of allogeneic stem cell transplantation: an ALWP/EBMT analysis. Biol. Blood Marrow Transplant [print-electronic]. 2020 Jul 7/24/2020; PMID: 32717436, PII: S1083-8791(20)30451-1, DOI: 10.1016/j.bbmt.2020.07.020, ISSN: 1523-6536.

Zhou Z, Nath R, Cerny J, Wang HL, Zhang MJ, Abdel-Azim H, Agrawal V, Ahmed G, Al-Homsi AS, Aljurf M, Alkhateeb HB, Assal A, Bacher U, Bajel A, Bashir Q, Battiwalla M, Bhatt VR, Byrne M, Cahn JY, Cairo M, Choe H, Copelan E, Cutler C, Damlaj MB, DeFilipp Z, De Lima M, Diaz MA, Farhadfar N, Foran J, Freytes CO, Gerds AT, Gergis U, Grunwald MR, Gul Z, Hamadani M, Hashmi S, Hertzberg M, Hildebrandt GC, Hossain N, Inamoto Y, Isola L, Jain T, Kamble RT, Khan MW, Kharfan-Dabaja MA, Kebriaei P, Kekre N, Khera N, Lazarus HM, Liesveld JL, Litzow M, Liu H, Marks DI, Martino R, Mathews V, Mishra A, Murthy HS, Nagler A, Nakamura R, Nathan S, Nishihori T, Olin R, Olsson RF, Palmisiano N, Patel SS, Patnaik MM, Pawarode A, Perales MA, Politikos I, Popat U, Rizzieri D, Sandmaier BM, Savani BN, Seo S, Shah NN, Uy GL, Valcárcel D, Verdonck LF, Waller EK, Wang Y, Weisdorf D, Wirk B, Wong E, Yared JA, Saber W. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020 Jul 7/14/2020; 4(13): 3180-90. PMID: 32663298, PII: 461319, DOI: 10.1182/bloodadvances.2019001266, ISSN: 2473-9537.

Hu B, Lin X, Lee HC, Huang X, Tidwell RSS, Ahn KW, Hu ZH, Jabbour E, Verstovsek S, Ravandi F, Garcia-Manero G, Kharfan-Dabaja MA, Hossain NM, Marks DI, Kamble RT, Inamoto Y, Kindwall-Keller T, Saad A, Litzow MR, Savani BN, Hale GA, Bacher U, Gerds AT, Liesveld JL, Ustun C, Olsson RF, Daly A, Grunwald MR, Solh M, DeFilipp Z, Aljurf M, Wirk B, Akpek G, Nishihori T, Cerny J, Seo S, Hsu JW, Champlin R, de Lima M, Alyea E, Popat U, Sobecks R, Scott BL, Kantarjian H, Cortes J, Saber W. Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients. Leuk. Lymphoma [print-electronic]. 2020 Jul 7/14/2020; 1-10. PMID: 32662346, DOI: 10.1080/10428194.2020.1783444, ISSN: 1029-2403.

Dholaria B, Labopin M, Angelucci E, Ciceri F, Diez-Martin JL, Bruno B, Sica S, Koc Y, Gülbas Z, Schmid C, Blaise D, Carella AM, Visani G, Savani BN, Nagler A, Mohty M. Impact of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning on Outcomes of Haploidentical Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia. Am. J. Hematol [print-electronic]. 2020 Jul 7/13/2020; PMID: 32656791, DOI: 10.1002/ajh.25934, ISSN: 1096-8652.

Bar M, Ott SM, Lewiecki EM, Sarafoglou K, Wu JY, Thompson MJ, Vaux JJ, Dean DR, Saag KG, Hashmi SK, Inamoto Y, Dholaria BR, Kharfan-Dabaja MA, Nagler A, Rodriguez C, Hamilton BK, Shah N, Flowers MED, Savani BN, Carpenter PA. Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. Biol. Blood Marrow Transplant [print-electronic]. 2020 Jul 7/9/2020; PMID: 32653624, PII: S1083-8791(20)30410-9, DOI: 10.1016/j.bbmt.2020.07.001.

Brissot E, Labopin M, Moiseev I, Cornelissen JJ, Meijer E, Van Gorkom G, Rovira M, Ciceri F, Griskevicius L, Blaise D, Forcade E, Mistrik M, Mielke S, Bulabois CE, Niittyvuopio R, Deconinck E, Ruggeri A, Sanz J, Spyridonidis A, Savani B, Giebel S, Nagler A, Mohty M. Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors. J Hematol Oncol. 2020 Jul 7/3/2020; 13(1): 87. PMID: 32620146, PMCID: PMC7333262, PII: 10.1186/s13045-020-00923-0, DOI: 10.1186/s13045-020-00923-0, ISSN: 1756-8722.

Gilleece MH, Savani BN. A stitch in time saves nine… MRD-based pre-emptive therapy. Br. J. Haematol [print-electronic]. 2020 Jun 6/30/2020; PMID: 32602941, DOI: 10.1111/bjh.16913, ISSN: 1365-2141.

Shouval R, Fein JA, Savani B, Mohty M, Nagler A. Machine learning and artificial intelligence in haematology. Br. J. Haematol [print-electronic]. 2020 Jun 6/30/2020; PMID: 32602593, DOI: 10.1111/bjh.16915, ISSN: 1365-2141.

Gilleece MH, Savani BN. A stitch in time saves nine… MRD-based pre-emptive therapy. Br. J. Haematol [print-electronic]. 2020 Jun 6/30/2020; PMID: 32602941, DOI: 10.1111/bjh.16913, ISSN: 1365-2141.

Nagler A, Dholaria B, Labopin M, Bruno B, Rambaldi A, Pioltelli P, La Nasa G, Socié G, Mielke S, Ruggeri M, Saccardi R, Franke GN, Finke J, Savani BN, Ruggeri A, Mohty M. The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study. Bone Marrow Transplant [print-electronic]. 2020 Jun 6/19/2020; PMID: 32561816, PII: 10.1038/s41409-020-0974-6, DOI: 10.1038/s41409-020-0974-6, ISSN: 1476-5365.

Brissot E, Labopin M, Baron F, Bazarbachi A, Bug G, Ciceri F, Esteve J, Giebel S, Gilleece MH, Gorin NC, Lanza F, Peric Z, Ruggeri A, Sanz J, Savani BN, Schmid C, Shouval R, Spyridonidis A, Versluis J, Nagler A, Mohty M. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant [print-electronic]. 2020 Jun 6/11/2020; PMID: 32528122, PMCID: PMC7289070, PII: 10.1038/s41409-020-0970-x, DOI: 10.1038/s41409-020-0970-x, ISSN: 1476-5365.

Dupuis LL, Quinones CM, Ritchie J, Carpenter PA, Bauters T, Yeh RF, Anasetti C, Boelens JJ, Hamerschlak N, Hassan M, Kang HJ, Kanda Y, Paci A, Perales MA, Shaw PJ, Seewaldt VL, Savani BN, Militano O, Pulsipher MA, McCune JS. Response to Kawedia et al Letter to Editor in Response to the Article by McCune Et Al "Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement" [letter]. Biol. Blood Marrow Transplant [print-electronic]. 2020 Jun 6/9/2020; PMID: 32531439, PII: S1083-8791(20)30348-7, DOI: 10.1016/j.bbmt.2020.06.001, ISSN: 1523-6536.

Farhadfar N, Murthy HS, Logan BR, Sees JA, Ayas M, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossmann S, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR. Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis. Bone Marrow Transplant [print-electronic]. 2020 Jun 6/8/2020; PMID: 32514157, PII: 10.1038/s41409-020-0963-9, DOI: 10.1038/s41409-020-0963-9, ISSN: 1476-5365.

Gehrie EA, Savani BN, Booth GS. Risk factors for hemolytic transfusion reactions resulting from ABO and minor red cell antigen incompatibility: From mislabeled samples to stem cell transplant and sickle cell disease. Blood Rev [print-electronic]. 2020 Jun 6/6/2020; 100719. PMID: 32561028, PII: S0268-960X(20)30069-2, DOI: 10.1016/j.blre.2020.100719, ISSN: 1532-1681.

Mohty M, Nagler A, Savani B. Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No Other [editorial]. Clin Hematol Int. 2020 Jun; 2(2): 41-2. PMID: 34595442, PMCID: PMC8432345, PII: CHI-2-2-41, DOI: 10.2991/chi.d.200506.001, ISSN: 2590-0048.

Byrne M, Savani B, Copelan E. Improving the Odds [editorial]. Biol. Blood Marrow Transplant [print-electronic]. 2020 May 5/14/2020; PMID: 32417492, PII: S1083-8791(20)30228-7, DOI: 10.1016/j.bbmt.2020.04.017, ISSN: 1523-6536.

Kahn JM, Brazauskas R, Tecca HR, Bo-Subait S, Buchbinder D, Battiwala M, Flowers MED, Savani BN, Phelan R, Broglie L, Abraham AA, Keating AK, Daly A, Wirk B, George B, Alter BP, Ustun C, Freytes CO, Beitinjaneh AM, Duncan C, Copelan E, Hildebrandt GC, Murthy HS, Lazarus HM, Auletta JJ, Myers KC, Williams KM, Page KM, Vrooman LM, Norkin M, Byrne M, Diaz MA, Kamani N, Bhatt NS, Rezvani A, Farhadfar N, Mehta PA, Hematti P, Shaw PJ, Kamble RT, Schears R, Olsson RF, Hayashi RJ, Gale RP, Mayo SJ, Chhabra S, Rotz SJ, Badawy SM, Ganguly S, Pavletic S, Nishihori T, Prestidge T, Agrawal V, Hogan WJ, Inamoto Y, Shaw BE, Satwani P. Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. Blood Adv. 2020 May 5/12/2020; 4(9): 2084-94. PMID: 32396620, PMCID: PMC7218429, PII: 455057, DOI: 10.1182/bloodadvances.2019000839, ISSN: 2473-9537.

Gowin K, Ballen K, Ahn KW, Hu ZH, Ali H, Arcasoy MO, Devlin R, Coakley M, Gerds AT, Green M, Gupta V, Hobbs G, Jain T, Kandarpa M, Komrokji R, Kuykendall AT, Luber K, Masarova L, Michaelis LC, Patches S, Pariser AC, Rampal R, Stein B, Talpaz M, Verstovsek S, Wadleigh M, Agrawal V, Aljurf M, Angel Diaz M, Avalos BR, Bacher U, Bashey A, Beitinjaneh AM, Cerny J, Chhabra S, Copelan E, Cutler CS, DeFilipp Z, Gadalla SM, Ganguly S, Grunwald MR, Hashmi SK, Kharfan-Dabaja MA, Kindwall-Keller T, Kröger N, Lazarus HM, Liesveld JL, Litzow MR, Marks DI, Nathan S, Nishihori T, Olsson RF, Pawarode A, Rowe JM, Savani BN, Savoie ML, Seo S, Solh M, Tamari R, Verdonck LF, Yared JA, Alyea E, Popat U, Sobecks R, Scott BL, Nakamura R, Mesa R, Saber W. Survival following allogeneic transplant in patients with myelofibrosis. Blood Adv. 2020 May 5/12/2020; 4(9): 1965-73. PMID: 32384540, PMCID: PMC7218417, PII: 454866, DOI: 10.1182/bloodadvances.2019001084, ISSN: 2473-9537.

Nagler A, Dholaria B, Labopin M, Savani BN, Angelucci E, Koc Y, Arat M, Pioltelli P, Sica S, Gülbas Z, Tischer J, Bernasconi P, Pavlu J, Socié G, Blaise D, Rigacci L, Martino M, Diez-Martin JL, Peric Z, Giebel S, Mohty M. Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia. Leukemia [print-electronic]. 2020 May 5/11/2020; PMID: 32393841, PII: 10.1038/s41375-020-0850-9, DOI: 10.1038/s41375-020-0850-9, ISSN: 1476-5551.

Byrne M, Danielson N, Sengsayadeth S, Rasche A, Culos K, Gatwood K, Wyatt H, Chinratanalab W, Dholaria B, Ferrell PB, Fogo K, Goodman S, Jagasia M, Jayani R, Kassim A, Mohan SR, Savani BN, Strickland SA, Engelhardt BG, Savona M. The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia. Am. J. Hematol [print-electronic]. 2020 May 5/10/2020; PMID: 32390196, DOI: 10.1002/ajh.25859, ISSN: 1096-8652.

Sanz J, Galimard JE, Labopin M, Afanasyev B, Angelucci E, Ciceri F, Blaise D, Cornelissen JJ, Meijer E, Diez-Martin JL, Koc Y, Rovira M, Castagna L, Savani B, Ruggeri A, Nagler A, Mohty M, . Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT. J Hematol Oncol. 2020 May 5/6/2020; 13(1): 46. PMID: 32375860, PMCID: PMC7201995, PII: 10.1186/s13045-020-00882-6, DOI: 10.1186/s13045-020-00882-6, ISSN: 1756-8722.

Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Agrawal V, Ahmed I, Al-Homsi AS, Aljurf M, Antin JH, Askar M, Auletta JJ, Bhatt VR, Chee L, Chhabra S, Daly A, DeFilipp Z, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Hogan WJ, Inamoto Y, Martino R, Majhail NS, Marks DI, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Rangarajan HG, Ringden O, Saad A, Savani BN, Schoemans H, Seo S, Schultz KR, Solh M, Spitzer T, Storek J, Teshima T, Verdonck LF, Wirk B, Yared JA, Cahn JY, Weisdorf DJ. Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT. J. Clin. Oncol [print-electronic]. 2020 May 5/4/2020; JCO1900396. PMID: 32364845, DOI: 10.1200/JCO.19.00396, ISSN: 1527-7755.

Farhadfar N, Murthy HS, Logan BR, Sees JA, Mouhab A, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossman SN, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR. Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis. Bone Marrow Transplant [print-electronic]. 2020 Apr 4/30/2020; PMID: 32355289, PII: 10.1038/s41409-020-0911-8, DOI: 10.1038/s41409-020-0911-8, ISSN: 1476-5365.

Nagler A, Kanate AS, Labopin M, Ciceri F, Angelucci E, Koc Y, Gülbas Z, Arcese W, Tischer J, Pioltelli P, Ozdogu H, Afanasyev B, Wu D, Arat M, Peric Z, Giebel S, Savani B, Mohty M. Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia. Haematologica [print-electronic]. 2020 Apr 4/30/2020; PMID: 32354866, PII: haematol.2020.247296, DOI: 10.3324/haematol.2020.247296, ISSN: 1592-8721.

Mohty M, Dulery R, Gauthier J, Malard F, Brissot E, Aljurf M, Bazarbachi A, Chabanon C, Kharfan-Dabaja MA, Savani BN, Huang H, Kenderian SS, Perales MA, Yakoub-Agha I, Nagler A. CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview. Bone Marrow Transplant [print-electronic]. 2020 Apr 4/18/2020; PMID: 32305998, PII: 10.1038/s41409-020-0892-7, DOI: 10.1038/s41409-020-0892-7, ISSN: 1476-5365.

Dholaria B, Malki MMA, Artz A, Savani BN. Securing the Graft during Pandemic: Are We Ready for Cryopreservation for All?. Biol. Blood Marrow Transplant [print-electronic]. 2020 Apr 4/17/2020; PMID: 32305358, PMCID: PMC7162777, PII: S1083-8791(20)30219-6, DOI: 10.1016/j.bbmt.2020.04.009, ISSN: 1523-6536.

Maffini E, Labopin M, Blaise D, Ciceri F, Gülbas Z, Deconinck E, Leblond V, Chevallier P, Sociè G, Araujo MC, Koc Y, Savani BN, Gorin NC, Lanza F, Nagler A, Mohty M. CD34+ cell dose effects on clinical outcomes after T-cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation (EBMT). Am. J. Hematol [print-electronic]. 2020 Apr 4/17/2020; PMID: 32303111, DOI: 10.1002/ajh.25826, ISSN: 1096-8652.

Bazarbachi A, Bug G, Baron F, Brissot E, Ciceri F, Abou Dalle I, Döhner H, Esteve J, Floisand Y, Giebel S, Gilleece M, Gorin NC, Jabbour E, Aljurf M, Kantarjian H, Kharfan Dabaja M, Labopin M, Lanza F, Malard F, Peric Z, Prebet T, Ravandi F, Ruggeri A, Sanz J, Schmid C, Shouval R, Spyridonidis A, Versluis J, Vey N, Savani BN, Nagler A, Mohty M. Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3 internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica [print-electronic]. 2020 Apr 4/2/2020; PMID: 32241850, PII: haematol.2019.243410, DOI: 10.3324/haematol.2019.243410, ISSN: 1592-8721.

Reddy OL, Savani BN, Stroncek DF, Panch SR. Advances in gene therapy for hematologic disease and considerations for transfusion medicine. Semin Hematol [print-electronic]. 2020 Apr; 57(2): 83-91. PMID: 32892847, PII: S0037-1963(20)30022-6, DOI: 10.1053/j.seminhematol.2020.07.004, ISSN: 1532-8686.

Panch S, Savani BN, Stroncek D. Transfusion support in patients with hematologic disease: Transfusions in special clinical circumstances [editorial]. Semin Hematol [print-electronic]. 2020 Apr; 57(2): 31-2. PMID: 32892840, PII: S0037-1963(20)30005-6, DOI: 10.1053/j.seminhematol.2020.06.002, ISSN: 1532-8686.

Baron F, Savani BN. Graft-versus-host-disease does not help acute lymphoblastic leukaemia patients with measurable residual disease. Br. J. Haematol [print-electronic]. 2020 Mar 3/17/2020; PMID: 32181881, DOI: 10.1111/bjh.16570, ISSN: 1365-2141.

Dholaria B, Savani BN. How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat?. Br. J. Haematol [print-electronic]. 2020 Mar 3/16/2020; PMID: 32180224, DOI: 10.1111/bjh.16597, ISSN: 1365-2141.

Kanate AS, Majhail NS, Savani BN, Bredeson C, Champlin RE, Crawford S, Giralt SA, LeMaistre CF, Marks DI, Omel JL, Orchard PJ, Palmer J, Saber W, Veys PA, Carpenter PA, Hamadani M. Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy: Guidelines for Hematopoietic Transplantation and Cellular Therapy. Biol. Blood Marrow Transplant [print-electronic]. 2020 Mar 3/9/2020; PMID: 32165328, PII: S1083-8791(20)30114-2, DOI: 10.1016/j.bbmt.2020.03.002, ISSN: 1523-6536.

Spyridonidis A, Labopin M, Savani BN, Niittyvuopio R, Blaise D, Craddock C, Socié G, Platzbecker U, Beelen D, Milpied N, Cornelissen JJ, Ganser A, Huynh A, Griskevicius L, Giebel S, Aljurf M, Brissot E, Malard F, Esteve J, Peric Z, Baron F, Ruggeri A, Schmid C, Gilleece M, Gorin NC, Lanza F, Shouval R, Versluis J, Bug G, Fløisand Y, Ciceri F, Sanz J, Bazarbachi A, Nagler A, Mohty M. Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients. Bone Marrow Transplant [print-electronic]. 2020 Mar 3/6/2020; PMID: 32144364, PII: 10.1038/s41409-020-0835-3, DOI: 10.1038/s41409-020-0835-3, ISSN: 1476-5365.

Baskett J, Culos KA, Satyanarayana G, Patel D, Engelhardt B, Savani B, Jagasia M, Kassim AA, Gatwood KS. Risk factors associated with early viral reactivation following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: a pilot study [letter]. Ann. Hematol [print-electronic]. 2020 Mar 3/6/2020; PMID: 32140894, PII: 10.1007/s00277-020-03972-0, DOI: 10.1007/s00277-020-03972-0, ISSN: 1432-0584.

Schmaelter AK, Labopin M, Socié G, Itälä-Remes M, Blaise D, Yakoub-Agha I, Forcade E, Cornelissen J, Ganser A, Beelen D, Labussière-Wallet H, Passweg J, Savani BN, Schmid C, Nagler A, Mohty M. Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia. Blood Cancer J. 2020 Mar 3/3/2020; 10(3): 26. PMID: 32127519, PII: 10.1038/s41408-020-0296-3, DOI: 10.1038/s41408-020-0296-3, ISSN: 2044-5385.

Mohty M, Nagler A, Savani B. Looking Ahead: Clinical Hematology International Turns One [editorial]. Clin Hematol Int. 2020 Mar; 2(1): 1. PMID: 34595435, PMCID: PMC8432340, PII: CHI-2-1-1, DOI: 10.2991/chi.d.200121.001, ISSN: 2590-0048.

Kanate AS, Nagler A, Savani B. Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell Transplantation. Clin Hematol Int. 2020 Mar; 2(1): 2-4. PMID: 34595436, PMCID: PMC8432337, PII: CHI-2-1-2, DOI: 10.2991/chi.d.191207.001, ISSN: 2590-0048.

Muhsen IN, Bar M, Savani BN, Estey EH, Hashmi SK. Follow-up issues in survivors of hematologic malignancies - Current stance and future perspectives. Blood Rev [print-electronic]. 2020 Feb 2/26/2020; 100674. PMID: 32199685, PII: S0268-960X(20)30024-2, DOI: 10.1016/j.blre.2020.100674, ISSN: 1532-1681.

Farhadfar N, Hsu JW, Logan BR, Sees JA, Chitphakdithai P, Sugrue MW, Abdel-Azim H, Anderlini PN, Bredeson C, Chhabra S, Diaz MA, Ganguly S, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Lynch DK, Murthy HS, Olsson RF, Papari M, Przepiorka D, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Yared JA, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR. Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield. Blood Adv. 2020 Feb 2/25/2020; 4(4): 706-16. PMID: 32092138, PMCID: PMC7042992, PII: 452531, DOI: 10.1182/bloodadvances.2019000923, ISSN: 2473-9537.

Hsu JW, Shaw BE, Kim S, Logan BR, Sees JA, Confer DL, Pulsipher MA, Shah N, Switzer GE, Abidi MH, Ahmed IA, Anderlini PN, Bredseon C, Chhabra S, Dandoy CE, Diaz MA, Farhadfar N, Ganguly S, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Olsson RF, Savani BN, Schears R, Seo S, Solh M, Spitzer T, Steinberg A, Sugure M, Warkentin P, Wingard JR. Collection of Peripheral Blood Progenitor Cells in One Day is Associated with Decreased Donor Toxicity compared to Two Days in Unrelated Donors. Biol. Blood Marrow Transplant [print-electronic]. 2020 Feb 2/20/2020; PMID: 32088366, PII: S1083-8791(20)30096-3, DOI: 10.1016/j.bbmt.2020.02.011, ISSN: 1523-6536.

Jagadeesh D, Majhail NS, He Y, Ahn KW, Litovich C, Ahmed S, Aljurf M, Bacher U, Badawy SM, Bejanyan N, Cairo M, Cerny J, Epperla N, Farhadfar N, Freytes CO, Gale RP, Haverkos B, Hossain N, Inwards D, Kamble RT, Kenkre VP, Lazarus HM, Lazaryan A, Lekakis L, Mei M, Murthy HS, Mussetti A, Nathan S, Nishihori T, Olsson RF, Ramakrishnan Geethakumari P, Savani BN, Yared JA, Fenske TS, Kharfan-Dabaja MA, Sureda A, Hamadani M. Outcomes of Rituximab-BEAM Versus BEAM Conditioning Regimen in Patients With Diffuse Large B Cell Lymphoma Undergoing Autologous Transplantation. Cancer [print-electronic]. 2020 Feb 2/12/2020; PMID: 32049359, DOI: 10.1002/cncr.32752, ISSN: 1097-0142.

Spyridonidis A, Labopin M, Savani BN, Niittyvuopio R, Blaise D, Craddock C, Socié G, Platzbecker U, Beelen D, Milpied N, Cornelissen JJ, Ganser A, Huynh A, Griskevicius L, Giebel S, Brissot E, Malard F, Esteve J, Peric Z, Baron F, Ruggeri A, Schmid C, Gilleece M, Gorin NC, Lanza F, Shouval R, Versluis J, Bug G, Fløisand Y, Ciceri F, Sanz J, Bazarbachi A, Nagler A, Mohty M. Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients. Bone Marrow Transplant [print-electronic]. 2020 Jan 1/29/2020; PMID: 31996792, PII: 10.1038/s41409-020-0803-y, DOI: 10.1038/s41409-020-0803-y, ISSN: 1476-5365.

Patel DA, Gopalakrishnan R, Engelhardt BG, McArthur E, Sengsayadeth S, Culos KA, Byrne M, Goodman S, Savani BN, Chinratanalab W, Jagasia M, Mosse CA, Cornell RF, Kassim AA. Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma. Bone Marrow Transplant [print-electronic]. 2020 Jan 1/28/2020; PMID: 31992845, PII: 10.1038/s41409-020-0791-y, DOI: 10.1038/s41409-020-0791-y, ISSN: 1476-5365.

El-Cheikh J, Labopin M, Al-Chami F, Bazarbachi A, Angelucci E, Santarone S, Bonifazi F, Carella AM, Castagna L, Bruno B, Iori AP, La Nasa G, Savani B, Nagler A, Mohty M. Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party. Clin Lymphoma Myeloma Leuk [print-electronic]. 2020 Jan 1/27/2020; PMID: 32081702, PII: S2152-2650(20)30044-6, DOI: 10.1016/j.clml.2020.01.007, ISSN: 2152-2669.

Fuji S, Nagler A, Mohty M, Savani B, Shouval R. Decision-analytic modeling as a tool for selecting optimal therapy incorporating hematopoietic stem cell transplantation in patients with hematological malignancy. Bone Marrow Transplant [print-electronic]. 2020 Jan 1/13/2020; PMID: 31932655, PII: 10.1038/s41409-020-0784-x, DOI: 10.1038/s41409-020-0784-x, ISSN: 1476-5365.

Eplin DD, Jackson AD, Smith AM, Salvig B, Chinratanalab W, Savani BN. Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation. Clin Hematol Int. 2019 Dec; 1(4): 229-33. PMID: 34595434, PMCID: PMC8432370, PII: CHI-1-4-229, DOI: 10.2991/chi.d.191008.001, ISSN: 2590-0048.

Matthews J, Eplin D, Savani B, Leon BGC, Matheny L. Managing Endocrine Disorders in Adults After Hematopoietic Stem Cell Transplantation. Clin Hematol Int. 2019 Dec; 1(4): 180-8. PMID: 34595429, PMCID: PMC8432373, PII: CHI-1-4-180, DOI: 10.2991/chi.d.190917.001, ISSN: 2590-0048.

Eplin DD, Jackson AD, Smith AM, Salvig B, Chinratanalab W, Savani BN. Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation. Clin Hematol Int. 2019 Dec; 1(4): 229-33. PMID: 34595434, PMCID: PMC8432370, PII: CHI-1-4-229, DOI: 10.2991/chi.d.191008.001, ISSN: 2590-0048.

Nagler A, Dholaria B, Labopin M, Socie G, Huynh A, Itälä-Remes M, Deconinck E, Yakoub-Agha I, Cahn JY, Bourhis JH, Labussière-Wallet H, Chantepie S, Esteve J, Savani B, Mohty M. The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation. Leukemia [print-electronic]. 2019 Nov 11/14/2019; PMID: 31728052, PII: 10.1038/s41375-019-0631-5, DOI: 10.1038/s41375-019-0631-5, ISSN: 1476-5551.

Shouval R, Fein JA, Labopin M, Bazarbachi A, Baron F, Bug G, Ciceri F, Corbacioglu S, Giebel S, Gilleece MH, Montoto S, Peric Z, Polge E, Ruggeri A, Sanz J, Savani BN, Schmid C, Spyridonidis A, Versluis J, Yakoub-Agha I, Mohty M, Nagler A. The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation. Blood. 2019 Nov 11/13/2019; 134(Supplement_1): 43. PMID: 31724016, PII: 427838, DOI: 10.1182/blood-2019-123310, ISSN: 1528-0020.

Buchbinder D, Brazauskas R, Bo-Subait K, Ballen K, Parsons S, John T, Hahn T, Sharma A, Steinberg A, D'Souza A, Kumar A, Yoshimi A, Wirk B, Shaw B, Freytes C, LeMaistre C, Bredeson C, Dandoy C, Almaguer D, Marks DI, Szwajcer D, Hale G, Schouten H, Hashem H, Schoemans H, Murthy HS, Lazarus HM, Cerny J, Tay J, Yared JA, Adekola K, Schultz KR, Lehmann L, Burns L, Aljurf M, Diaz MA, Majhail N, Farhadfar N, Kamble R, Olsson R, Schears R, Seo S, Beattie S, Chhabra S, Savani BN, Badawy S, Ganguly S, Ciurea S, Marino S, Gergis U, Kuwatsuka Y, Inamoto Y, Khera N, Hashmi S, Wood W, Saber W. Predictors of lost to follow-up among pediatric and adult hematopoietic cell transplant survivors: A report from the Center for International Blood and Marrow Transplant Research. Biol. Blood Marrow Transplant [print-electronic]. 2019 Nov 11/11/2019; PMID: 31726205, PII: S1083-8791(19)30743-8, DOI: 10.1016/j.bbmt.2019.11.003, ISSN: 1523-6536.

Dholaria B, Savani BN. Allogeneic haematopoietic cell transplantation after CAR T-cell therapy: safe, effective and contentious [editorial]. Br. J. Haematol [print-electronic]. 2019 Nov 11/8/2019; PMID: 31702832, DOI: 10.1111/bjh.16262, ISSN: 1365-2141.

Mohty M, Gautier J, Malard F, Aljurf M, Bazarbachi A, Chabannon C, Kharfan-Dabaja MA, Savani BN, Huang H, Kenderian S, Nagler A, Perales MA. CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives. Leukemia [print-electronic]. 2019 Nov 11/5/2019; PMID: 31690821, PII: 10.1038/s41375-019-0615-5, DOI: 10.1038/s41375-019-0615-5, ISSN: 1476-5551.

Kansagra AJ, Frey NV, Bar M, Laetsch TW, Carpenter PA, Savani BN, Heslop HE, Bollard CM, Komanduri KV, Gastineau DA, Chabannon C, Perales MA, Hudecek M, Aljurf M, Andritsos L, Barrett JA, Bachanova V, Bonini C, Ghobadi A, Gill SI, Hill JA, Kenderian S, Kebriaei P, Nagler A, Maloney D, Liu HD, Shah NN, Kharfan-Dabaja MA, Shpall EJ, Mufti GJ, Johnston L, Jacoby E, Bazarbachi A, DiPersio JF, Pavletic SZ, Porter DL, Grupp SA, Sadelain M, Litzow MR, Mohty M, Hashmi SK. Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT). Bone Marrow Transplant [print-electronic]. 2019 Nov; 54(11): 1868-80. PMID: 31092900, PII: 10.1038/s41409-019-0451-2, DOI: 10.1038/s41409-019-0451-2, ISSN: 1476-5365.

Adkins BD, Savani BN, Booth GS. Transgender individuals represent an overlooked population amongst stem cell donors [editorial]. Bone Marrow Transplant [print-electronic]. 2019 Nov; 54(11): 1721-2. PMID: 30659243, PII: 10.1038/s41409-019-0437-0, DOI: 10.1038/s41409-019-0437-0, ISSN: 1476-5365.

DeFilipp Z, Ancheta R, Liu Y, Hu ZH, Gale RP, Snyder D, Schouten HC, Kalaycio M, Hildebrandt GC, Ustun C, Daly A, Ganguly S, Inamoto Y, Litzow M, Szer J, Savoie ML, Hossain N, Kharfan-Dabaja MA, Hamadani M, Reshef R, Bajel A, Schultz KR, Gadalla S, Gerds A, Liesveld J, Juckett MB, Kamble R, Hashmi S, Abdel-Azim H, Solh M, Bacher U, Lazarus H, Olsson R, Cahn JY, Grunwald MR, Savani BN, Yared J, Rowe JM, Cerny J, Chaudhri NA, Aljurf M, Beitinjaneh A, Seo S, Nishihori T, Hsu JW, Ramanathan M, Alyea E, Popat U, Sobecks R, Saber W. Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study. Biol. Blood Marrow Transplant [print-electronic]. 2019 Oct 10/25/2019; PMID: 31669399, PII: S1083-8791(19)30674-3, DOI: 10.1016/j.bbmt.2019.10.017, ISSN: 1523-6536.

Heinicke T, Labopin M, Polge E, Niederwieser D, Platzbecker U, Sengelov H, Choi G, Cornelissen J, Blaise D, Kuball J, van Gorkom G, Schaap N, Potter V, Paul F, Savani BN, Nagler A, Mohty M. Fludarabine/busulfan versus fludarabine/total-body-irradiation (2¿Gy) as conditioning prior to allogeneic stem cell transplantation in patients (=60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT. Bone Marrow Transplant [print-electronic]. 2019 Oct 10/23/2019; PMID: 31645668, PII: 10.1038/s41409-019-0720-0, DOI: 10.1038/s41409-019-0720-0, ISSN: 1476-5365.

Bejanyan N, Kim S, Hebert KM, Kekre N, Abdel-Azim H, Ahmed I, Aljurf M, Badawy SM, Beitinjaneh A, Boelens JJ, Diaz MA, Dvorak CC, Gadalla S, Gajewski J, Gale RP, Ganguly S, Gennery AR, George B, Gergis U, Gómez-Almaguer D, Vicent MG, Hashem H, Kamble RT, Kasow KA, Lazarus HM, Mathews V, Orchard PJ, Pulsipher M, Ringden O, Schultz K, Teira P, Woolfrey AE, Saldaña BD, Savani B, Winiarski J, Yared J, Weisdorf DJ, Antin JH, Eapen M. Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia. Blood Adv. 2019 Oct 10/22/2019; 3(20): 3123-31. PMID: 31648332, PII: 422500, DOI: 10.1182/bloodadvances.2019000722, ISSN: 2473-9537.

Baron F, Labopin M, Savani BN, Beohou E, Niederwieser D, Eder M, Potter V, Kröger N, Beelen D, Socié G, Itälä-Remes M, Bornhäuser M, Mohty M, Nagler A. Graft-versus-host disease and graft-versus-leukaemia effects in secondary acute myeloid leukaemia: a retrospective, multicentre registry analysis from the Acute Leukaemia Working Party of the EBMT. Br. J. Haematol [print-electronic]. 2019 Oct 10/14/2019; PMID: 31612473, DOI: 10.1111/bjh.16185, ISSN: 1365-2141.

Mohty M, Malard F, Abecasis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Basak G, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Kuball J, Lachance S, Lazarus H, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Saber W, Savani BN, Soiffer R, Styczynski J, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E. Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group. Bone Marrow Transplant [print-electronic]. 2019 Oct 10/1/2019; PMID: 31576023, PII: 10.1038/s41409-019-0705-z, DOI: 10.1038/s41409-019-0705-z, ISSN: 1476-5365.

Giebel S, Boumendil A, Labopin M, Seesaghur A, Baron F, Ciceri F, Esteve J, Gorin NC, Savani B, Schmid C, Wetten S, Mohty M, Nagler A. Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Ann. Hematol [print-electronic]. 2019 Oct; 98(10): 2389-98. PMID: 31392462, PMCID: PMC6733814, PII: 10.1007/s00277-019-03771-2, DOI: 10.1007/s00277-019-03771-2, ISSN: 1432-0584.

Naik S, Riches M, Hari P, Kim S, Chen M, Bachier C, Shaughnessy P, Hill J, Ljungman P, Battiwalla M, Chhabra S, Daly A, Storek J, Ustun C, Diaz MA, Cerny J, Beitinjaneh A, Yared J, Brown V, Page K, Dahi PB, Ganguly S, Seo S, Chao N, Freytes CO, Saad A, Savani BN, Woo Ahn K, Boeckh M, Heslop HE, Lazarus HM, Auletta JJ, Kamble RT. Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study. Transpl Infect Dis [print-electronic]. 2019 Oct; 21(5): e13145. PMID: 31301099, DOI: 10.1111/tid.13145, ISSN: 1399-3062.

Ringdén O, Boumendil A, Labopin M, Canaani J, Beelen D, Ehninger G, Niederwieser D, Finke J, Stelljes M, Gerbitz A, Ganser A, Kröger N, Kantz L, Brecht A, Savani B, Sadeghi B, Mohty M, Nagler A. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2019 Oct; 25(10): 1975-83. PMID: 31181255, PII: S1083-8791(19)30362-3, DOI: 10.1016/j.bbmt.2019.05.037, ISSN: 1523-6536.

Panch SR, Savani BN, Stroncek DF. Transfusion Support in Patients with Hematologic Disease: New and Novel Transfusion Modalities [editorial]. Semin. Hematol. 2019 Oct; 56(4): 227-8. PMID: 31836027, PMCID: PMC6917036, PII: S0037-1963(19)30069-1, DOI: 10.1053/j.seminhematol.2019.11.007, ISSN: 1532-8686.

Zinter MS, Logan BR, Fretham C, Sapru A, Abraham A, Aljurf MD, Arnold SD, Artz A, Auletta JJ, Chhabra S, Copelan E, Duncan C, Gale RP, Guinan E, Hematti P, Keating AK, Marks DI, Olsson R, Savani BN, Ustun C, Williams KM, Pasquini MC, Dvorak CC. Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries. Biol. Blood Marrow Transplant [print-electronic]. 2019 Sep 9/26/2019; PMID: 31563573, PII: S1083-8791(19)30638-X, DOI: 10.1016/j.bbmt.2019.09.027, ISSN: 1523-6536.

Lazaryan A, Dolan M, Zhang MJ, Wang HL, Kharfan-Dabaja MA, Marks DI, Bejanyan N, Copelan E, Majhail NS, Waller EK, Chao N, Prestidge T, Nishihori T, Kebriaei P, Inamoto Y, Hamilton B, Hashmi SK, Kamble RT, Bacher U, Hildebrandt GC, Stiff PJ, McGuirk J, Aldoss I, Beitinjaneh AM, Muffly L, Vij R, Olsson RF, Byrne M, Schultz KR, Aljurf M, Seftel M, Savoie ML, Savani BN, Verdonck LF, Cairo MS, Hossain N, Bhatt VR, Frangoul HA, Abdel-Azim H, Al Malki M, Munker R, Rizzieri D, Khera N, Nakamura R, Ringdén O, van der Poel M, Murthy HS, Liu H, Mori S, De Oliveira S, Bolaños-Meade J, Elsawy M, Barba P, Nathan S, George B, Pawarode A, Grunwald M, Agrawal V, Wang Y, Assal A, Castillo Caro P, Kuwatsuka Y, Seo S, Ustun C, Politikos I, Lazarus HM, Saber W, Sandmaier BM, De Lima M, Litzow M, Bachanova V, Weisdorf D, . Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Haematologica [print-electronic]. 2019 Sep 9/26/2019; PMID: 31558669, PII: haematol.2019.220756, DOI: 10.3324/haematol.2019.220756, ISSN: 1592-8721.

Dholaria B, Savani BN, Labopin M, Luznik L, Ruggeri A, Mielke S, Al Malki MM, Kongtim P, Fuchs E, Huang XJ, Locatelli F, Aversa F, Castagna L, Bacigalupo A, Martelli M, Blaise D, Ben Soussan P, Arnault Y, Handgretinger R, Roy DC, O'Donnell P, Bashey A, Solomon S, Romee R, Lewalle P, Gayoso J, Maschan M, Lazarus HM, Ballen K, Giebel S, Baron F, Ciceri F, Esteve J, Gorin NC, Spyridonidis A, Schmid C, Ciurea SO, Nagler A, Mohty M. Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the acute leukemia working party of the EBMT. Haematologica [print-electronic]. 2019 Sep 9/19/2019; PMID: 31537691, PII: haematol.2019.219790, DOI: 10.3324/haematol.2019.219790, ISSN: 1592-8721.

Gatwood KS, Labopin M, Savani BN, Finke J, Socie G, Beelen D, Yakoub-Agha I, Chevallier P, Ganser A, Blaise D, Milpied N, Bruno L, Mailhol A, Mohty M, Nagler A. Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study. Bone Marrow Transplant [print-electronic]. 2019 Sep 9/16/2019; PMID: 31527819, PII: 10.1038/s41409-019-0673-3, DOI: 10.1038/s41409-019-0673-3, ISSN: 1476-5365.

Kanate AS, Savani BN. Who is the best relative - optimizing haploidentical donor transplantation in lymphoma? [editorial]. Br. J. Haematol [print-electronic]. 2019 Sep 9/2/2019; PMID: 31475355, DOI: 10.1111/bjh.16178, ISSN: 1365-2141.

Hamilton BK, Liu Y, Hemmer MT, Majhail N, Ringden O, Kim D, Costa L, Stuart R, Alousi A, Pidala JA, Couriel DR, Aljurf M, Antin JH, Bredeson C, Cahn JY, Cairo M, Choi SW, Dandoy C, Gale RP, Gergis U, Hematti P, Inamoto Y, Kamble RT, MacMillan M, Marks DI, Nemecek E, Nishihori T, Saad A, Savani BN, Schriber J, Seo S, Socié G, Teshima T, Verdonck LF, Waller EK, Wirk M, Spellman SR, Arora M, Chhabra S. Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2019 Sep; 25(9): 1744-55. PMID: 31158502, PII: S1083-8791(19)30330-1, DOI: 10.1016/j.bbmt.2019.05.019, ISSN: 1523-6536.

McCune JS, Quinones CM, Ritchie J, Carpenter PA, van Maarseveen E, Yeh RF, Anasetti C, Boelens JJ, Hamerschlak N, Hassan M, Kang HJ, Kanda Y, Paci A, Perales MA, Shaw PJ, Seewaldt VL, Savani BN, Hsieh A, Poon B, Mohty M, Pulsipher MA, Pasquini M, Dupuis LL. Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement. Biol. Blood Marrow Transplant [print-electronic]. 2019 Sep; 25(9): 1890-7. PMID: 31136799, PMCID: PMC6755045, PII: S1083-8791(19)30332-5, DOI: 10.1016/j.bbmt.2019.05.021, ISSN: 1523-6536.

Ahmed S, Kanakry JA, Ahn KW, Litovich C, Abdel-Azim H, Aljurf M, Bacher VU, Bejanyan N, Cohen JB, Farooq U, Fuchs EJ, Bolaños-Meade J, Ghosh N, Herrera AF, Hossain NM, Inwards D, Kanate AS, Martino R, Munshi PN, Murthy H, Mussetti A, Nieto Y, Perales MA, Romee R, Savani BN, Seo S, Wirk B, Yared JA, Sureda A, Fenske TS, Hamadani M. Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma. Biol. Blood Marrow Transplant [print-electronic]. 2019 Sep; 25(9): 1859-68. PMID: 31132455, PMCID: PMC6755039, PII: S1083-8791(19)30336-2, DOI: 10.1016/j.bbmt.2019.05.025, ISSN: 1523-6536.

Nagler A, Labopin M, Dholaria B, Finke J, Brecht A, Schanz U, Niittyvuopio R, Neubauer A, Bornhäuser M, Santarone S, Beelen D, Shimoni A, Rösler W, Giebel S, Savani BN, Mohty M. Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation. Br. J. Haematol [print-electronic]. 2019 Sep; 186(5): 767-76. PMID: 31115916, DOI: 10.1111/bjh.15973, ISSN: 1365-2141.

Saad A, Lamb L, Wang T, Hemmer MT, Spellman S, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Agrawal V, Aljurf M, Beitinjaneh AM, Bhatt VR, Buchbinder D, Byrne M, Cahn JY, Cairo M, Castillo P, Chhabra S, Diaz MA, Farhan S, Floisand Y, Frangoul HA, Gadalla SM, Gajewski J, Gale RP, Gandhi M, Gergis U, Hamilton BK, Hematti P, Hildebrandt GC, Kamble RT, Kanate AS, Khandelwal P, Lazaryan A, MacMillan M, Marks DI, Martino R, Mehta PA, Nishihori T, Olsson RF, Patel SS, Qayed M, Rangarajan HG, Reshef R, Ringden O, Savani BN, Schouten HC, Schultz KR, Seo S, Shaffer BC, Solh M, Teshima T, Urbano-Ispizua A, Verdonck LF, Vij R, Waller EK, William B, Wirk B, Yared JA, Yu LC, Arora M, Hashmi S. Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2019 Sep; 25(9): 1875-83. PMID: 31085303, PII: S1083-8791(19)30291-5, DOI: 10.1016/j.bbmt.2019.05.007, ISSN: 1523-6536.

Tanweer MS, Aljurf M, Savani BN, Iqbal PK, Hashmi S. Lower Genital Tract Precancer and Cancer in Hematopoietic Cell Transplant Survivors and the Role of HPV: A Systematic Review and Future Perspectives. Clin Hematol Int. 2019 Sep; 1(3): 142-53. PMID: 34595424, PMCID: PMC8432365, PII: CHI-1-3-142, DOI: 10.2991/chi.d.190519.001, ISSN: 2590-0048.

Adkins BD, Savani BN, Booth GS. Management of Sickle Cell Intrahepatic Cholestasis: An Argument in Favor of Automated Exchange Transfusion. Clin Hematol Int. 2019 Sep; 1(3): 127-33. PMID: 34595422, PMCID: PMC8432363, PII: CHI-1-3-127, DOI: 10.2991/chi.d.190630.001, ISSN: 2590-0048.

Tanweer MS, Aljurf M, Savani BN, Iqbal PK, Hashmi S. Lower Genital Tract Precancer and Cancer in Hematopoietic Cell Transplant Survivors and the Role of HPV: A Systematic Review and Future Perspectives. Clin Hematol Int. 2019 Sep; 1(3): 142-53. PMID: 34595424, PMCID: PMC8432365, PII: CHI-1-3-142, DOI: 10.2991/chi.d.190519.001, ISSN: 2590-0048.

Epperla N, Hamadani M, Reljic T, Kharfan-Dabaja MA, Savani BN, Kumar A. Upfront autologous hematopoietic stem cell transplantation consolidation for patients with aggressive B-cell lymphomas in first remission in the rituximab era: A systematic review and meta-analysis. Cancer [print-electronic]. 2019 Aug 8/23/2019; PMID: 31441943, DOI: 10.1002/cncr.32464, ISSN: 1097-0142.

Jain T, Bar M, Kansagra AJ, Chong EA, Hashmi SK, Neelapu SS, Byrne M, Jacoby E, Lazaryan A, Jacobson CA, Ansell SM, Awan FT, Burns L, Bachanova V, Bollard CM, Carpenter PA, DiPersio JF, Hamadani M, Heslop HE, Hill JA, Komanduri KV, Kovitz CA, Lazarus HM, Serrette JM, Mohty M, Miklos D, Nagler A, Pavletic SZ, Savani BN, Schuster SJ, Kharfan-Dabaja MA, Perales MA, Lin Y. Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. Biol. Blood Marrow Transplant [print-electronic]. 2019 Aug 8/22/2019; PMID: 31446199, PII: S1083-8791(19)30529-4, DOI: 10.1016/j.bbmt.2019.08.015, ISSN: 1523-6536.

DeFilipp Z, Advani AS, Bachanova V, Cassaday RD, Deangelo DJ, Kebriaei P, Rowe JM, Seftel MD, Stock W, Tallman MS, Fanning S, Inamoto Y, Kansagra A, Johnston L, Nagler A, Sauter CS, Savani BN, Perales MA, Carpenter PA, Larson RA, Weisdorf D. Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy. Biol. Blood Marrow Transplant [print-electronic]. 2019 Aug 8/22/2019; PMID: 31446198, PII: S1083-8791(19)30528-2, DOI: 10.1016/j.bbmt.2019.08.014, ISSN: 1523-6536.

El Fakih R, Savani B, Mohty M, Aljurf M. Hematopoietic Cell Transplant Consideration for Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia Patients. Biol. Blood Marrow Transplant [print-electronic]. 2019 Aug 8/21/2019; PMID: 31445182, PII: S1083-8791(19)30524-5, DOI: 10.1016/j.bbmt.2019.08.010, ISSN: 1523-6536.

Shichijo T, Fuji S, Nagler A, Bazarbachi A, Mohty M, Savani BN. Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?. Bone Marrow Transplant [print-electronic]. 2019 Aug 8/21/2019; PMID: 31435032, PII: 10.1038/s41409-019-0643-9, DOI: 10.1038/s41409-019-0643-9, ISSN: 1476-5365.

Kim HT, Ahn KW, Hu ZH, Davids MS, Volpe VO, Antin JH, Sorror ML, Shadman M, Press O, Pidala J, Hogan W, Negrin R, Devine S, Uberti J, Agura E, Nash R, Mehta J, McGuirk J, Forman S, Langston A, Giralt SA, Perales MA, Battiwalla M, Hale GA, Gale RP, Marks DI, Hamadani M, Ganguly S, Bacher U, Lazarus H, Reshef R, Hildebrandt GC, Inamoto Y, Cahn JY, Solh M, Kharfan-Dabaja MA, Ghosh N, Saad A, Aljurf M, Schouten HC, Hill BT, Pawarode A, Kindwall-Keller T, Saba N, Copelan EA, Nathan S, Beitinjaneh A, Savani BN, Cerny J, Grunwald MR, Yared J, Wirk BM, Nishihori T, Chhabra S, Olsson RF, Bashey A, Gergis U, Popat U, Sobecks R, Alyea E, Saber W, Brown JR. Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report. Clin Cancer Res [print-electronic]. 2019 Aug 8/15/2019; 25(16): 5143-55. PMID: 31253630, PMCID: PMC6697588, PII: 1078-0432.CCR-18-3988, DOI: 10.1158/1078-0432.CCR-18-3988, ISSN: 1557-3265.

Pergam SA, Englund JA, Kamboj M, Gans HA, Young JH, Hill JA, Savani B, Chemaly RF, Dadwal SS, Storek J, Duchin J, Carpenter PA. Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy. Biol. Blood Marrow Transplant [print-electronic]. 2019 Aug 8/5/2019; PMID: 31394271, PII: S1083-8791(19)30506-3, DOI: 10.1016/j.bbmt.2019.07.034, ISSN: 1523-6536.

Ustun C, Young JH, Papanicolaou GA, Kim S, Ahn KW, Chen M, Abdel-Azim H, Aljurf M, Beitinjaneh A, Brown V, Cerny J, Chhabra S, Kharfan-Dabaja MA, Dahi PB, Daly A, Dandoy CE, Dvorak CC, Freytes CO, Hashmi S, Lazarus H, Ljungman P, Nishihori T, Page K, Pingali SRK, Saad A, Savani BN, Weisdorf D, Williams K, Wirk B, Auletta JJ, Lindemans CA, Komanduri K, Riches M. Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant [print-electronic]. 2019 Aug; 54(8): 1254-65. PMID: 30546070, PMCID: PMC6565512, PII: 10.1038/s41409-018-0401-4, DOI: 10.1038/s41409-018-0401-4, ISSN: 1476-5365.

Christensen BW, Rubinstein SM, Bastakoty D, Savani BN, Booth GS. A retrospective cost analysis of the frequency and cost of transfusion premedications. Transfusion [print-electronic]. 2019 Aug; 59(8): 2523-7. PMID: 33764542, DOI: 10.1111/trf.15301, ISSN: 1537-2995.

Gilleece MH, Labopin M, Savani BN, Yakoub-Agha I, Socié G, Gedde-Dahl T, Blaise D, Byrne JL, Craddock C, Cornelissen JJ, Arcese W, Forcade E, Crawley C, Polge E, Mohty M, Nagler A. Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT. Leukemia [print-electronic]. 2019 Jul 7/30/2019; PMID: 31363160, PII: 10.1038/s41375-019-0527-4, DOI: 10.1038/s41375-019-0527-4, ISSN: 1476-5551.

Nagler A, Labopin M, Dholaria B, Niittyvuopio R, Maertens J, Poiré X, Cornelissen J, Reményi P, Bourhis JH, Beguin Y, Malladi R, Kerre T, Schroyens W, Savani BN, Mohty M. Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI. Blood Adv. 2019 Jul 7/9/2019; 3(13): 1950-60. PMID: 31262738, PMCID: PMC6616257, PII: bloodadvances.2019000030, DOI: 10.1182/bloodadvances.2019000030, ISSN: 2473-9537.

Byrne M, Oluwole OO, Savani B, Majhail NS, Hill BT, Locke FL. Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy. Biol. Blood Marrow Transplant [print-electronic]. 2019 Jul 7/4/2019; PMID: 31279751, PII: S1083-8791(19)30420-3, DOI: 10.1016/j.bbmt.2019.06.036, ISSN: 1523-6536.

Shimoni A, Labopin M, Savani B, Byrne M, Volin L, Finke J, Niederwieser D, Ehninger G, Blaise D, Beelen D, Tabrizi R, Sengeloev H, Ganser A, Cornelissen JJ, Mohty M, Nagler A. Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2019 Jul 7/2/2019; PMID: 31271887, PII: S1083-8791(19)30415-X, DOI: 10.1016/j.bbmt.2019.06.031, ISSN: 1523-6536.

Prokopishyn NL, Logan BR, Kiefer DM, Sees JA, Chitphakdithai P, Ahmed IA, Anderlini PN, Beitinjaneh AM, Bredeson C, Cerny J, Chhabra S, Daly A, Diaz MA, Farhadfar N, Frangoul HA, Ganguly S, Gastineau DA, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Norkin M, Olsson RF, Papari M, Savani BN, Szer J, Waller EK, Wirk B, Yared JA, Pulsipher MA, Shah NN, Switzer GE, O'Donnell PV, Confer DL, Shaw BE. The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time. Biol. Blood Marrow Transplant [print-electronic]. 2019 Jul; 25(7): 1325-30. PMID: 30716454, PMCID: PMC6615955, PII: S1083-8791(19)30092-8, DOI: 10.1016/j.bbmt.2019.01.034, ISSN: 1523-6536.

Kilari D, D'Souza A, Fraser R, Qayed M, Davila O, Agrawal V, Diaz MA, Chhabra S, Cerny J, Copelan E, Farhadfar N, Freytes CO, Gale RP, Ganguly S, Hildebrandt GC, Holmberg L, Kamble RT, Kapoor P, Lazarus H, Lee C, Murthy HS, Naik S, Nishihori T, Saad A, Savani BN, Seo S, Warwick A, Wirk B, Yared JA, Nieto Y, Hari P. Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades. Biol. Blood Marrow Transplant [print-electronic]. 2019 Jun; 25(6): 1099-106. PMID: 30794931, PMCID: PMC6559839, PII: S1083-8791(19)30140-5, DOI: 10.1016/j.bbmt.2019.02.015, ISSN: 1523-6536.

Mohammed J, Smith SR, Burns L, Basak G, Aljurf M, Savani BN, Schoemans H, Peric Z, Chaudhri NA, Chigbo N, Alfred A, Bakhsh H, Salooja N, Chris Chim A, Hashmi SK. Role of Physical Therapy before and after Hematopoietic Stem Cell Transplantation: White Paper Report. Biol. Blood Marrow Transplant [print-electronic]. 2019 Jun; 25(6): e191-e198. PMID: 30658224, PII: S1083-8791(19)30067-9, DOI: 10.1016/j.bbmt.2019.01.018, ISSN: 1523-6536.

Giebel S, Marks DI, Boissel N, Baron F, Chiaretti S, Ciceri F, Cornelissen JJ, Doubek M, Esteve J, Fielding A, Foa R, Gorin NC, Gökbuget N, Hallböök H, Hoelzer D, Paravichnikova E, Ribera JM, Savani B, Rijneveld AW, Schmid C, Wartiovaara-Kautto U, Mohty M, Nagler A, Dombret H. Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant [print-electronic]. 2019 Jun; 54(6): 798-809. PMID: 30385870, PII: 10.1038/s41409-018-0373-4, DOI: 10.1038/s41409-018-0373-4, ISSN: 1476-5365.

Gatwood KS, Savani BN. The Essentials of Drug Interactions in Hematopoietic Stem Cell Transplantation. Clin Hematol Int. 2019 Jun; 1(2): 124-6. PMID: 34595421, PMCID: PMC8432391, PII: CHI-1-2-124, DOI: 10.2991/chi.d.190504.002, ISSN: 2590-0048.

Ruggeri A, Labopin M, Savani B, Paviglianiti A, Blaise D, Volt F, Ciceri F, Bacigalupo A, Tischer J, Chevallier P, Koc Y, Cornelissen JJ, Ehninger G, Sanz G, Deconinck E, Rocha V, Baron F, Mohty M, Gluckman E, Nagler A. Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT. Bone Marrow Transplant [print-electronic]. 2019 May 5/31/2019; PMID: 31150016, PII: 10.1038/s41409-019-0582-5, DOI: 10.1038/s41409-019-0582-5, ISSN: 1476-5365.

Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Ahmed I, Aljurf M, Askar M, Auletta JJ, Bhatt V, Bredeson C, Chhabra S, Gadalla S, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Inamoto Y, Kitko C, Khandelwal P, MacMillan ML, Majhail N, Marks DI, Mehta P, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Qayed M, Rangarajan H, Ringden O, Saad A, Savani BN, Seo S, Shah A, Shah N, Schultz KR, Solh M, Spitzer T, Szer J, Teshima T, Verdonck LF, Williams KM, Wirk B, Wagner J, Yared JA, Weisdorf DJ. GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia. Blood Adv. 2019 May 5/14/2019; 3(9): 1441-9. PMID: 31053571, PMCID: PMC6517657, PII: bloodadvances.2018030171, DOI: 10.1182/bloodadvances.2018030171, ISSN: 2473-9537.

Parikh SH, Satwani P, Ahn KW, Sahr NA, Fretham C, Abraham AA, Agrawal V, Auletta JJ, Abdel-Azim H, Copelan E, Diaz MA, Dvorak CC, Frangoul HA, Freytes CO, Gadalla SM, Gale RP, George B, Gergis U, Hashmi S, Hematti P, Hildebrandt GC, Keating AK, Lazarus HM, Myers KC, Olsson RF, Prestidge T, Rotz SJ, Savani BN, Shereck EB, Williams KM, Wirk B, Pasquini MC, Loren AW. Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant. JAMA Pediatr [print-electronic]. 2019 May 5/1/2019; 173(5): e190081. PMID: 30882883, PMCID: PMC6503511, PII: 2728108, DOI: 10.1001/jamapediatrics.2019.0081, ISSN: 2168-6211.

Kanate AS, Kumar A, Dreger P, Dreyling M, Le Gouill S, Corradini P, Bredeson C, Fenske TS, Smith SM, Sureda A, Moskowitz A, Friedberg JW, Inwards DJ, Herrera AF, Kharfan-Dabaja MA, Reddy N, Montoto S, Robinson SP, Abutalib SA, Gisselbrecht C, Vose J, Gopal A, Shadman M, Perales MA, Carpenter P, Savani BN, Hamadani M. Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT. JAMA Oncol. 2019 May 5/1/2019; 5(5): 715-22. PMID: 30816957, PII: 2726032, DOI: 10.1001/jamaoncol.2018.6278, ISSN: 2374-2445.

Inamoto Y, Petricek I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Al-Khinji A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N. Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant. 2019 May; 54(5): 782-3. PMID: 30809032, PII: 10.1038/s41409-019-0472-x, DOI: 10.1038/s41409-019-0472-x, ISSN: 1476-5365.

Cohen JA, Baldassari LE, Atkins HL, Bowen JD, Bredeson C, Carpenter PA, Corboy JR, Freedman MS, Griffith LM, Lowsky R, Majhail NS, Muraro PA, Nash RA, Pasquini MC, Sarantopoulos S, Savani BN, Storek J, Sullivan KM, Georges GE. Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2019 May; 25(5): 845-54. PMID: 30794930, PII: S1083-8791(19)30139-9, DOI: 10.1016/j.bbmt.2019.02.014, ISSN: 1523-6536.

Santoro N, Labopin M, Ciceri F, Van Lint MT, Nasso D, Blaise D, Arcese W, Tischer J, Bruno B, Ehninger G, Koc Y, Santarone S, Huang XJ, Savani BN, Mohty M, Ruggeri A, Nagler A. Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over. Cancer [print-electronic]. 2019 May 5/1/2019; 125(9): 1499-506. PMID: 30620383, DOI: 10.1002/cncr.31941, ISSN: 1097-0142.

Inamoto Y, Petricek I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Al-Khinji A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N. Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant [print-electronic]. 2019 May; 54(5): 648-61. PMID: 30531955, PMCID: PMC6497536, PII: 10.1038/s41409-018-0339-6, DOI: 10.1038/s41409-018-0339-6, ISSN: 1476-5365.

Inamoto Y, Valdés-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Lupo Stanghellini MT, Agrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S, DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rovó A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Petricek I. Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant [print-electronic]. 2019 May; 54(5): 662-73. PMID: 30531954, PII: 10.1038/s41409-018-0340-0, DOI: 10.1038/s41409-018-0340-0, ISSN: 1476-5365.

Inamoto Y, Petricek I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Ahmed A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hashmi S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N. Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2019 May; 25(5): e145-e154. PMID: 30521975, PMCID: PMC6511311, PII: S1083-8791(18)30798-5, DOI: 10.1016/j.bbmt.2018.11.033, ISSN: 1523-6536.

Saraceni F, Labopin M, Brecht A, Kröger N, Eder M, Tischer J, Labussière-Wallet H, Einsele H, Beelen D, Bunjes D, Niederwieser D, Bochtler T, Savani BN, Mohty M, Nagler A. Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). J Hematol Oncol. 2019 Apr 4/25/2019; 12(1): 44. PMID: 31023346, PMCID: PMC6482556, PII: 10.1186/s13045-019-0727-4, DOI: 10.1186/s13045-019-0727-4, ISSN: 1756-8722.

Lee CJ, Labopin M, Beelen D, Finke J, Blaise D, Ganser A, Itälä-Remes M, Chevallier P, Labussière-Wallet H, Maertens J, Yakoub-Agha I, Bourhis JH, Mailhol A, Mohty M, Savani BN, Nagler A. Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation. Am. J. Hematol [print-electronic]. 2019 Apr; 94(4): 431-8. PMID: 30597620, DOI: 10.1002/ajh.25395, ISSN: 1096-8652.

Gopalakrishnan S, D'Souza A, Scott E, Fraser R, Davila O, Shah N, Gale RP, Kamble R, Diaz MA, Lazarus HM, Savani BN, Hildebrandt GC, Solh M, Freytes CO, Lee C, Kyle RA, Usmani SZ, Ganguly S, Assal A, Berdeja J, Kanate AS, Dhakal B, Meehan K, Kindwall-Keller T, Saad A, Locke F, Seo S, Nishihori T, Gergis U, Gasparetto C, Mark T, Nieto Y, Kumar S, Hari P. Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma. Biol. Blood Marrow Transplant [print-electronic]. 2019 Apr; 25(4): 683-8. PMID: 30579965, PMCID: PMC6453717, PII: S1083-8791(18)30963-7, DOI: 10.1016/j.bbmt.2018.12.141, ISSN: 1523-6536.

Baron F, Labopin M, Ruggeri A, Volt F, Mohty M, Blaise D, Chevallier P, Sanz J, Fegueux N, Cornelissen JJ, Rambaldi A, Savani BN, Gluckman E, Nagler A. Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remission. J. Intern. Med [print-electronic]. 2019 Apr; 285(4): 446-54. PMID: 30561052, DOI: 10.1111/joim.12870, ISSN: 1365-2796.

Lee CJ, Savani BN, Mohty M, Gorin NC, Labopin M, Ruggeri A, Schmid C, Baron F, Esteve J, Giebel S, Ciceri F, Nagler A. Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant [print-electronic]. 2019 Apr; 54(4): 519-30. PMID: 30104717, PII: 10.1038/s41409-018-0286-2, DOI: 10.1038/s41409-018-0286-2, ISSN: 1476-5365.

Sheth V, Labopin M, Canaani J, Volin L, Brecht A, Ganser A, Mayer J, Labussière-Wallet H, Bittenbring J, Shouval R, Savani B, Mohty M, Nagler A. Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysis. Bone Marrow Transplant [print-electronic]. 2019 Apr; 54(4): 531-9. PMID: 30087463, PII: 10.1038/s41409-018-0288-0, DOI: 10.1038/s41409-018-0288-0, ISSN: 1476-5365.

Ciurea SO, Al Malki MM, Kongtim P, Fuchs EJ, Luznik L, Huang XJ, Ciceri F, Locatelli F, Aversa F, Castagna L, Bacigalupo A, Martelli M, Blaise D, Ben Soussan P, Arnault Y, Handgretinger R, Roy DC, O'Donnell PV, Bashey A, Solomon S, Romee R, Gayoso J, Lazarus HM, Ballen K, Savani BN, Mohty M, Nagler A. The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation. Bone Marrow Transplant [print-electronic]. 2019 Mar 3/4/2019; PMID: 30833742, PII: 10.1038/s41409-019-0499-z, DOI: 10.1038/s41409-019-0499-z, ISSN: 1476-5365.

Sauter CS, DeFilipp Z, Inamoto Y, Johnston L, Nagler A, Savani BN, Carpenter PA, Perales MA. ASBMT Statement on Routine Prophylaxis for Central Nervous System Recurrence of Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2019 Mar; 25(3): e86-e88. PMID: 30590125, PII: S1083-8791(18)31626-4, DOI: 10.1016/j.bbmt.2018.12.757, ISSN: 1523-6536.

Kansagra AJ, Frey NV, Bar M, Laetsch TW, Carpenter PA, Savani BN, Heslop HE, Bollard CM, Komanduri KV, Gastineau DA, Chabannon C, Perales MA, Hudecek M, Aljurf M, Andritsos L, Barrett JA, Bachanova V, Bonini C, Ghobadi A, Gill SI, Hill J, Kenderian S, Kebriaei P, Nagler A, Maloney D, Liu HD, Shah NN, Kharfan-Dabaja MA, Shpall EJ, Mufti GJ, Johnston L, Jacoby E, Bazarbachi A, DiPersio JF, Pavletic SZ, Porter DL, Grupp SA, Sadelain M, Litzow MR, Mohty M, Hashmi SK. Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2019 Mar; 25(3): e76-e85. PMID: 30576834, PII: S1083-8791(18)30890-5, DOI: 10.1016/j.bbmt.2018.12.068, ISSN: 1523-6536.

Schmid C, Labopin M, Schaap N, Veelken H, Schleuning M, Stadler M, Finke J, Hurst E, Baron F, Ringden O, Bug G, Blaise D, Tischer J, Bloor A, Esteve J, Giebel S, Savani B, Gorin NC, Ciceri F, Mohty M, Nagler A, . Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT. Br. J. Haematol [print-electronic]. 2019 Mar; 184(5): 782-7. PMID: 30467839, DOI: 10.1111/bjh.15691, ISSN: 1365-2141.

Brunstein CG, Pasquini MC, Kim S, Fei M, Adekola K, Ahmed I, Aljurf M, Agrawal V, Auletta JJ, Battiwalla M, Bejanyan N, Bubalo J, Cerny J, Chee L, Ciurea SO, Freytes C, Gadalla SM, Gale RP, Ganguly S, Hashmi SK, Hematti P, Hildebrandt G, Holmberg LA, Lahoud OB, Landau H, Lazarus HM, de Lima M, Mathews V, Maziarz R, Nishihori T, Norkin M, Olsson R, Reshef R, Rotz S, Savani B, Schouten HC, Seo S, Wirk BM, Yared J, Mineishi S, Rogosheske J, Perales MA. Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2019 Mar; 25(3): 480-7. PMID: 30423481, PMCID: PMC6445718, PII: S1083-8791(18)30699-2, DOI: 10.1016/j.bbmt.2018.11.005, ISSN: 1523-6536.

Potdar RR, Gupta S, Giebel S, Savani BN, Varadi G, Nagler A, Blamek S. Current Status and Perspectives of Irradiation-Based Conditioning Regimens for Patients with Acute Leukemia Undergoing Hematopoietic Stem Cell Transplantation. Clin Hematol Int. 2019 Mar; 1(1): 19-27. PMID: 34595407, PMCID: PMC8432382, PII: CHI-1-1-19, DOI: 10.2991/chi.d.190218.002, ISSN: 2590-0048.

Mohty M, Nagler A, Savani B. Clinical Hematology International: Why a New Journal in Hematology? [editorial]. Clin Hematol Int. 2019 Mar; 1(1): 1. PMID: 34595404, PMCID: PMC8432383, PII: CHI-1-1-1, DOI: 10.2991/chi.d.190402.001, ISSN: 2590-0048.

Potdar RR, Gupta S, Giebel S, Savani BN, Varadi G, Nagler A, Blamek S. Current Status and Perspectives of Irradiation-Based Conditioning Regimens for Patients with Acute Leukemia Undergoing Hematopoietic Stem Cell Transplantation. Clin Hematol Int. 2019 Mar; 1(1): 19-27. PMID: 34595407, PMCID: PMC8432382, PII: CHI-1-1-19, DOI: 10.2991/chi.d.190218.002, ISSN: 2590-0048.

Yeshurun M, Weisdorf D, Rowe JM, Tallman MS, Zhang MJ, Wang HL, Saber W, de Lima M, Sandmaier BM, Uy G, Kamble RT, Cairo MS, Cooper BW, Cahn JY, Ganguly S, Camitta B, Verdonck LF, Dandoy C, Diaz MA, Savani BN, George B, Liesveld J, McGuirk J, Byrne M, Grunwald MR, Drobyski WR, Pulsipher MA, Abdel-Azim H, Prestidge T, Wieduwilt MJ, Martino R, Norkin M, Beitinjaneh A, Seo S, Nishihori T, Wirk B, Frangoul H, Bashey A, Mori S, Marks DI, Bachanova V. The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia. Blood Adv. 2019 Feb 2/26/2019; 3(4): 670-80. PMID: 30808685, PMCID: PMC6391668, PII: bloodadvances.2018027003, DOI: 10.1182/bloodadvances.2018027003, ISSN: 2473-9537.

Inamoto Y, Valdés-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Lupo Stanghellini MT, Agrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S, DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rovó A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Petricek I. Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2019 Feb; 25(2): e46-e54. PMID: 30481594, PMCID: PMC6362842, PII: S1083-8791(18)30754-7, DOI: 10.1016/j.bbmt.2018.11.021, ISSN: 1523-6536.

Norkin M, Shaw BE, Brazauskas R, Tecca HR, Leather HL, Gea-Banacloche J, T Kamble R, DeFilipp Z, Jacobsohn DA, Ringden O, Inamoto Y, A Kasow K, Buchbinder D, Shaw P, Hematti P, Schears R, Badawy SM, Lazarus HM, Bhatt N, Horn B, Chhabra S, M Page K, Hamilton B, Hildebrandt GC, Yared JA, Agrawal V, M Beitinjaneh A, Majhail N, Kindwall-Keller T, Olsson RF, Schoemans H, Gale RP, Ganguly S, A Ahmed I, Schouten HC, L Liesveld J, Khera N, Steinberg A, Shah AJ, Solh M, Marks DI, Rybka W, Aljurf M, Dietz AC, Gergis U, George B, Seo S, Flowers MED, Battiwalla M, Savani BN, Riches ML, Wingard JR. Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2019 Feb; 25(2): 362-8. PMID: 30287390, PMCID: PMC6339825, PII: S1083-8791(18)30598-6, DOI: 10.1016/j.bbmt.2018.09.031, ISSN: 1523-6536.

Sheth V, Kennedy V, de Lavallade H, Mclornan D, Potter V, Engelhardt BG, Savani B, Chinratanalab W, Goodman S, Greer J, Kassim A, York S, Kenyon M, Gandhi S, Kulasekararaj A, Marsh J, Mufti G, Pagliuca A, Jagasia M, Raj K. Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience. Front Oncol. 2019; 9: 623. PMID: 31355140, PMCID: PMC6636242, DOI: 10.3389/fonc.2019.00623, ISSN: 2234-943X.

Chhabra S, Liu Y, Hemmer MT, Costa L, Pidala JA, Couriel DR, Alousi AM, Majhail NS, Stuart RK, Kim D, Ringden O, Urbano-Ispizua A, Saad A, Savani BN, Cooper B, Marks DI, Socie G, Schouten HC, Schoemans H, Abdel-Azim H, Yared J, Cahn JY, Wagner J, Antin JH, Verdonck LF, Lehmann L, Aljurf MD, MacMillan ML, Litzow MR, Solh MM, Qayed M, Hematti P, Kamble RT, Vij R, Hayashi RJ, Gale RP, Martino R, Seo S, Hashmi SK, Nishihori T, Teshima T, Gergis U, Inamoto Y, Spellman SR, Arora M, Hamilton BK. Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2019 Jan; 25(1): 73-85. PMID: 30153491, PMCID: PMC6355336, PII: S1083-8791(18)30489-0, DOI: 10.1016/j.bbmt.2018.08.018, ISSN: 1523-6536.

Clark CA, Mosse CA, Chen H, Byrne M, Chinratanalab W, Engelhardt BG, Goodman SA, Harrell SL, Kassim AA, Savani BN, Sengsayadeth S, Jagasia M, Cornell RF. Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapy [letter]. Bone Marrow Transplant [print-electronic]. 2018 Dec; 53(12): 1589-92. PMID: 29915217, PII: 10.1038/s41409-018-0241-2, DOI: 10.1038/s41409-018-0241-2, ISSN: 1476-5365.

Chhabra S, Ahn KW, Hu ZH, Jain S, Assal A, Cerny J, Copelan EA, Daly A, DeFilipp Z, Gadalla SM, Gale RP, Ganguly S, Hamilton BK, Hildebrandt GC, Hsu JW, Inamoto Y, Kanate AS, Khoury HJ, Lazarus HM, Litzow MR, Nathan S, Olsson RF, Pawarode A, Ringden O, Rowe JM, Saad A, Savani BN, Schouten HC, Seo S, Shah NN, Solh M, Stuart RK, Ustun C, Woolfrey AE, Yared JA, Alyea EP, Kalaycio ME, Popat U, Sobecks RM, Saber W. Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia. Blood Adv. 2018 Nov 11/13/2018; 2(21): 2922-36. PMID: 30396912, PMCID: PMC6234373, PII: bloodadvances.2018024844, DOI: 10.1182/bloodadvances.2018024844, ISSN: 2473-9537.

Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, Hamilton BK, Kalaycio M, Maciejewski JP, Ahmed I, Akpek G, Bajel A, Buchbinder D, Cahn JY, D'Souza A, Daly A, DeFilipp Z, Ganguly S, Hamadani M, Hayashi RJ, Hematti P, Inamoto Y, Khera N, Kindwall-Keller T, Landau H, Lazarus H, Majhail NS, Marks DI, Olsson RF, Seo S, Steinberg A, William BM, Wirk B, Yared JA, Aljurf M, Abidi MH, Allewelt H, Beitinjaneh A, Cook R, Cornell RF, Fay JW, Hale G, Chakrabarty JH, Jodele S, Kasow KA, Mahindra A, Malone AK, Popat U, Rizzo JD, Schouten HC, Warwick AB, Wood WA, Sekeres MA, Litzow MR, Gale RP, Hashmi SK. Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. Leuk. Res [print-electronic]. 2018 Nov; 74: 130-6. PMID: 30055822, PMCID: PMC6219911, PII: S0145-2126(18)30160-7, DOI: 10.1016/j.leukres.2018.07.016, ISSN: 1873-5835.

Heinicke T, Labopin M, Schmid C, Polge E, Socié G, Blaise D, Mufti GJ, Huynh A, Brecht A, Ledoux MP, Cahn JY, Milpied N, Scheid C, Hicheri Y, Mohty M, Savani BN, Nagler A. Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2018 Nov; 24(11): 2224-32. PMID: 30009981, PII: S1083-8791(18)30394-X, DOI: 10.1016/j.bbmt.2018.07.007, ISSN: 1523-6536.

Saraceni F, Beohou E, Labopin M, Arcese W, Bonifazi F, Stepensky P, Aljurf M, Bruno B, Pioltelli P, Passweg J, Sociè G, Santarone S, Yakoub-Agha I, Lanza F, Savani BN, Mohty M, Nagler A, . Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia. Am. J. Hematol [print-electronic]. 2018 Oct; 93(10): 1211-9. PMID: 30033639, DOI: 10.1002/ajh.25225, ISSN: 1096-8652.

Sullivan KM, Majhail NS, Bredeson C, Carpenter PA, Chatterjee S, Crofford LJ, Georges GE, Nash RA, Pasquini MC, Sarantopoulos S, Storek J, Savani B, St Clair EW. Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2018 Oct; 24(10): 1961-4. PMID: 29953945, PMCID: PMC6239926, PII: S1083-8791(18)30362-8, DOI: 10.1016/j.bbmt.2018.06.025, ISSN: 1523-6536.

McDonald MK, Culos KA, Gatwood KS, Prow C, Chen H, Savani BN, Byrne M, Kassim AA, Engelhardt BG, Jagasia M, Satyanarayana G. Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program. Biol. Blood Marrow Transplant [print-electronic]. 2018 Oct; 24(10): 2081-7. PMID: 29753159, PII: S1083-8791(18)30253-2, DOI: 10.1016/j.bbmt.2018.04.031, ISSN: 1523-6536.

Duncan CN, Brazauskas R, Huang J, Shaw BE, Majhail NS, Savani BN, Flowers MED, Battiwalla M, Beebe K, Dietz AC, Dvorak CC, Giller R, Jacobsohn DA, Kletzel M, Martin PL, Nemecek ER, Nuechterlein B, Talano JA, Pulsipher MA, Baker KS. Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. Bone Marrow Transplant [print-electronic]. 2018 Oct; 53(10): 1278-87. PMID: 29581480, PMCID: PMC6158112, PII: 10.1038/s41409-018-0155-z, DOI: 10.1038/s41409-018-0155-z, ISSN: 1476-5365.

Byrne M, Savani B, Savona MR. Leveraging JAK-STAT regulation in myelofibrosis to improve outcomes with allogeneic hematopoietic stem-cell transplant. Ther Adv Hematol. 2018 Sep; 9(9): 251-9. PMID: 30210754, PMCID: PMC6130097, PII: 10.1177_2040620718786437, DOI: 10.1177/2040620718786437, ISSN: 2040-6207.

Gilleece MH, Labopin M, Yakoub-Agha I, Volin L, Socié G, Ljungman P, Huynh A, Deconinck E, Wu D, Bourhis JH, Cahn JY, Polge E, Mohty M, Savani BN, Nagler A. Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation. Am. J. Hematol [print-electronic]. 2018 Sep; 93(9): 1142-52. PMID: 29981272, DOI: 10.1002/ajh.25211, ISSN: 1096-8652.

Lee CJ, Savani BN, Ljungman P. Varicella Zoster Virus Reactivation in Adult Survivors of Hematopoietic Cell Transplantation: How Do We Best Protect Our Patients?. Biol. Blood Marrow Transplant [print-electronic]. 2018 Sep; 24(9): 1783-7. PMID: 29653205, PII: S1083-8791(18)30183-6, DOI: 10.1016/j.bbmt.2018.04.003, ISSN: 1523-6536.

Wood WA, Brazauskas R, Hu ZH, Abdel-Azim H, Ahmed IA, Aljurf M, Badawy S, Beitinjaneh A, George B, Buchbinder D, Cerny J, Dedeken L, Diaz MA, Freytes CO, Ganguly S, Gergis U, Almaguer DG, Gupta A, Hale G, Hashmi SK, Inamoto Y, Kamble RT, Adekola K, Kindwall-Keller T, Knight J, Kumar L, Kuwatsuka Y, Law J, Lazarus HM, LeMaistre C, Olsson RF, Pulsipher MA, Savani BN, Schultz KR, Saad AA, Seftel M, Seo S, Shea TC, Steinberg A, Sullivan K, Szwajcer D, Wirk B, Yared J, Yong A, Dalal J, Hahn T, Khera N, Bonfim C, Atsuta Y, Saber W. Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis. Biol. Blood Marrow Transplant [print-electronic]. 2018 Sep; 24(9): 1928-35. PMID: 29567340, PMCID: PMC6146070, PII: S1083-8791(18)30129-0, DOI: 10.1016/j.bbmt.2018.03.016, ISSN: 1523-6536.

Sengsayadeth S, Gatwood KS, Boumendil A, Labopin M, Finke J, Ganser A, Stelljes M, Ehninger G, Beelen D, Niederwieser D, Blaise D, Dreger P, Mufti G, Chevallier P, Mailhol A, Gilleece MH, Gorin N, Esteve J, Ciceri F, Baron F, Schmid C, Giebel S, Mohty M, Savani BN, Nagler A. Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study. Blood Adv. 2018 Aug 8/28/2018; 2(16): 2127-35. PMID: 30143527, PMCID: PMC6113606, PII: bloodadvances.2018019976, DOI: 10.1182/bloodadvances.2018019976, ISSN: 2473-9537.

Hourigan CS, Savani BN. Leukaemia risk associated with low-dose radiation. Lancet Haematol [print-electronic]. 2018 Aug; 5(8): e324-e325. PMID: 30026009, PMCID: PMC6097528, PII: S2352-3026(18)30106-6, DOI: 10.1016/S2352-3026(18)30106-6, ISSN: 2352-3026.

Sengsayadeth S, Labopin M, Boumendil A, Finke J, Ganser A, Stelljes M, Ehninger G, Beelen D, Niederwieser D, Blaise D, Dreger P, Mufti G, Chevallier P, Mailhol A, Gatwood KS, Gorin N, Esteve J, Ciceri F, Baron F, Schmid C, Giebel S, Mohty M, Savani BN, Nagler A. Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study. Biol. Blood Marrow Transplant [print-electronic]. 2018 Jul; 24(7): 1406-14. PMID: 29678639, PII: S1083-8791(18)30189-7, DOI: 10.1016/j.bbmt.2018.04.008, ISSN: 1523-6536.

Turcotte LM, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Ahmed I, Beitinjaneh A, Buchbinder D, Byrne M, Callander N, Chao N, Choi SW, DeFilipp Z, Gadalla SM, Gale RP, Gergis U, Hashmi S, Hematti P, Holmberg L, Inamoto Y, Kamble RT, Lehmann L, MacMillan MA, McIver Z, Nishihori T, Norkin M, O'Brien T, Olsson RF, Reshef R, Saad A, Savani BN, Schouten HC, Seo S, Solh M, Verdonck L, Vij R, Wirk B, Yared J, Horowitz MM, Knight JM, Verneris MR. Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation. Bone Marrow Transplant [print-electronic]. 2018 Jul; 53(7): 932-7. PMID: 29382954, PMCID: PMC6041147, PII: 10.1038/s41409-018-0100-1, DOI: 10.1038/s41409-018-0100-1, ISSN: 1476-5365.

Mohammed J, Akomolafe T, Aljurf M, Savani B, Hashmi SK. 'To treat or not to treat': raising awareness on the effects of graft versus host disease drugs on musculoskeletal system. Bone Marrow Transplant [print-electronic]. 2018 Jul; 53(7): 909-12. PMID: 29371684, PII: 10.1038/s41409-018-0095-7, DOI: 10.1038/s41409-018-0095-7, ISSN: 1476-5365.

Smith SM, Godfrey J, Ahn KW, DiGilio A, Ahmed S, Agrawal V, Bachanova V, Bacher U, Bashey A, Bolaños-Meade J, Cairo M, Chen A, Chhabra S, Copelan E, Dahi PB, Aljurf M, Farooq U, Ganguly S, Hertzberg M, Holmberg L, Inwards D, Kanate AS, Karmali R, Kenkre VP, Kharfan-Dabaja MA, Klein A, Lazarus HM, Mei M, Mussetti A, Nishihori T, Ramakrishnan Geethakumari P, Saad A, Savani BN, Schouten HC, Shah N, Urbano-Ispizua A, Vij R, Vose J, Sureda A, Hamadani M. Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure. Cancer [print-electronic]. 2018 Jun 6/15/2018; 124(12): 2541-51. PMID: 29645093, PMCID: PMC5990449, DOI: 10.1002/cncr.31374, ISSN: 1097-0142.

Baron F, Labopin M, Ruggeri A, Cornelissen JJ, Meijer E, Sengeloev H, Niederwieser D, De Groot MR, Schouten HC, Milpied N, Blaise D, Savani BN, Gluckman E, Mohty M, Nagler A. Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen. Clin. Cancer Res [print-electronic]. 2018 Jun 6/15/2018; 24(12): 2794-803. PMID: 29555662, PII: 1078-0432.CCR-17-3622, DOI: 10.1158/1078-0432.CCR-17-3622, ISSN: 1078-0432.

Huang J, Phillips S, Byrne M, Chinratanalab W, Engelhardt BG, Goodman SA, Harrell SL, Jagasia M, Kassim A, Rawling KT, Savani BN, Sengsayadeth S, Cornell RF. Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma. Bone Marrow Transplant [print-electronic]. 2018 Jun; 53(6): 701-7. PMID: 29703965, PII: 10.1038/s41409-018-0177-6, DOI: 10.1038/s41409-018-0177-6, ISSN: 1476-5365.

Hashmi SK, Lee SJ, Savani BN, Burns L, Wingard JR, Perales MA, Palmer J, Chow E, Meyer E, Marks D, Mohty M, Inamoto Y, Rodriguez C, Nagler A, Sauter C, Komanduri KV, Pidala J, Hamadani M, Johnston L, Shah N, Shaughnessy P, Hamilton BK, Majhail N, Kharfan-Dabaja MA, Schriber J, DeFilipp Z, Tarlock KG, Fanning S, Curtin P, Rizzo JD, Carpenter PA. ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors. Biol. Blood Marrow Transplant [print-electronic]. 2018 Jun; 24(6): 1119-24. PMID: 29608957, PII: S1083-8791(18)30157-5, DOI: 10.1016/j.bbmt.2018.03.023.

Gatwood KS, Culos KA, Binari LA, Engelhardt BG, Kassim A, Byrne MT, Goodman SA, Chinratanalab W, Sengsayadeth SM, Greer JP, Jagasia M, Savani BN. Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia [letter]. Bone Marrow Transplant [print-electronic]. 2018 Jun; 53(6): 795-9. PMID: 29540851, PII: 10.1038/s41409-018-0124-6, DOI: 10.1038/s41409-018-0124-6, ISSN: 1476-5365.

Li Z, Labopin M, Ciceri F, Blaise D, Tischer J, Ehninger G, Van Lint MT, Koc Y, Santarone S, Forcade E, Castagna L, Polge E, Mailhol A, Ruggeri A, Mohty M, Savani BN, Nagler A. Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study. Am. J. Hematol [print-electronic]. 2018 Jun; 93(6): 769-77. PMID: 29536560, DOI: 10.1002/ajh.25087, ISSN: 1096-8652.

Ciurea SO, Labopin M, Socie G, Volin L, Passweg J, Chevallier P, Beelen D, Milpied N, Blaise D, Cornelissen JJ, Fegueux N, Polge E, Kongtim P, Rondon G, Esteve J, Mohty M, Savani BN, Champlin RE, Nagler A. Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center. Cancer [print-electronic]. 2018 May 5/15/2018; 124(10): 2134-41. PMID: 29469961, DOI: 10.1002/cncr.31311, ISSN: 1097-0142.

Buchbinder D, Kelly DL, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick AB, Wirk BM, Yi J, Battiwalla M, Flowers MDE, Savani B, Shaw BE. Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplant [print-electronic]. 2018 May; 53(5): 535-55. PMID: 29343837, PMCID: PMC5985976, PII: 10.1038/s41409-017-0055-7, DOI: 10.1038/s41409-017-0055-7, ISSN: 1476-5365.

Ciurea SO, Cao K, Fernandez-Vina M, Kongtim P, Malki MA, Fuchs E, Luznik L, Huang XJ, Ciceri F, Locatelli F, Aversa F, Castagna L, Bacigalupo A, Martelli M, Blaise D, Handgretinger R, Roy DC, O'Donnell P, Bashey A, Lazarus HM, Ballen K, Savani BN, Mohty M, Nagler A. The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation. Bone Marrow Transplant [print-electronic]. 2018 May; 53(5): 521-34. PMID: 29335625, PII: 10.1038/s41409-017-0062-8, DOI: 10.1038/s41409-017-0062-8.

Shah NN, Ahn KW, Litovich C, Fenske TS, Ahmed S, Battiwalla M, Bejanyan N, Dahi PB, Bolaños-Meade J, Chen AI, Ciurea SO, Bachanova V, DeFilipp Z, Epperla N, Farhadfar N, Herrera AF, Haverkos BM, Holmberg L, Hossain NM, Kharfan-Dabaja MA, Kenkre VP, Lazarus HM, Murthy HS, Nishihori T, Rezvani AR, D'Souza A, Savani BN, Ulrickson ML, Waller EK, Sureda A, Smith SM, Hamadani M. Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis. Blood Adv. 2018 Apr 4/24/2018; 2(8): 933-40. PMID: 29685953, PMCID: PMC5916010, PII: bloodadvances.2018018531, DOI: 10.1182/bloodadvances.2018018531, ISSN: 2473-9537.

Shimoni A, Labopin M, Savani B, Hamladji RM, Beelen D, Mufti G, Socié G, Delage J, Blaise D, Chevallier P, Forcade E, Deconinck E, Mohty M, Nagler A. Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2018 Apr; 24(4): 751-7. PMID: 29247780, PII: S1083-8791(17)31680-4, DOI: 10.1016/j.bbmt.2017.12.776, ISSN: 1523-6536.

Kharfan-Dabaja MA, Raj R, Nikolaenko L, Ahmed S, Reddy N, Nathan S, Cherry M, El-Jurdi N, Obiozor C, Fenske TS, Song J, Muzzafar T, Ayala E, Savani B, Khawandanah M, Caimi PF, Hamadani M, Forman SJ, Hussaini M, de Lima M, Olteanu H, Shah B, Chavez JC, Al Malki M, Kumar A, Ganguly S. Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Gray Zone Lymphoma: A US Multicenter Collaborative Study. Biol. Blood Marrow Transplant [print-electronic]. 2018 Mar; 24(3): 486-93. PMID: 29225164, PII: S1083-8791(17)30880-7, DOI: 10.1016/j.bbmt.2017.11.033, ISSN: 1523-6536.

Qayed M, Wang T, Hemmer MT, Spellman S, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Aljurf M, Ayas M, Bitan M, Cairo M, Choi SW, Dandoy C, Delgado D, Gale RP, Hale G, Frangoul H, Kamble RT, Kharfan-Dabaja M, Lehman L, Levine J, MacMillan M, Marks DI, Nishihori T, Olsson RF, Hematti P, Ringden O, Saad A, Satwani P, Savani BN, Schultz KR, Seo S, Shenoy S, Waller EK, Yu L, Horowitz MM, Horan J. Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis. Biol. Blood Marrow Transplant [print-electronic]. 2018 Mar; 24(3): 521-8. PMID: 29155316, PMCID: PMC5826854, PII: S1083-8791(17)30818-2, DOI: 10.1016/j.bbmt.2017.11.004, ISSN: 1523-6536.

Myers RM, Hill BT, Shaw BE, Kim S, Millard HR, Battiwalla M, Majhail NS, Buchbinder D, Lazarus HM, Savani BN, Flowers MED, D'Souza A, Ehrhardt MJ, Langston A, Yared JA, Hayashi RJ, Daly A, Olsson RF, Inamoto Y, Malone AK, DeFilipp Z, Margossian SP, Warwick AB, Jaglowski S, Beitinjaneh A, Fung H, Kasow KA, Marks DI, Reynolds J, Stockerl-Goldstein K, Wirk B, Wood WA, Hamadani M, Satwani P. Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma. Cancer [print-electronic]. 2018 Feb 2/15/2018; 124(4): 816-25. PMID: 29125192, PMCID: PMC5871233, DOI: 10.1002/cncr.31114, ISSN: 1097-0142.

Canaani J, Savani BN, Labopin M, Huang XJ, Ciceri F, Arcese W, Koc Y, Tischer J, Blaise D, Gülbas Z, Van Lint MT, Bruno B, Mohty M, Nagler A. Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation. Am. J. Hematol [print-electronic]. 2018 Feb; 93(2): 246-53. PMID: 29114918, DOI: 10.1002/ajh.24963, ISSN: 1096-8652.

Rubinstein SM, Culos KA, Savani B, Satyanarayana G. Foiling fungal disease post hematopoietic cell transplant: review of prophylactic strategies. Bone Marrow Transplant [print-electronic]. 2018 Feb; 53(2): 123-8. PMID: 29058698, PII: bmt2017222, DOI: 10.1038/bmt.2017.222, ISSN: 1476-5365.

Baron F, Ruggeri A, Beohou E, Labopin M, Mohty M, Sanz J, Vigouroux S, Furst S, Bosi A, Chevallier P, Cornelissen JJ, Michallet M, Sierra J, Karakasis D, Savani BN, Gluckman E, Nagler A. Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT. J. Intern. Med [print-electronic]. 2018 Feb; 283(2): 178-89. PMID: 28977716, DOI: 10.1111/joim.12696, ISSN: 1365-2796.

Kelly DL, Buchbinder D, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick A, Wirk BM, Yi J, Battiwalla M, Flowers ME, Savani B, Shaw BE. Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2018 Feb; 24(2): 228-41. PMID: 28939455, PMCID: PMC5768142, PII: S1083-8791(17)30698-5, DOI: 10.1016/j.bbmt.2017.09.004, ISSN: 1523-6536.

Saraceni F, Labopin M, Hamladji RM, Mufti G, Socié G, Shimoni A, Delage J, Deconinck E, Chevallier P, Blaise D, Sanz J, Huynh A, Forcade E, Savani BN, Mohty M, Nagler A, . Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission. Oncotarget. 2018 Jan 1/9/2018; 9(3): 3379-93. PMID: 29423053, PMCID: PMC5790470, PII: 23273, DOI: 10.18632/oncotarget.23273, ISSN: 1949-2553.

Shanis D, Anandi P, Grant C, Bachi A, Vyas N, Merideth MA, Pophali PA, Koklanaris E, Ito S, Savani BN, Barrett AJ, Battiwalla M, Stratton P. Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study. Bone Marrow Transplant [print-electronic]. 2018 Jan; 53(1): 78-83. PMID: 29035398, PII: bmt2017210, DOI: 10.1038/bmt.2017.210, ISSN: 1476-5365.

Epperla N, Ahn KW, Armand P, Jaglowski S, Ahmed S, Kenkre VP, Savani B, Jagasia M, Shah NN, Fenske TS, Sureda A, Smith SM, Hamadani M. Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma. Biol. Blood Marrow Transplant [print-electronic]. 2018 Jan; 24(1): 78-85. PMID: 29032272, PMCID: PMC5743624, PII: S1083-8791(17)30770-X, DOI: 10.1016/j.bbmt.2017.10.011, ISSN: 1523-6536.

Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, Anderlini P, Bredeson CN, Hematti P, Ganguly S, Diaz MA, Abdel-Azim H, Ahmed I, Maharaj D, Seftel M, Beitinjaneh A, Seo S, Yared JA, Halter J, O'Donnell PV, Hale GA, DeFilipp Z, Lazarus H, Liesveld JL, Zhou Z, Munshi P, Olsson RF, Kasow KA, Szer J, Switzer GE, Chitphakdithai P, Shah N, Confer DL, Pulsipher MA. Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less. Biol. Blood Marrow Transplant [print-electronic]. 2018 Jan; 24(1): 175-84. PMID: 28958894, PMCID: PMC5743544, PII: S1083-8791(17)30724-3, DOI: 10.1016/j.bbmt.2017.09.013, ISSN: 1523-6536.

Kennedy VE, Chen H, Savani BN, Greer J, Kassim AA, Engelhardt BG, Goodman S, Sengsayadeth S, Chinratanalab W, Jagasia M. Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count. Biol. Blood Marrow Transplant [print-electronic]. 2018 Jan; 24(1): 150-5. PMID: 28864139, PII: S1083-8791(17)30682-1, DOI: 10.1016/j.bbmt.2017.08.029, ISSN: 1523-6536.

Mahindra A, Hari P, Fraser R, Fei M, Huang J, Berdeja J, Callander N, Costa L, Diaz MA, Freytes C, Gale RP, Girnius S, Holmberg L, Kharfan-Dabaja M, Kumar S, Kyle R, Lazarus H, Lee C, Maiolino A, Moreb J, Nishihori T, Pawarode A, Saad A, Savani BN, Schriber J, William B, Wirk BM, Krishnan A, Nieto Y, D'Souza A. Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis. Bone Marrow Transplant [print-electronic]. 2017 Dec; 52(12): 1616-22. PMID: 28920949, PMCID: PMC5859934, PII: bmt2017198, DOI: 10.1038/bmt.2017.198, ISSN: 1476-5365.

Lee CJ, Savani BN, Mohty M, Labopin M, Ruggeri A, Schmid C, Baron F, Esteve J, Gorin NC, Giebel S, Ciceri F, Nagler A. Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica [print-electronic]. 2017 Nov; 102(11): 1810-22. PMID: 28883081, PMCID: PMC5664385, PII: haematol.2017.176107, DOI: 10.3324/haematol.2017.176107, ISSN: 1592-8721.

Arnold SD, Brazauskas R, He N, Li Y, Aplenc R, Jin Z, Hall M, Atsuta Y, Dalal J, Hahn T, Khera N, Bonfim C, Majhail NS, Diaz MA, Freytes CO, Wood WA, Savani BN, Kamble RT, Parsons S, Ahmed I, Sullivan K, Beattie S, Dandoy C, Munker R, Marino S, Bitan M, Abdel-Azim H, Aljurf M, Olsson RF, Joshi S, Buchbinder D, Eckrich MJ, Hashmi S, Lazarus H, Marks DI, Steinberg A, Saad A, Gergis U, Krishnamurti L, Abraham A, Rangarajan HG, Walters M, Lipscomb J, Saber W, Satwani P. Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases. Haematologica [print-electronic]. 2017 Nov; 102(11): 1823-32. PMID: 28818869, PMCID: PMC5664386, PII: haematol.2017.169581, DOI: 10.3324/haematol.2017.169581, ISSN: 1592-8721.

Mohammed J, Savani BN, El-Jawahri A, Vanderklish J, Cheville AL, Hashmi SK. Is there any role for physical therapy in chronic GvHD?. Bone Marrow Transplant [print-electronic]. 2017 Aug 8/7/2017; PMID: 28783145, PII: bmt2017155, DOI: 10.1038/bmt.2017.155, ISSN: 1476-5365.

Kharfan-Dabaja MA, Kumar A, Ayala E, Hamadani M, Reimer P, Gisselbrecht C, d'Amore F, Jantunen E, Ishida T, Bazarbachi A, Foss F, Advani R, Fenske TS, Lazarus HM, Friedberg JW, Aljurf M, Sokol L, Tobinai K, Tse E, Burns LJ, Chavez JC, Reddy NM, Suzuki R, Ahmed S, Nademanee A, Mohty M, Gopal AK, Fanale MA, Pro B, Moskowitz AJ, Sureda A, Perales MA, Carpenter PA, Savani BN. Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T-Cell and NK/T-Cell Lymphomas: an International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2017 Aug 8/7/2017; PMID: 28797780, PII: S1083-8791(17)30623-7, DOI: 10.1016/j.bbmt.2017.07.027, ISSN: 1523-6536.

Kanate AS, DiGilio A, Ahn KW, Al Malki M, Jacobsen E, Steinberg A, Hamerschlak N, Kharfan-Dabaja M, Salit R, Ball E, Bashir Q, Cashen A, Couriel D, Diez-Martin J, Katsanis E, Linhares Y, Mori S, Nash R, Pawarode A, Perales MA, Phipps CD, Richman C, Savani BN, Shapira MY, Stiff P, Strair R, Fenske TS, Smith SM, Sureda A, Olteanu H, Hamadani M. Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis [letter]. Br. J. Haematol [print-electronic]. 2017 Aug 8/2/2017; PMID: 28771676, DOI: 10.1111/bjh.14879, ISSN: 1365-2141.

Kanate AS, DiGilio A, Ahn KW, Al Malki M, Jacobsen E, Steinberg A, Hamerschlak N, Kharfan-Dabaja M, Salit R, Ball E, Bashir Q, Cashen A, Couriel D, Diez-Martin J, Katsanis E, Linhares Y, Mori S, Nash R, Pawarode A, Perales MA, Phipps CD, Richman C, Savani BN, Shapira MY, Stiff P, Strair R, Fenske TS, Smith SM, Sureda A, Olteanu H, Hamadani M. Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis [letter]. Br. J. Haematol [print-electronic]. 2017 Aug 8/2/2017; PMID: 28771676, DOI: 10.1111/bjh.14879, ISSN: 1365-2141.

Panch SR, Szymanski J, Savani BN, Stroncek DF. Sources of Hematopoietic Stem and Progenitor Cells and Methods to Optimize Yields for Clinical Cell Therapy. Biol. Blood Marrow Transplant [print-electronic]. 2017 Aug; 23(8): 1241-9. PMID: 28495640, PII: S1083-8791(17)30450-0, DOI: 10.1016/j.bbmt.2017.05.003, ISSN: 1523-6536.

Vrooman LM, Millard HR, Brazauskas R, Majhail NS, Battiwalla M, Flowers ME, Savani BN, Akpek G, Aljurf M, Bajwa R, Baker KS, Beitinjaneh A, Bitan M, Buchbinder D, Chow E, Dandoy C, Dietz AC, Diller L, Gale RP, Hashmi SK, Hayashi RJ, Hematti P, Kamble RT, Kasow KA, Kletzel M, Lazarus HM, Malone AK, Marks DI, O'Brien TA, Olsson RF, Ringden O, Seo S, Steinberg A, Yu LC, Warwick A, Shaw B, Duncan C. Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age. Biol. Blood Marrow Transplant [print-electronic]. 2017 Aug; 23(8): 1327-34. PMID: 28461213, PII: S1083-8791(17)30426-3, DOI: 10.1016/j.bbmt.2017.04.017, ISSN: 1523-6536.

Canaani J, Savani BN, Labopin M, Michallet M, Craddock C, Socié G, Volin L, Maertens JA, Crawley C, Blaise D, Ljungman PT, Cornelissen J, Russell N, Baron F, Gorin N, Esteve J, Ciceri F, Schmid C, Giebel S, Mohty M, Nagler A. ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT. Am. J. Hematol [print-electronic]. 2017 Aug; 92(8): 789-96. PMID: 28439910, DOI: 10.1002/ajh.24771, ISSN: 1096-8652.

Gabriel M, Shaw BE, Brazauskas R, Chen M, Margolis DA, Sengelov H, Dahlberg A, Ahmed IA, Delgado D, Lazarus HM, Gibson B, Myers KC, Kamble RT, Abdel-Mageed A, Li CK, Flowers MED, Battiwalla M, Savani BN, Majhail N, Shaw PJ. Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol. Blood Marrow Transplant [print-electronic]. 2017 Aug; 23(8): 1320-6. PMID: 28411175, PMCID: PMC5518678, PII: S1083-8791(17)30392-0, DOI: 10.1016/j.bbmt.2017.04.004, ISSN: 1523-6536.

Gabriel M, Shaw BE, Brazauskas R, Chen M, Margolis DA, Sengelov H, Dahlberg A, Ahmed IA, Delgado D, Lazarus HM, Gibson B, Myers KC, Kamble RT, Abdel-Mageed A, Li CK, Flowers MED, Battiwalla M, Savani BN, Majhail N, Shaw PJ. Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol. Blood Marrow Transplant [print-electronic]. 2017 Aug; 23(8): 1320-6. PMID: 28411175, PMCID: PMC5518678, PII: S1083-8791(17)30392-0, DOI: 10.1016/j.bbmt.2017.04.004, ISSN: 1523-6536.

Canaani J, Savani BN, Labopin M, Michallet M, Craddock C, Socié G, Volin L, Maertens JA, Crawley C, Blaise D, Ljungman PT, Cornelissen J, Russell N, Baron F, Gorin N, Esteve J, Ciceri F, Schmid C, Giebel S, Mohty M, Nagler A. ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT. Am. J. Hematol [print-electronic]. 2017 Aug; 92(8): 789-96. PMID: 28439910, DOI: 10.1002/ajh.24771, ISSN: 1096-8652.

Vrooman LM, Millard HR, Brazauskas R, Majhail NS, Battiwalla M, Flowers ME, Savani BN, Akpek G, Aljurf M, Bajwa R, Baker KS, Beitinjaneh A, Bitan M, Buchbinder D, Chow E, Dandoy C, Dietz AC, Diller L, Gale RP, Hashmi SK, Hayashi RJ, Hematti P, Kamble RT, Kasow KA, Kletzel M, Lazarus HM, Malone AK, Marks DI, O'Brien TA, Olsson RF, Ringden O, Seo S, Steinberg A, Yu LC, Warwick A, Shaw B, Duncan C. Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age. Biol. Blood Marrow Transplant [print-electronic]. 2017 Aug; 23(8): 1327-34. PMID: 28461213, PII: S1083-8791(17)30426-3, DOI: 10.1016/j.bbmt.2017.04.017, ISSN: 1523-6536.

Panch SR, Szymanski J, Savani BN, Stroncek DF. Sources of Hematopoietic Stem and Progenitor Cells and Methods to Optimize Yields for Clinical Cell Therapy. Biol. Blood Marrow Transplant [print-electronic]. 2017 Aug; 23(8): 1241-9. PMID: 28495640, PII: S1083-8791(17)30450-0, DOI: 10.1016/j.bbmt.2017.05.003, ISSN: 1523-6536.

Nagler A, Labopin M, Beelen D, Ciceri F, Volin L, Shimoni A, Foá R, Milpied N, Peccatori J, Polge E, Mailhol A, Mohty M, Savani BN. Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Cancer [print-electronic]. 2017 Jul 7/15/2017; 123(14): 2671-9. PMID: 28329410, DOI: 10.1002/cncr.30646, ISSN: 1097-0142.

Nagler A, Labopin M, Beelen D, Ciceri F, Volin L, Shimoni A, Foá R, Milpied N, Peccatori J, Polge E, Mailhol A, Mohty M, Savani BN. Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Cancer [print-electronic]. 2017 Jul 7/15/2017; 123(14): 2671-9. PMID: 28329410, DOI: 10.1002/cncr.30646, ISSN: 1097-0142.

Chaudhri NA, Aljurf M, Almohareb FI, Alzahrani HA, Bashir Q, Savani B, Gupta V, Hashmi SK. Establishing an autologous versus allogeneic hematopoietic cell transplant program in nations with emerging economies. Hematol Oncol Stem Cell Ther [print-electronic]. 2017 Jul 7/3/2017; PMID: 28692818, PII: S1658-3876(17)30054-7, DOI: 10.1016/j.hemonc.2017.05.016, ISSN: 1658-3876.

Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea S, Copelan E, D'Souza A, Edwards J, Foran J, Freytes CO, Fung HC, Gale RP, Giralt S, Hashmi SK, Hildebrandt GC, Ho V, Jakubowski A, Lazarus H, Luskin MR, Martino R, Maziarz R, McCarthy P, Nishihori T, Olin R, Olsson RF, Pawarode A, Peres E, Rezvani AR, Rizzieri D, Savani BN, Schouten HC, Sabloff M, Seftel M, Seo S, Sorror ML, Szer J, Wirk BM, Wood WA, Artz A. Increasing use of allogeneic hematopoietic cell transplantation in patients age 70 years and older in the United States. Blood [print-electronic]. 2017 Jul 7/3/2017; PMID: 28674027, PII: blood-2017-03-772368, DOI: 10.1182/blood-2017-03-772368, ISSN: 1528-0020.

Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea S, Copelan E, D'Souza A, Edwards J, Foran J, Freytes CO, Fung HC, Gale RP, Giralt S, Hashmi SK, Hildebrandt GC, Ho V, Jakubowski A, Lazarus H, Luskin MR, Martino R, Maziarz R, McCarthy P, Nishihori T, Olin R, Olsson RF, Pawarode A, Peres E, Rezvani AR, Rizzieri D, Savani BN, Schouten HC, Sabloff M, Seftel M, Seo S, Sorror ML, Szer J, Wirk BM, Wood WA, Artz A. Increasing use of allogeneic hematopoietic cell transplantation in patients age 70 years and older in the United States. Blood [print-electronic]. 2017 Jul 7/3/2017; PMID: 28674027, PII: blood-2017-03-772368, DOI: 10.1182/blood-2017-03-772368, ISSN: 1528-0020.

Baron F, Ruggeri A, Beohou E, Labopin M, Mohty M, Blaise D, Cornelissen JJ, Chevallier P, Sanz G, Petersen E, Savani BN, Gluckman E, Nagler A. Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT. J Hematol Oncol. 2017 Jun 6/21/2017; 10(1): 128. PMID: 28637512, PMCID: PMC5479038, PII: 10.1186/s13045-017-0497-9, DOI: 10.1186/s13045-017-0497-9, ISSN: 1756-8722.

Baron F, Ruggeri A, Beohou E, Labopin M, Mohty M, Blaise D, Cornelissen JJ, Chevallier P, Sanz G, Petersen E, Savani BN, Gluckman E, Nagler A. Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT. J Hematol Oncol. 2017 Jun 6/21/2017; 10(1): 128. PMID: 28637512, PMCID: PMC5479038, PII: 10.1186/s13045-017-0497-9, DOI: 10.1186/s13045-017-0497-9, ISSN: 1756-8722.

Kassim AA, Savani BN. Hematopoietic stem cell transplantation for acute myeloid leukemia: A review. Hematol Oncol Stem Cell Ther [print-electronic]. 2017 Jun 6/20/2017; PMID: 28666104, PII: S1658-3876(17)30059-6, DOI: 10.1016/j.hemonc.2017.05.021, ISSN: 1658-3876.

Kassim AA, Savani BN. Hematopoietic stem cell transplantation for acute myeloid leukemia: A review. Hematol Oncol Stem Cell Ther [print-electronic]. 2017 Jun 6/20/2017; PMID: 28666104, PII: S1658-3876(17)30059-6, DOI: 10.1016/j.hemonc.2017.05.021, ISSN: 1658-3876.

Kennedy LB, Li Z, Savani BN, Ljungman P. Measuring Immune Response to Commonly Used Vaccinations in Adult Recipients of Allogeneic Hematopoietic Cell Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2017 Jun 6/15/2017; PMID: 28624476, PII: S1083-8791(17)30515-3, DOI: 10.1016/j.bbmt.2017.06.006, ISSN: 1523-6536.

Kennedy LB, Li Z, Savani BN, Ljungman P. Measuring Immune Response to Commonly Used Vaccinations in Adult Recipients of Allogeneic Hematopoietic Cell Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2017 Jun 6/15/2017; PMID: 28624476, PII: S1083-8791(17)30515-3, DOI: 10.1016/j.bbmt.2017.06.006, ISSN: 1523-6536.

Canaani J, Savani BN, Labopin M, Huang XJ, Ciceri F, Arcese W, Tischer J, Koc Y, Bruno B, Gülbas Z, Blaise D, Maertens J, Ehninger G, Mohty M, Nagler A. Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT. Haematologica [print-electronic]. 2017 Jun; 102(6): 1066-74. PMID: 28255020, PMCID: PMC5451338, PII: haematol.2016.160804, DOI: 10.3324/haematol.2016.160804, ISSN: 1592-8721.

Hamilton BK, Goje O, Savani BN, Majhail NS, Stratton P. Clinical management of genital chronic GvHD. Bone Marrow Transplant [print-electronic]. 2017 Jun; 52(6): 803-10. PMID: 28067883, PII: bmt2016315, DOI: 10.1038/bmt.2016.315, ISSN: 1476-5365.

Gea-Banacloche J, Komanduri KV, Carpenter P, Paczesny S, Sarantopoulos S, Young JA, El Kassar N, Le RQ, Schultz KR, Griffith LM, Savani BN, Wingard JR. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report. Biol. Blood Marrow Transplant [print-electronic]. 2017 Jun; 23(6): 870-81. PMID: 27751936, PMCID: PMC5392182, PII: S1083-8791(16)30391-3, DOI: 10.1016/j.bbmt.2016.10.001, ISSN: 1523-6536.

Canaani J, Savani BN, Labopin M, Huang XJ, Ciceri F, Arcese W, Tischer J, Koc Y, Bruno B, Gülbas Z, Blaise D, Maertens J, Ehninger G, Mohty M, Nagler A. Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT. Haematologica [print-electronic]. 2017 Jun; 102(6): 1066-74. PMID: 28255020, PMCID: PMC5451338, PII: haematol.2016.160804, DOI: 10.3324/haematol.2016.160804, ISSN: 1592-8721.

Hamilton BK, Goje O, Savani BN, Majhail NS, Stratton P. Clinical management of genital chronic GvHD. Bone Marrow Transplant [print-electronic]. 2017 Jun; 52(6): 803-10. PMID: 28067883, PII: bmt2016315, DOI: 10.1038/bmt.2016.315, ISSN: 1476-5365.

Gea-Banacloche J, Komanduri KV, Carpenter P, Paczesny S, Sarantopoulos S, Young JA, El Kassar N, Le RQ, Schultz KR, Griffith LM, Savani BN, Wingard JR. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report. Biol. Blood Marrow Transplant [print-electronic]. 2017 Jun; 23(6): 870-81. PMID: 27751936, PMCID: PMC5392182, PII: S1083-8791(16)30391-3, DOI: 10.1016/j.bbmt.2016.10.001, ISSN: 1523-6536.

Jethava YS, Sica S, Savani B, Socola F, Jagasia M, Mohty M, Nagler A, Bacigalupo A. Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia. Bone Marrow Transplant [print-electronic]. 2017 May 5/15/2017; PMID: 28504666, PII: bmt201783, DOI: 10.1038/bmt.2017.83, ISSN: 1476-5365.

El-Jawahri A, Chen YB, Brazauskas R, He N, Lee SJ, Knight JM, Majhail N, Buchbinder D, Schears RM, Wirk BM, Wood WA, Ahmed I, Aljurf M, Szer J, Beattie SM, Battiwalla M, Dandoy C, Diaz MA, D'Souza A, Freytes CO, Gajewski J, Gergis U, Hashmi SK, Jakubowski A, Kamble RT, Kindwall-Keller T, Lazarus HM, Malone AK, Marks DI, Meehan K, Savani BN, Olsson RF, Rizzieri D, Steinberg A, Speckhart D, Szwajcer D, Schoemans H, Seo S, Ustun C, Atsuta Y, Dalal J, Sales-Bonfim C, Khera N, Hahn T, Saber W. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation. Cancer [print-electronic]. 2017 May 5/15/2017; 123(10): 1828-38. PMID: 28102896, PMCID: PMC5419891, DOI: 10.1002/cncr.30546, ISSN: 1097-0142.

El-Jawahri A, Chen YB, Brazauskas R, He N, Lee SJ, Knight JM, Majhail N, Buchbinder D, Schears RM, Wirk BM, Wood WA, Ahmed I, Aljurf M, Szer J, Beattie SM, Battiwalla M, Dandoy C, Diaz MA, D'Souza A, Freytes CO, Gajewski J, Gergis U, Hashmi SK, Jakubowski A, Kamble RT, Kindwall-Keller T, Lazarus HM, Malone AK, Marks DI, Meehan K, Savani BN, Olsson RF, Rizzieri D, Steinberg A, Speckhart D, Szwajcer D, Schoemans H, Seo S, Ustun C, Atsuta Y, Dalal J, Sales-Bonfim C, Khera N, Hahn T, Saber W. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation. Cancer [print-electronic]. 2017 May 5/15/2017; 123(10): 1828-38. PMID: 28102896, PMCID: PMC5419891, DOI: 10.1002/cncr.30546, ISSN: 1097-0142.

Khoury HJ, Wang T, Hemmer MT, Couriel D, Alousi A, Cutler C, Aljurf M, Antin JH, Ayas M, Battiwalla M, Cahn JY, Cairo M, Chen YB, Gale RP, Hashmi S, Hayashi RJ, Jagasia M, Juckett M, Kamble RT, Kharfan-Dabaja M, Litzow M, Majhail N, Miller A, Nishihori T, Qayed M, Schoemans H, Schouten HC, Socie G, Storek J, Verdonck L, Vij R, Wood WA, Yu L, Martino R, Carabasi M, Dandoy C, Gergis U, Hematti P, Solh M, Jamani K, Lehmann L, Savani B, Schultz KR, Wirk BM, Spellman S, Arora M, Pidala J. Improved survival after acute graft-versus-host disease diagnosis in the modern era. Haematologica [print-electronic]. 2017 May; 102(5): 958-66. PMID: 28302712, PMCID: PMC5477615, PII: haematol.2016.156356, DOI: 10.3324/haematol.2016.156356, ISSN: 1592-8721.

Byrne M, Danielson N, Harris A, Savani BN. Making inroads to the cure: Barriers to clinical trial enrollment in hematopoietic cell transplantation. Clin Transplant [print-electronic]. 2017 May; 31(5): PMID: 28256053, DOI: 10.1111/ctr.12948, ISSN: 1399-0012.

Liu HD, Ahn KW, Hu ZH, Hamadani M, Nishihori T, Wirk B, Beitinjaneh A, Rizzieri D, Grunwald MR, Sabloff M, Olsson RF, Bajel A, Bredeson C, Daly A, Inamoto Y, Majhail N, Saad A, Gupta V, Gerds A, Malone A, Tallman M, Reshef R, Marks DI, Copelan E, Gergis U, Savoie ML, Ustun C, Litzow MR, Cahn JY, Kindwall-Keller T, Akpek G, Savani BN, Aljurf M, Rowe JM, Wiernik PH, Hsu JW, Cortes J, Kalaycio M, Maziarz R, Sobecks R, Popat U, Alyea E, Saber W. Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia. Biol. Blood Marrow Transplant [print-electronic]. 2017 May; 23(5): 767-75. PMID: 28115276, PII: S1083-8791(17)30203-3, DOI: 10.1016/j.bbmt.2017.01.078, ISSN: 1523-6536.

Fuji S, Löffler J, Savani BN, Einsele H, Kapp M. Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant [print-electronic]. 2017 May; 52(5): 657-62. PMID: 27941771, PII: bmt2016306, DOI: 10.1038/bmt.2016.306, ISSN: 1476-5365.

Byrne M, Danielson N, Harris A, Savani BN. Making inroads to the cure: Barriers to clinical trial enrollment in hematopoietic cell transplantation. Clin Transplant [print-electronic]. 2017 May; 31(5): PMID: 28256053, DOI: 10.1111/ctr.12948, ISSN: 1399-0012.

Liu HD, Ahn KW, Hu ZH, Hamadani M, Nishihori T, Wirk B, Beitinjaneh A, Rizzieri D, Grunwald MR, Sabloff M, Olsson RF, Bajel A, Bredeson C, Daly A, Inamoto Y, Majhail N, Saad A, Gupta V, Gerds A, Malone A, Tallman M, Reshef R, Marks DI, Copelan E, Gergis U, Savoie ML, Ustun C, Litzow MR, Cahn JY, Kindwall-Keller T, Akpek G, Savani BN, Aljurf M, Rowe JM, Wiernik PH, Hsu JW, Cortes J, Kalaycio M, Maziarz R, Sobecks R, Popat U, Alyea E, Saber W. Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia. Biol. Blood Marrow Transplant [print-electronic]. 2017 May; 23(5): 767-75. PMID: 28115276, PII: S1083-8791(17)30203-3, DOI: 10.1016/j.bbmt.2017.01.078, ISSN: 1523-6536.

Fuji S, Löffler J, Savani BN, Einsele H, Kapp M. Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant [print-electronic]. 2017 May; 52(5): 657-62. PMID: 27941771, PII: bmt2016306, DOI: 10.1038/bmt.2016.306, ISSN: 1476-5365.

Kharfan-Dabaja MA, El-Jurdi N, Ayala E, Kanate AS, Savani BN, Hamadani M. Is myeloablative dose intensity necessary in allogeneic hematopoietic cell transplantation for lymphomas?. Bone Marrow Transplant [print-electronic]. 2017 Apr 4/3/2017; PMID: 28368373, PII: bmt201755, DOI: 10.1038/bmt.2017.55, ISSN: 1476-5365.

Kharfan-Dabaja MA, El-Jurdi N, Ayala E, Kanate AS, Savani BN, Hamadani M. Is myeloablative dose intensity necessary in allogeneic hematopoietic cell transplantation for lymphomas?. Bone Marrow Transplant [print-electronic]. 2017 Apr 4/3/2017; PMID: 28368373, PII: bmt201755, DOI: 10.1038/bmt.2017.55, ISSN: 1476-5365.

Sengsayadeth S, Malard F, Savani BN, Garderet L, Mohty M. Posttransplant maintenance therapy in multiple myeloma: the changing landscape. Blood Cancer J. 2017 Mar 3/24/2017; 7(3): e545. PMID: 28338672, PMCID: PMC5380907, PII: bcj201723, DOI: 10.1038/bcj.2017.23, ISSN: 2044-5385.

Sengsayadeth S, Malard F, Savani BN, Garderet L, Mohty M. Posttransplant maintenance therapy in multiple myeloma: the changing landscape. Blood Cancer J. 2017 Mar 3/24/2017; 7(3): e545. PMID: 28338672, PMCID: PMC5380907, PII: bcj201723, DOI: 10.1038/bcj.2017.23, ISSN: 2044-5385.

Johnpulle RA, Paczesny S, Jung DK, Daguindau E, Jagasia MH, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Byrne MT, Engelhardt BG. Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling. Biol. Blood Marrow Transplant [print-electronic]. 2017 Mar; 23(3): 529-32. PMID: 28013014, PMCID: PMC5321545, PII: S1083-8791(16)31186-7, DOI: 10.1016/j.bbmt.2016.12.627, ISSN: 1523-6536.

Chen YB, Wang T, Hemmer MT, Brady C, Couriel DR, Alousi A, Pidala J, Urbano-Ispizua A, Choi SW, Nishihori T, Teshima T, Inamoto Y, Wirk B, Marks DI, Abdel-Azim H, Lehmann L, Yu L, Bitan M, Cairo MS, Qayed M, Salit R, Gale RP, Martino R, Jaglowski S, Bajel A, Savani B, Frangoul H, Lewis ID, Storek J, Askar M, Kharfan-Dabaja MA, Aljurf M, Ringden O, Reshef R, Olsson RF, Hashmi S, Seo S, Spitzer TR, MacMillan ML, Lazaryan A, Spellman SR, Arora M, Cutler CS. GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes. Bone Marrow Transplant [print-electronic]. 2017 Mar; 52(3): 400-8. PMID: 27941764, PMCID: PMC5332289, PII: bmt2016265, DOI: 10.1038/bmt.2016.265, ISSN: 1476-5365.

Johnpulle RA, Paczesny S, Jung DK, Daguindau E, Jagasia MH, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Byrne MT, Engelhardt BG. Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling. Biol. Blood Marrow Transplant [print-electronic]. 2017 Mar; 23(3): 529-32. PMID: 28013014, PMCID: PMC5321545, PII: S1083-8791(16)31186-7, DOI: 10.1016/j.bbmt.2016.12.627, ISSN: 1523-6536.

Rapoport Y, Freeman T, Koyama T, Engelhardt BG, Jagasia M, Savani BN, Tran U, Kassim AA. Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric. Cornea. 2017 Feb; 36(2): 258-63. PMID: 28060078, PII: 00003226-201702000-00022, DOI: 10.1097/ICO.0000000000001109, ISSN: 1536-4798.

Maziarz RT, Brazauskas R, Chen M, McLeod AA, Martino R, Wingard JR, Aljurf M, Battiwalla M, Dvorak CC, Geroge B, Guinan EC, Hale GA, Lazarus HM, Lee JW, Liesveld JL, Ramanathan M, Reddy V, Savani BN, Smith FO, Strasfeld L, Taplitz RA, Ustun C, Boeckh MJ, Gea-Banacloche J, Lindemans CA, Auletta JJ, Riches ML. Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study. Bone Marrow Transplant [print-electronic]. 2017 Feb; 52(2): 270-8. PMID: 27991895, PMCID: PMC5358320, PII: bmt2016259, DOI: 10.1038/bmt.2016.259, ISSN: 1476-5365.

Baron F, Mohty M, Blaise D, Socié G, Labopin M, Esteve J, Ciceri F, Giebel S, Gorin NC, Savani BN, Schmid C, Nagler A. Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica [print-electronic]. 2017 Feb; 102(2): 224-34. PMID: 27927772, PMCID: PMC5286931, PII: haematol.2016.148510, DOI: 10.3324/haematol.2016.148510, ISSN: 1592-8721.

Malard F, Labopin M, Stuhler G, Bittenbring J, Ganser A, Tischer J, Michallet M, Kröger N, Schmid C, Huynh A, Hallek M, Savani BN, Mohty M, Nagler A. Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2017 Feb; 23(2): 278-84. PMID: 27816650, PII: S1083-8791(16)30460-8, DOI: 10.1016/j.bbmt.2016.11.002, ISSN: 1523-6536.

Rapoport Y, Freeman T, Koyama T, Engelhardt BG, Jagasia M, Savani BN, Tran U, Kassim AA. Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric. Cornea. 2017 Feb; 36(2): 258-63. PMID: 28060078, PII: 00003226-201702000-00022, DOI: 10.1097/ICO.0000000000001109, ISSN: 1536-4798.

Maziarz RT, Brazauskas R, Chen M, McLeod AA, Martino R, Wingard JR, Aljurf M, Battiwalla M, Dvorak CC, Geroge B, Guinan EC, Hale GA, Lazarus HM, Lee JW, Liesveld JL, Ramanathan M, Reddy V, Savani BN, Smith FO, Strasfeld L, Taplitz RA, Ustun C, Boeckh MJ, Gea-Banacloche J, Lindemans CA, Auletta JJ, Riches ML. Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study. Bone Marrow Transplant [print-electronic]. 2017 Feb; 52(2): 270-8. PMID: 27991895, PMCID: PMC5358320, PII: bmt2016259, DOI: 10.1038/bmt.2016.259, ISSN: 1476-5365.

Baron F, Mohty M, Blaise D, Socié G, Labopin M, Esteve J, Ciceri F, Giebel S, Gorin NC, Savani BN, Schmid C, Nagler A. Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica [print-electronic]. 2017 Feb; 102(2): 224-34. PMID: 27927772, PMCID: PMC5286931, PII: haematol.2016.148510, DOI: 10.3324/haematol.2016.148510, ISSN: 1592-8721.

Malard F, Labopin M, Stuhler G, Bittenbring J, Ganser A, Tischer J, Michallet M, Kröger N, Schmid C, Huynh A, Hallek M, Savani BN, Mohty M, Nagler A. Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2017 Feb; 23(2): 278-84. PMID: 27816650, PII: S1083-8791(16)30460-8, DOI: 10.1016/j.bbmt.2016.11.002, ISSN: 1523-6536.

Rubio MT, D'Aveni-Piney M, Labopin M, Hamladji RM, Sanz MA, Blaise D, Ozdogu H, Daguindeau E, Richard C, Santarone S, Irrera G, Yakoub-Agha I, Yeshurun M, Diez-Martin JL, Mohty M, Savani BN, Nagler A. Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party. J Hematol Oncol. 2017 Jan 1/24/2017; 10(1): 31. PMID: 28118857, PMCID: PMC5259921, PII: 10.1186/s13045-016-0389-4, DOI: 10.1186/s13045-016-0389-4, ISSN: 1756-8722.

Rubio MT, D'Aveni-Piney M, Labopin M, Hamladji RM, Sanz MA, Blaise D, Ozdogu H, Daguindeau E, Richard C, Santarone S, Irrera G, Yakoub-Agha I, Yeshurun M, Diez-Martin JL, Mohty M, Savani BN, Nagler A. Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party. J Hematol Oncol. 2017 Jan 1/24/2017; 10(1): 31. PMID: 28118857, PMCID: PMC5259921, PII: 10.1186/s13045-016-0389-4, DOI: 10.1186/s13045-016-0389-4, ISSN: 1756-8722.

Battiwalla M, Hashmi S, Majhail N, Pavletic S, Savani BN, Shelburne N. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes. Biol. Blood Marrow Transplant [print-electronic]. 2017 Jan; 23(1): 6-9. PMID: 27989931, PMCID: PMC5182086, PII: S1083-8791(16)30455-4, DOI: 10.1016/j.bbmt.2016.10.020, ISSN: 1523-6536.

Battiwalla M, Hashmi S, Majhail N, Pavletic S, Savani BN, Shelburne N. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes. Biol. Blood Marrow Transplant [print-electronic]. 2017 Jan; 23(1): 6-9. PMID: 27989931, PMCID: PMC5182086, PII: S1083-8791(16)30455-4, DOI: 10.1016/j.bbmt.2016.10.020, ISSN: 1523-6536.

Rapoport Y, Freeman T, Koyama T, Engelhardt BG, Jagasia M, Savani BN, Tran U, Kassim AA. Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric. Cornea [print-electronic]. 2016 Dec 12/14/2016; PMID: 27984363, DOI: 10.1097/ICO.0000000000001109, ISSN: 1536-4798.

Rapoport Y, Freeman T, Koyama T, Engelhardt BG, Jagasia M, Savani BN, Tran U, Kassim AA. Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric. Cornea [print-electronic]. 2016 Dec 12/14/2016; PMID: 27984363, DOI: 10.1097/ICO.0000000000001109, ISSN: 1536-4798.

Kharfan-Dabaja MA, Kumar A, Hamadani M, Stilgenbauer S, Ghia P, Anasetti C, Dreger P, Montserrat E, Perales MA, Alyea EP, Awan FT, Ayala E, Barrientos JC, Brown JR, Castro JE, Furman RR, Gribben J, Hill BT, Mohty M, Moreno C, O'Brien S, Pavletic SZ, Pinilla-Ibarz J, Reddy NM, Sorror M, Bredeson C, Carpenter P, Savani BN. Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2016 Dec; 22(12): 2117-25. PMID: 27660167, PMCID: PMC5116249, PII: S1083-8791(16)30353-6, DOI: 10.1016/j.bbmt.2016.09.013, ISSN: 1523-6536.

Kharfan-Dabaja MA, Kumar A, Hamadani M, Stilgenbauer S, Ghia P, Anasetti C, Dreger P, Montserrat E, Perales MA, Alyea EP, Awan FT, Ayala E, Barrientos JC, Brown JR, Castro JE, Furman RR, Gribben J, Hill BT, Mohty M, Moreno C, O'Brien S, Pavletic SZ, Pinilla-Ibarz J, Reddy NM, Sorror M, Bredeson C, Carpenter P, Savani BN. Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2016 Dec; 22(12): 2117-25. PMID: 27660167, PMCID: PMC5116249, PII: S1083-8791(16)30353-6, DOI: 10.1016/j.bbmt.2016.09.013, ISSN: 1523-6536.

Shimoni A, Labopin M, Savani B, Volin L, Ehninger G, Kuball J, Bunjes D, Schaap N, Vigouroux S, Bacigalupo A, Veelken H, Sierra J, Eder M, Niederwieser D, Mohty M, Nagler A. Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantation. J Hematol Oncol. 2016 Nov 11/8/2016; 9(1): 118. PMID: 27821187, PMCID: PMC5100212, PII: 10.1186/s13045-016-0347-1, DOI: 10.1186/s13045-016-0347-1, ISSN: 1756-8722.

Palmer J, McCune JS, Perales MA, Marks D, Bubalo J, Mohty M, Wingard JR, Paci A, Hassan M, Bredeson C, Pidala J, Shah N, Shaughnessy P, Majhail N, Schriber J, Savani BN, Carpenter PA. Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee. Biol. Blood Marrow Transplant [print-electronic]. 2016 Nov; 22(11): 1915-25. PMID: 27481448, PII: S1083-8791(16)30249-X, DOI: 10.1016/j.bbmt.2016.07.013.

Giebel S, Czyz A, Ottmann O, Baron F, Brissot E, Ciceri F, Cornelissen JJ, Esteve J, Gorin NC, Savani B, Schmid C, Mohty M, Nagler A. Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Cancer [print-electronic]. 2016 Oct; 122(19): 2941-51. PMID: 27309127, DOI: 10.1002/cncr.30130, ISSN: 1097-0142.

Lazaryan A, Wang T, Spellman SR, Wang HL, Pidala J, Nishihori T, Askar M, Olsson R, Oudshoorn M, Abdel-Azim H, Yong A, Gandhi M, Dandoy C, Savani B, Hale G, Page K, Bitan M, Reshef R, Drobyski W, Marsh SG, Schultz K, Müller CR, Fernandez-Viña MA, Verneris MR, Horowitz MM, Arora M, Weisdorf DJ, Lee SJ. Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research. Haematologica [print-electronic]. 2016 Oct; 101(10): 1267-74. PMID: 27247320, PMCID: PMC5046657, PII: haematol.2016.143271, DOI: 10.3324/haematol.2016.143271, ISSN: 1592-8721.

Ballen K, Woo Ahn K, Chen M, Abdel-Azim H, Ahmed I, Aljurf M, Antin J, Bhatt AS, Boeckh M, Chen G, Dandoy C, George B, Laughlin MJ, Lazarus HM, MacMillan ML, Margolis DA, Marks DI, Norkin M, Rosenthal J, Saad A, Savani B, Schouten HC, Storek J, Szabolcs P, Ustun C, Verneris MR, Waller EK, Weisdorf DJ, Williams KM, Wingard JR, Wirk B, Wolfs T, Young JA, Auletta J, Komanduri KV, Lindemans C, Riches ML. Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2016 Sep; 22(9): 1636-45. PMID: 27343716, PMCID: PMC5008458, PII: S1083-8791(16)30147-1, DOI: 10.1016/j.bbmt.2016.06.012, ISSN: 1523-6536.

Zahid MF, Parnes A, Savani BN, Litzow MR, Hashmi SK. Therapy-related myeloid neoplasms - what have we learned so far?. World J Stem Cells. 2016 Aug 8/26/2016; 8(8): 231-42. PMID: 27621757, PMCID: PMC4999650, DOI: 10.4252/wjsc.v8.i8.231, ISSN: 1948-0210.

DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers ME, Savani BN, Shaw BE. Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT. Bone Marrow Transplant [print-electronic]. 2016 Aug 8/22/2016; PMID: 27548466, PII: bmt2016203, DOI: 10.1038/bmt.2016.203, ISSN: 1476-5365.

Scott EC, Hari P, Sharma M, Le-Rademacher J, Huang J, Vogl D, Abidi M, Beitinjaneh A, Fung H, Ganguly S, Hildebrandt G, Holmberg L, Kalaycio M, Kumar S, Kyle R, Lazarus H, Lee C, Maziarz RT, Meehan K, Mikhael J, Nishihori T, Ramanathan M, Usmani S, Tay J, Vesole D, Wirk B, Yared J, Savani BN, Gasparetto C, Krishnan A, Mark T, Nieto Y, D'Souza A. Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis. Biol. Blood Marrow Transplant [print-electronic]. 2016 Aug 8/2/2016; PMID: 27496215, PII: S1083-8791(16)30223-3, DOI: 10.1016/j.bbmt.2016.07.007, ISSN: 1523-6536.

Ramanathan M, Teira P, Battiwalla M, Barrett J, Ahn KW, Chen M, Green J, Laughlin M, Lazarus HM, Marks D, Saad A, Seftel M, Saber W, Savani B, Waller EK, Wingard J, Auletta JJ, Lindemans CA, Boeckh M, Riches ML. Impact of early CMV reactivation in cord blood stem cell recipients in the current era. Bone Marrow Transplant [print-electronic]. 2016 Aug; 51(8): 1113-20. PMID: 27042847, PMCID: PMC4972682, PII: bmt201689, DOI: 10.1038/bmt.2016.89, ISSN: 1476-5365.

Slade M, Fakhri B, Savani BN, Romee R. Halfway there: the past, present and future of haploidentical transplantation. Bone Marrow Transplant [print-electronic]. 2016 Jul 7/25/2016; PMID: 27454072, PII: bmt2016190, DOI: 10.1038/bmt.2016.190, ISSN: 1476-5365.

Zhao X, Tian X, Kajigaya S, Cantilena CR, Strickland S, Savani BN, Mohan S, Feng X, Keyvanfar K, Dunavin N, Townsley DM, Dumitriu B, Battiwalla M, Rezvani K, Young NS, Barrett AJ, Ito S. Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS. Br. J. Haematol [print-electronic]. 2016 Jul 7/19/2016; PMID: 27433923, DOI: 10.1111/bjh.14244, ISSN: 1365-2141.

Kennedy VE, Savani BN, Greer JP, Kassim AA, Engelhardt BG, Goodman SA, Sengsayadeth S, Chinratanalab W, Jagasia M. Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies. Biol. Blood Marrow Transplant [print-electronic]. 2016 Jul 7/1/2016; PMID: 27377900, PII: S1083-8791(16)30202-6, DOI: 10.1016/j.bbmt.2016.06.029, ISSN: 1523-6536.

Tsirigotis P, Byrne M, Schmid C, Baron F, Ciceri F, Esteve J, Gorin NC, Giebel S, Mohty M, Savani BN, Nagler A. Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT. Bone Marrow Transplant [print-electronic]. 2016 Jun 6/13/2016; PMID: 27295272, PII: bmt2016167, DOI: 10.1038/bmt.2016.167, ISSN: 1476-5365.

Ghosh N, Karmali R, Rocha V, Ahn KW, DiGilio A, Hari PN, Bachanova V, Bacher U, Dahi P, de Lima M, D'Souza A, Fenske TS, Ganguly S, Kharfan-Dabaja MA, Prestidge TD, Savani BN, Smith SM, Sureda AM, Waller EK, Jaglowski S, Herrera AF, Armand P, Salit RB, Wagner-Johnston ND, Fuchs E, Bolaños-Meade J, Hamadani M. Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis. J. Clin. Oncol [print-electronic]. 2016 Jun 6/6/2016; PMID: 27269951, PII: JCO.2015.66.3476, DOI: 10.1200/JCO.2015.66.3476, ISSN: 1527-7755.

Savani BN, Labopin M, Kröger N, Finke J, Ehninger G, Niederwieser D, Schwerdtfeger R, Bunjes D, Glass B, Socié G, Ljungman P, Craddock C, Baron F, Ciceri F, Gorin NC, Esteve J, Schmid C, Giebel S, Mohty M, Nagler A. Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT. Haematologica [print-electronic]. 2016 Jun; 101(6): 773-80. PMID: 26969081, PII: haematol.2015.138180, DOI: 10.3324/haematol.2015.138180, ISSN: 1592-8721.

Shaffer BC, Ahn KW, Hu ZH, Nishihori T, Malone AK, Valcárcel D, Grunwald MR, Bacher U, Hamilton B, Kharfan-Dabaja MA, Saad A, Cutler C, Warlick E, Reshef R, Wirk BM, Sabloff M, Fasan O, Gerds A, Marks D, Olsson R, Wood WA, Costa LJ, Miller AM, Cortes J, Daly A, Kindwall-Keller TL, Kamble R, Rizzieri DA, Cahn JY, Gale RP, William B, Litzow M, Wiernik PH, Liesveld J, Savani BN, Vij R, Ustun C, Copelan E, Popat U, Kalaycio M, Maziarz R, Alyea E, Sobecks R, Pavletic S, Tallman M, Saber W. Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome. J. Clin. Oncol [print-electronic]. 2016 Jun 6/1/2016; 34(16): 1864-71. PMID: 27044940, PII: JCO.2015.65.0515, DOI: 10.1200/JCO.2015.65.0515, ISSN: 1527-7755.

Chaudhury S, Sparapani R, Hu ZH, Nishihori T, Abdel-Azim H, Malone A, Olsson R, Hamadani M, Daly A, Bacher U, Wirk BM, Kamble RT, Gale RP, Wood WA, Hale G, Wiernik PH, Hashmi SK, Marks D, Ustun C, Munker R, Savani BN, Alyea E, Popat U, Sobecks R, Kalaycio M, Maziarz R, Hijiya N, Saber W. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis. Biol. Blood Marrow Transplant [print-electronic]. 2016 Jun; 22(6): 1056-64. PMID: 26964698, PMCID: PMC4877686, PII: S1083-8791(16)00120-8, DOI: 10.1016/j.bbmt.2016.02.015, ISSN: 1523-6536.

Baron F, Ruggeri A, Beohou E, Labopin M, Sanz G, Milpied N, Michallet M, Bacigalupo A, Blaise D, Sierra J, Socié G, Cornelissen JJ, Schmid C, Giebel S, Gorin NC, Esteve J, Ciceri F, Savani BN, Mohty M, Gluckman E, Nagler A. RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT. Oncotarget [print-electronic]. 2016 May 5/26/2016; PMID: 27250025, PII: 9599, DOI: 10.18632/oncotarget.9599, ISSN: 1949-2553.

Tsirigotis P, Savani BN, Nagler A. Programmed death-1 immune checkpoint blockade in the treatment of hematological malignancies. Ann. Med [print-electronic]. 2016 May 5/25/2016; 1-12. PMID: 27224873, DOI: 10.1080/07853890.2016.1186827, ISSN: 1365-2060.

Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn KW, Chen M, Green JS, Saad A, Antin JH, Savani BN, Lazarus HM, Seftel M, Saber W, Marks D, Aljurf M, Norkin M, Wingard JR, Lindemans CA, Boeckh M, Riches ML, Auletta JJ. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood [print-electronic]. 2016 May 5/19/2016; 127(20): 2427-38. PMID: 26884374, PMCID: PMC4874224, PII: blood-2015-11-679639, DOI: 10.1182/blood-2015-11-679639, ISSN: 1528-0020.

Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant [print-electronic]. 2016 May 5/16/2016; PMID: 27183098, PII: bmt2016130, DOI: 10.1038/bmt.2016.130, ISSN: 1476-5365.

DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers ME, Savani BN, Shaw BE, . Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT. Biol. Blood Marrow Transplant [print-electronic]. 2016 May 5/14/2016; PMID: 27184625, PII: S1083-8791(16)30079-9, DOI: 10.1016/j.bbmt.2016.05.007, ISSN: 1523-6536.

Engelhardt BG, Paczesny S, Jung DK, Daguindau E, Jagasia M, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Yoder SM, Rock MT, Crowe JE. Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation [letter]. Haematologica [print-electronic]. 2016 May; 101(5): e204-8. PMID: 26819055, PII: haematol.2015.139501, DOI: 10.3324/haematol.2015.139501, ISSN: 1592-8721.

Byrne M, Savani BN. Hosting an Unruly Guest: The Impact of Late Acute and Chronic Graft-versus-Host Disease [editorial]. Biol. Blood Marrow Transplant [print-electronic]. 2016 May; 22(5): 779-80. PMID: 26903379, PII: S1083-8791(16)00119-1, DOI: 10.1016/j.bbmt.2016.02.014, ISSN: 1523-6536.

Byrne M, Savani BN, Mohty M, Nagler A. Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Exp. Hematol [print-electronic]. 2016 Apr 4/19/2016; PMID: 27106798, PII: S0301-472X(16)30077-7, DOI: 10.1016/j.exphem.2016.04.005, ISSN: 1873-2399.

Byrne M, Savani BN. The devil is in the T cells: relapsing after haploidentical hematopoietic cell transplantation. Bone Marrow Transplant [print-electronic]. 2016 Apr 4/18/2016; PMID: 27088377, PII: bmt2016106, DOI: 10.1038/bmt.2016.106, ISSN: 1476-5365.

Li Z, Rubinstein SM, Thota R, Savani M, Brissot E, Shaw BE, Majhail NS, Mohty M, Savani BN. Immune-Mediated Complications after Hematopoietic Stem Cell Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2016 Apr 4/14/2016; PMID: 27095688, PII: S1083-8791(16)30024-6, DOI: 10.1016/j.bbmt.2016.04.005, ISSN: 1523-6536.

Clark CA, Savani M, Mohty M, Savani BN. What do we need to know about allogeneic hematopoietic stem cell transplant survivors?. Bone Marrow Transplant [print-electronic]. 2016 Apr 4/11/2016; PMID: 27064688, PII: bmt201695, DOI: 10.1038/bmt.2016.95, ISSN: 1476-5365.

Fuji S, Rovó A, Ohashi K, Griffith M, Einsele H, Kapp M, Mohty M, Majhail NS, Engelhardt BG, Tichelli A, Savani BN. How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT. Bone Marrow Transplant [print-electronic]. 2016 Apr 4/4/2016; PMID: 27042848, PII: bmt201681, DOI: 10.1038/bmt.2016.81, ISSN: 1476-5365.

Anandi P, Jain NA, Tian X, Wu CO, Pophali PA, Koklanaris E, Ito S, Savani BN, Barrett J, Battiwalla M. Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivors. Bone Marrow Transplant [print-electronic]. 2016 Apr 4/4/2016; PMID: 27042843, PII: bmt201685, DOI: 10.1038/bmt.2016.85, ISSN: 1476-5365.

Chaturvedi S, Neff A, Nagler A, Savani U, Mohty M, Savani BN. Venous thromboembolism in hematopoietic stem cell transplant recipients. Bone Marrow Transplant [print-electronic]. 2016 Apr; 51(4): 473-8. PMID: 26691425, PII: bmt2015308, DOI: 10.1038/bmt.2015.308, ISSN: 1476-5365.

Williams KM, Ahn KW, Chen M, Aljurf MD, Agwu AL, Chen AR, Walsh TJ, Szabolcs P, Boeckh MJ, Auletta JJ, Lindemans CA, Zanis-Neto J, Malvezzi M, Lister J, de Toledo Codina JS, Sackey K, Chakrabarty JL, Ljungman P, Wingard JR, Seftel MD, Seo S, Hale GA, Wirk B, Smith MS, Savani BN, Lazarus HM, Marks DI, Ustun C, Abdel-Azim H, Dvorak CC, Szer J, Storek J, Yong A, Riches MR. The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis. Bone Marrow Transplant [print-electronic]. 2016 Apr; 51(4): 573-80. PMID: 26726945, PMCID: PMC4823157, PII: bmt2015316, DOI: 10.1038/bmt.2015.316, ISSN: 1476-5365.

Sengsayadeth S, Savani BN, Blaise D, Mohty M. Haploidentical transplantation: selecting optimal conditioning regimen and stem cell source. Semin. Hematol [print-electronic]. 2016 Apr; 53(2): 111-4. PMID: 27000735, PII: S0037-1963(16)00013-5, DOI: 10.1053/j.seminhematol.2016.01.012, ISSN: 1532-8686.

Savani BN, Mohty M. Introduction: Why alternative donor transplantation and what are the different options and current challenges?. Semin. Hematol [print-electronic]. 2016 Apr; 53(2): 55-6. PMID: 27000726, PII: S0037-1963(16)00009-3, DOI: 10.1053/j.seminhematol.2016.01.008, ISSN: 1532-8686.

Anthias C, O'Donnell PV, Kiefer DM, Yared J, Norkin M, Anderlini P, Savani BN, Diaz MA, Bitan M, Halter JP, Logan BR, Switzer GE, Pulsipher MA, Confer DL, Shaw BE. European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards. Biol. Blood Marrow Transplant [print-electronic]. 2016 Mar; 22(3): 514-9. PMID: 26597079, PMCID: PMC4760354, PII: S1083-8791(15)00736-3, DOI: 10.1016/j.bbmt.2015.11.009, ISSN: 1523-6536.

Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel MD, Norkin M, DeFilipp Z, Kasow KA, Abidi MH, Savani BN, Shah NN, Anderlini P, Diaz MA, Malone AK, Halter JP, Lazarus HM, Logan BR, Switzer GE, Pulsipher MA, Confer DL, O'Donnell PV. Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers. Biol. Blood Marrow Transplant [print-electronic]. 2016 Mar; 22(3): 520-7. PMID: 26597080, PMCID: PMC4760616, PII: S1083-8791(15)00735-1, DOI: 10.1016/j.bbmt.2015.11.008, ISSN: 1523-6536.

Halasa NB, Savani BN, Asokan I, Kassim A, Simons R, Summers C, Bourgeois J, Clifton C, Vaughan LA, Lucid C, Wang L, Fonnesbeck C, Jagasia M. Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients. Biol. Blood Marrow Transplant [print-electronic]. 2016 Mar; 22(3): 528-35. PMID: 26705931, PII: S1083-8791(15)01864-9, DOI: 10.1016/j.bbmt.2015.12.003, ISSN: 1523-6536.

Savani BN, Labopin M, Blaise D, Niederwieser D, Ciceri F, Ganser A, Arnold R, Afanasyev B, Vigouroux S, Milpied N, Hallek M, Cornelissen JJ, Schwerdtfeger R, Polge E, Baron F, Esteve J, Gorin NC, Schmid C, Giebel S, Mohty M, Nagler A. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT. Haematologica [print-electronic]. 2016 Feb; 101(2): 256-62. PMID: 26565001, PII: haematol.2015.135699, DOI: 10.3324/haematol.2015.135699, ISSN: 1592-8721.

Pasquini MC, Zhang MJ, Medeiros BC, Armand P, Hu ZH, Nishihori T, Aljurf MD, Akpek G, Cahn JY, Cairo MS, Cerny J, Copelan EA, Deol A, Freytes CO, Gale RP, Ganguly S, George B, Gupta V, Hale GA, Kamble RT, Klumpp TR, Lazarus HM, Luger SM, Liesveld JL, Litzow MR, Marks DI, Martino R, Norkin M, Olsson RF, Oran B, Pawarode A, Pulsipher MA, Ramanathan M, Reshef R, Saad AA, Saber W, Savani BN, Schouten HC, Ringdén O, Tallman MS, Uy GL, Wood WA, Wirk B, Pérez WS, Batiwalla M, Weisdorf DJ. Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies. Biol. Blood Marrow Transplant [print-electronic]. 2016 Feb; 22(2): 248-57. PMID: 26327629, PMCID: PMC4716890, PII: S1083-8791(15)00572-8, DOI: 10.1016/j.bbmt.2015.08.024, ISSN: 1523-6536.

Cupit MC, Duncan C, Savani BN, Hashmi SK. Childhood to adult transition and long-term follow-up after blood and marrow transplantation. Bone Marrow Transplant [print-electronic]. 2016 Feb; 51(2): 176-81. PMID: 26642340, PII: bmt2015228, DOI: 10.1038/bmt.2015.228, ISSN: 1476-5365.

Klyuchnikov E, Bacher U, Woo Ahn K, Carreras J, Kröger NM, Hari PN, Ku GH, Ayala E, Chen AI, Chen YB, Cohen JB, Freytes CO, Gale RP, Kamble RT, Kharfan-Dabaja MA, Lazarus HM, Martino R, Mussetti A, Savani BN, Schouten HC, Usmani SZ, Wiernik PH, Wirk B, Smith SM, Sureda A, Hamadani M. Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma. Bone Marrow Transplant [print-electronic]. 2016 Jan; 51(1): 58-66. PMID: 26437062, PMCID: PMC4703480, PII: bmt2015223, DOI: 10.1038/bmt.2015.223, ISSN: 1476-5365.

Rioth MJ, Warner J, Savani BN, Jagasia M. Next-generation long-term transplant clinics: improving resource utilization and the quality of care through health information technology. Bone Marrow Transplant [print-electronic]. 2016 Jan; 51(1): 34-40. PMID: 26367235, PII: bmt2015210, DOI: 10.1038/bmt.2015.210, ISSN: 1476-5365.

Rubio MT, Savani BN, Labopin M, Piemontese S, Polge E, Ciceri F, Bacigalupo A, Arcese W, Koc Y, Beelen D, Gülbas Z, Wu D, Santarone S, Tischer J, Afanasyev B, Schmid C, Giebel S, Mohty M, Nagler A. Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT. J Hematol Oncol. 2016; 9: 25. PMID: 26980295, PMCID: PMC4791867, PII: 10.1186/s13045-016-0248-3, DOI: 10.1186/s13045-016-0248-3, ISSN: 1756-8722.

Rubio MT, Savani BN, Labopin M, Polge E, Niederwieser D, Ganser A, Schwerdtfeger R, Ehninger G, Finke J, Renate A, Craddock C, Kröger N, Hallek M, Jindra P, Mohty M, Nagler A. The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party. J Hematol Oncol. 2016; 9(1): 65. PMID: 27488518, PMCID: PMC4971653, PII: 10.1186/s13045-016-0295-9, DOI: 10.1186/s13045-016-0295-9, ISSN: 1756-8722.

Shouval R, Labopin M, Unger R, Giebel S, Ciceri F, Schmid C, Esteve J, Baron F, Gorin NC, Savani B, Shimoni A, Mohty M, Nagler A. Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study. PLoS ONE. 2016; 11(3): e0150637. PMID: 26942424, PMCID: PMC4778768, PII: PONE-D-16-01076, DOI: 10.1371/journal.pone.0150637, ISSN: 1932-6203.

Li Z, Mewawalla P, Stratton P, Yong AS, Shaw BE, Hashmi S, Jagasia M, Mohty M, Majhail NS, Savani BN, Rovó A. Sexual health in hematopoietic stem cell transplant recipients. Cancer [print-electronic]. 2015 Dec 12/1/2015; 121(23): 4124-31. PMID: 26372459, DOI: 10.1002/cncr.29675, ISSN: 1097-0142.

Yong AS, Brissot E, Rubinstein S, Savani BN, Mohty M. Transplant to treatment-free remission: the evolving view of 'cure' in chronic myeloid leukemia. Expert Rev Hematol [print-electronic]. 2015 Dec; 8(6): 785-97. PMID: 26364871, DOI: 10.1586/17474086.2015.1087843, ISSN: 1747-4094.

Uy GL, Costa LJ, Hari PN, Zhang MJ, Huang JX, Anderson KC, Bredeson CN, Callander NS, Cornell RF, Perez MA, Dispenzieri A, Freytes CO, Gale RP, Garfall A, Gertz MA, Gibson J, Hamadani M, Lazarus HM, Kalaycio ME, Kamble RT, Kharfan-Dabaja MA, Krishnan AY, Kumar SK, Kyle RA, Landau HJ, Lee CH, Maiolino A, Marks DI, Mark TM, Munker R, Nishihori T, Olsson RF, Ramanathan M, Rodriguez TE, Saad AA, Savani BN, Schiller GJ, Schouten HC, Schriber JR, Scott E, Seo S, Sharma M, Ganguly S, Stadtmauer EA, Tay J, To LB, Vesole DH, Vogl DT, Wagner JL, Wirk B, Wood WA, D'Souza A. Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation. Bone Marrow Transplant [print-electronic]. 2015 Dec; 50(12): 1513-8. PMID: 26301967, PMCID: PMC4548821, PII: bmt2015190, DOI: 10.1038/bmt.2015.190, ISSN: 1476-5365.

Gorin NC, Giebel S, Labopin M, Savani BN, Mohty M, Nagler A. Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects. Bone Marrow Transplant [print-electronic]. 2015 Dec; 50(12): 1495-502. PMID: 26281031, PII: bmt2015179, DOI: 10.1038/bmt.2015.179, ISSN: 1476-5365.

Li Z, Mewawalla P, Stratton P, Yong AS, Shaw BE, Hashmi S, Jagasia M, Mohty M, Majhail NS, Savani BN, Rovó A. Sexual health in hematopoietic stem cell transplant recipients. Cancer [print-electronic]. 2015 Dec 12/1/2015; 121(23): 4124-31. PMID: 26372459, DOI: 10.1002/cncr.29675, ISSN: 1097-0142.

Yong AS, Brissot E, Rubinstein S, Savani BN, Mohty M. Transplant to treatment-free remission: the evolving view of 'cure' in chronic myeloid leukemia. Expert Rev Hematol [print-electronic]. 2015 Dec; 8(6): 785-97. PMID: 26364871, DOI: 10.1586/17474086.2015.1087843, ISSN: 1747-4094.

Uy GL, Costa LJ, Hari PN, Zhang MJ, Huang JX, Anderson KC, Bredeson CN, Callander NS, Cornell RF, Perez MA, Dispenzieri A, Freytes CO, Gale RP, Garfall A, Gertz MA, Gibson J, Hamadani M, Lazarus HM, Kalaycio ME, Kamble RT, Kharfan-Dabaja MA, Krishnan AY, Kumar SK, Kyle RA, Landau HJ, Lee CH, Maiolino A, Marks DI, Mark TM, Munker R, Nishihori T, Olsson RF, Ramanathan M, Rodriguez TE, Saad AA, Savani BN, Schiller GJ, Schouten HC, Schriber JR, Scott E, Seo S, Sharma M, Ganguly S, Stadtmauer EA, Tay J, To LB, Vesole DH, Vogl DT, Wagner JL, Wirk B, Wood WA, D'Souza A. Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation. Bone Marrow Transplant [print-electronic]. 2015 Dec; 50(12): 1513-8. PMID: 26301967, PMCID: PMC4548821, PII: bmt2015190, DOI: 10.1038/bmt.2015.190, ISSN: 1476-5365.

Gorin NC, Giebel S, Labopin M, Savani BN, Mohty M, Nagler A. Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects. Bone Marrow Transplant [print-electronic]. 2015 Dec; 50(12): 1495-502. PMID: 26281031, PII: bmt2015179, DOI: 10.1038/bmt.2015.179, ISSN: 1476-5365.

Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel MD, Norkin M, DeFilipp ZM, Kasow KA, Abidi MH, Savani BN, Shah NN, Anderlini P, Diaz MA, Malone AK, Halter JP, Lazarus HM, Logan BR, Switzer GE, Pulsipher MA, Confer DL, O'Donnell PV. Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers. Biol. Blood Marrow Transplant [print-electronic]. 2015 Nov 11/18/2015; PMID: 26597080, PII: S1083-8791(15)00735-1, DOI: 10.1016/j.bbmt.2015.11.008, ISSN: 1523-6536.

Anthias C, O'Donnell PV, Kiefer DM, Yared J, Norkin M, Anderlini P, Savani BN, Diaz MA, Bitan M, Halter JP, Logan BR, Switzer GE, Pulsipher MA, Confer DL, Shaw BE. European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards. Biol. Blood Marrow Transplant [print-electronic]. 2015 Nov 11/18/2015; PMID: 26597079, PII: S1083-8791(15)00736-3, DOI: 10.1016/j.bbmt.2015.11.009, ISSN: 1523-6536.

Savani BN, Labopin M, Blaise D, Niederwieser D, Ciceri F, Ganser A, Arnold R, Afanasyev B, Vigouroux S, Milpied N, Hallek M, Cornelissen JJ, Schwerdtfeger R, Polge E, Baron F, Esteve J, Gorin NC, Schmid C, Giebel S, Mohty M, Nagler A. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia - A report from the ALWP of the EBMT. Haematologica [print-electronic]. 2015 Nov 11/12/2015; PMID: 26565001, PII: haematol.2015.135699, DOI: 10.3324/haematol.2015.135699, ISSN: 1592-8721.

D'Souza A, Dispenzieri A, Wirk B, Zhang MJ, Huang J, Gertz MA, Kyle RA, Kumar S, Comenzo RL, Peter Gale R, Lazarus HM, Savani BN, Cornell RF, Weiss BM, Vogl DT, Freytes CO, Scott EC, Landau HJ, Moreb JS, Costa LJ, Ramanathan M, Callander NS, Kamble RT, Olsson RF, Ganguly S, Nishihori T, Kindwall-Keller TL, Wood WA, Mark TM, Hari P. Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study. J. Clin. Oncol [print-electronic]. 2015 Nov 11/10/2015; 33(32): 3741-9. PMID: 26371138, PII: JCO.2015.62.4015, DOI: 10.1200/JCO.2015.62.4015, ISSN: 1527-7755.

D'Souza A, Dispenzieri A, Wirk B, Zhang MJ, Huang J, Gertz MA, Kyle RA, Kumar S, Comenzo RL, Peter Gale R, Lazarus HM, Savani BN, Cornell RF, Weiss BM, Vogl DT, Freytes CO, Scott EC, Landau HJ, Moreb JS, Costa LJ, Ramanathan M, Callander NS, Kamble RT, Olsson RF, Ganguly S, Nishihori T, Kindwall-Keller TL, Wood WA, Mark TM, Hari P. Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study. J. Clin. Oncol [print-electronic]. 2015 Nov 11/10/2015; 33(32): 3741-9. PMID: 26371138, PMCID: PMC4737858, PII: JCO.2015.62.4015, DOI: 10.1200/JCO.2015.62.4015, ISSN: 1527-7755.

Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, Omel JL, Orchard PJ, Palmer J, Saber W, Savani BN, Veys PA, Bredeson CN, Giralt SA, LeMaistre CF. Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2015 Nov; 21(11): 1863-9. PMID: 26256941, PII: S1083-8791(15)00512-1, DOI: 10.1016/j.bbmt.2015.07.032, ISSN: 1523-6536.

Booth GS, Gehrie EA, Jagasia MH, Shaw BE, Savani BN. When Can You Discard Stem Cells? [letter]. Biol. Blood Marrow Transplant [print-electronic]. 2015 Nov; 21(11): 2033. PMID: 26253004, PII: S1083-8791(15)00501-7, DOI: 10.1016/j.bbmt.2015.07.024, ISSN: 1523-6536.

Satwani P, Ahn KW, Carreras J, Abdel-Azim H, Cairo MS, Cashen A, Chen AI, Cohen JB, Costa LJ, Dandoy C, Fenske TS, Freytes CO, Ganguly S, Gale RP, Ghosh N, Hertzberg MS, Hayashi RJ, Kamble RT, Kanate AS, Keating A, Kharfan-Dabaja MA, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Prestidge TD, Rolon JM, Savani BN, Vose JM, Wood WA, Inwards DJ, Bachanova V, Smith SM, Maloney DG, Sureda A, Hamadani M. A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma. Bone Marrow Transplant [print-electronic]. 2015 Nov; 50(11): 1416-23. PMID: 26237164, PMCID: PMC4633349, PII: bmt2015177, DOI: 10.1038/bmt.2015.177, ISSN: 1476-5365.

Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, Omel JL, Orchard PJ, Palmer J, Saber W, Savani BN, Veys PA, Bredeson CN, Giralt SA, LeMaistre CF. Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2015 Nov; 21(11): 1863-9. PMID: 26256941, PMCID: PMC4830270, PII: S1083-8791(15)00512-1, DOI: 10.1016/j.bbmt.2015.07.032, ISSN: 1523-6536.

Booth GS, Gehrie EA, Jagasia MH, Shaw BE, Savani BN. When Can You Discard Stem Cells? [letter]. Biol. Blood Marrow Transplant [print-electronic]. 2015 Nov; 21(11): 2033. PMID: 26253004, PII: S1083-8791(15)00501-7, DOI: 10.1016/j.bbmt.2015.07.024, ISSN: 1523-6536.

Satwani P, Ahn KW, Carreras J, Abdel-Azim H, Cairo MS, Cashen A, Chen AI, Cohen JB, Costa LJ, Dandoy C, Fenske TS, Freytes CO, Ganguly S, Gale RP, Ghosh N, Hertzberg MS, Hayashi RJ, Kamble RT, Kanate AS, Keating A, Kharfan-Dabaja MA, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Prestidge TD, Rolon JM, Savani BN, Vose JM, Wood WA, Inwards DJ, Bachanova V, Smith SM, Maloney DG, Sureda A, Hamadani M. A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma. Bone Marrow Transplant [print-electronic]. 2015 Nov; 50(11): 1416-23. PMID: 26237164, PMCID: PMC4633349, PII: bmt2015177, DOI: 10.1038/bmt.2015.177, ISSN: 1476-5365.

Schmid C, Labopin M, Socié G, Daguindau E, Volin L, Huynh A, Bourhis JH, Milpied N, Cornelissen J, Chevallier P, Maertens J, Jindra P, Blaise D, Lenhoff S, Ifrah N, Baron F, Ciceri F, Gorin C, Savani B, Giebel S, Polge E, Esteve J, Nagler A, Mohty M, . Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation. Blood [print-electronic]. 2015 Oct 10/22/2015; 126(17): 2062-9. PMID: 26351297, PII: blood-2015-06-651562, DOI: 10.1182/blood-2015-06-651562, ISSN: 1528-0020.

Klyuchnikov E, Bacher U, Woo Ahn K, Carreras J, Kröger NM, Hari PN, Ku GH, Ayala E, Chen AI, Chen YB, Cohen JB, Freytes CO, Gale RP, Kamble RT, Kharfan-Dabaja MA, Lazarus HM, Martino R, Mussetti A, Savani BN, Schouten HC, Usmani SZ, Wiernik PH, Wirk B, Smith SM, Sureda A, Hamadani M. Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma. Bone Marrow Transplant [print-electronic]. 2015 Oct 10/5/2015; PMID: 26437062, PII: bmt2015223, DOI: 10.1038/bmt.2015.223, ISSN: 1476-5365.

Fuji S, Einsele H, Savani BN, Kapp M. Systematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Biol. Blood Marrow Transplant [print-electronic]. 2015 Oct; 21(10): 1707-13. PMID: 26172477, PII: S1083-8791(15)00459-0, DOI: 10.1016/j.bbmt.2015.07.003, ISSN: 1523-6536.

Shaw BE, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Abdel-Azim H, Abidi MH, Akpek G, Diaz MA, Artz AS, Dandoy C, Gajewski JL, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Majhail NS, O'Donnell PV, Olsson RF, Savani BN, Schears RM, Stroncek DF, Switzer GE, Williams EP, Wingard JR, Wirk BM, Confer DL, Pulsipher MA. Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers. Biol. Blood Marrow Transplant [print-electronic]. 2015 Oct; 21(10): 1830-8. PMID: 26116089, PMCID: PMC4568129, PII: S1083-8791(15)00415-2, DOI: 10.1016/j.bbmt.2015.06.013, ISSN: 1523-6536.

Urbano-Ispizua A, Pavletic SZ, Flowers ME, Klein JP, Zhang MJ, Carreras J, Montoto S, Perales MA, Aljurf MD, Akpek G, Bredeson CN, Costa LJ, Dandoy C, Freytes CO, Fung HC, Gale RP, Gibson J, Hamadani M, Hayashi RJ, Inamoto Y, Inwards DJ, Lazarus HM, Maloney DG, Martino R, Munker R, Nishihori T, Olsson RF, Rizzieri DA, Reshef R, Saad A, Savani BN, Schouten HC, Smith SM, Socié G, Wirk B, Yu LC, Saber W. The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen. Biol. Blood Marrow Transplant [print-electronic]. 2015 Oct; 21(10): 1746-53. PMID: 25981509, PMCID: PMC4568162, PII: S1083-8791(15)00333-X, DOI: 10.1016/j.bbmt.2015.05.010, ISSN: 1523-6536.

Fuji S, Einsele H, Savani BN, Kapp M. Systematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Biol. Blood Marrow Transplant [print-electronic]. 2015 Oct; 21(10): 1707-13. PMID: 26172477, PII: S1083-8791(15)00459-0, DOI: 10.1016/j.bbmt.2015.07.003, ISSN: 1523-6536.

Shaw BE, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Abdel-Azim H, Abidi MH, Akpek G, Diaz MA, Artz AS, Dandoy C, Gajewski JL, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Majhail NS, O'Donnell PV, Olsson RF, Savani BN, Schears RM, Stroncek DF, Switzer GE, Williams EP, Wingard JR, Wirk BM, Confer DL, Pulsipher MA. Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers. Biol. Blood Marrow Transplant [print-electronic]. 2015 Oct; 21(10): 1830-8. PMID: 26116089, PMCID: PMC4568129, PII: S1083-8791(15)00415-2, DOI: 10.1016/j.bbmt.2015.06.013, ISSN: 1523-6536.

Urbano-Ispizua A, Pavletic SZ, Flowers ME, Klein JP, Zhang MJ, Carreras J, Montoto S, Perales MA, Aljurf MD, Akpek G, Bredeson CN, Costa LJ, Dandoy C, Freytes CO, Fung HC, Gale RP, Gibson J, Hamadani M, Hayashi RJ, Inamoto Y, Inwards DJ, Lazarus HM, Maloney DG, Martino R, Munker R, Nishihori T, Olsson RF, Rizzieri DA, Reshef R, Saad A, Savani BN, Schouten HC, Smith SM, Socié G, Wirk B, Yu LC, Saber W. The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen. Biol. Blood Marrow Transplant [print-electronic]. 2015 Oct; 21(10): 1746-53. PMID: 25981509, PMCID: PMC4568162, PII: S1083-8791(15)00333-X, DOI: 10.1016/j.bbmt.2015.05.010, ISSN: 1523-6536.

Rioth MJ, Warner J, Savani BN, Jagasia M. Next-generation long-term transplant clinics: improving resource utilization and the quality of care through health information technology. Bone Marrow Transplant [print-electronic]. 2015 Sep 9/14/2015; PMID: 26367235, PII: bmt2015210, DOI: 10.1038/bmt.2015.210, ISSN: 1476-5365.

Nagler A, Savani BN, Labopin M, Polge E, Passweg J, Finke J, Kyrcz-Krzemien S, Volin L, Anagnostopoulos A, Aljurf M, Beelen DW, Vigouroux S, Milpied N, Suarez F, Mohty M. Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis. Lancet Haematol [print-electronic]. 2015 Sep; 2(9): e384-92. PMID: 26685771, PII: S2352-3026(15)00146-5, DOI: 10.1016/S2352-3026(15)00146-5, ISSN: 2352-3026.

Pasquini MC, Zhang MJ, Medeiros BC, Armand P, Hu ZH, Nishihori T, Aljurf MD, Akpek G, Cahn JY, Cairo MS, Cerny J, Copelan EA, Deol A, Freytes CO, Gale RP, Ganguly S, George B, Gupta V, Hale GA, Kamble RT, Klumpp TR, Lazarus HM, Luger SM, Liesveld JL, Litzow MR, Marks DI, Martino R, Norkin M, Olsson RF, Oran B, Pawarode A, Pulsipher MA, Ramanathan M, Reshef R, Saad AA, Saber W, Savani BN, Schouten HC, Ringdén O, Tallman MS, Uy GL, Wood WA, Wirk B, Pérez WS, Batiwalla M, Weisdorf DJ. Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies. Biol. Blood Marrow Transplant [print-electronic]. 2015 Aug 8/29/2015; PMID: 26327629, PII: S1083-8791(15)00572-8, DOI: 10.1016/j.bbmt.2015.08.024, ISSN: 1523-6536.

Lapusan S, Yong A, Savani BN, Mohty M. Achieving early molecular response in chronic myeloid leukemia in chronic phase to reduce the risk of progression: clinical relevance of the 3- and 6-month time points. Eur. J. Haematol [print-electronic]. 2015 Aug; 95(2): 103-12. PMID: 25256677, DOI: 10.1111/ejh.12453, ISSN: 1600-0609.

Goyal SD, Zhang MJ, Wang HL, Akpek G, Copelan EA, Freytes C, Gale RP, Hamadani M, Inamoto Y, Kamble RT, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Reshef R, Ritchie DS, Saber W, Savani BN, Seber A, Shea TC, Tallman MS, Wirk B, Bunjes DW, Devine SM, de Lima M, Weisdorf DJ, Uy GL. Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome. Bone Marrow Transplant [print-electronic]. 2015 Aug; 50(8): 1057-62. PMID: 25915806, PMCID: PMC4527880, PII: bmt201582, DOI: 10.1038/bmt.2015.82, ISSN: 1476-5365.

Goyal SD, Zhang MJ, Wang HL, Akpek G, Copelan EA, Freytes C, Gale RP, Hamadani M, Inamoto Y, Kamble RT, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Reshef R, Ritchie DS, Saber W, Savani BN, Seber A, Shea TC, Tallman MS, Wirk B, Bunjes DW, Devine SM, de Lima M, Weisdorf DJ, Uy GL. Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome. Bone Marrow Transplant [print-electronic]. 2015 Aug; 50(8): 1057-62. PMID: 25915806, PMCID: PMC4527880, PII: bmt201582, DOI: 10.1038/bmt.2015.82, ISSN: 1476-5365.

Inamoto Y, Shah NN, Savani BN, Shaw BE, Abraham AA, Ahmed IA, Akpek G, Atsuta Y, Baker KS, Basak GW, Bitan M, DeFilipp Z, Gregory TK, Greinix HT, Hamadani M, Hamilton BK, Hayashi RJ, Jacobsohn DA, Kamble RT, Kasow KA, Khera N, Lazarus HM, Malone AK, Lupo-Stanghellini MT, Margossian SP, Muffly LS, Norkin M, Ramanathan M, Salooja N, Schoemans H, Wingard JR, Wirk B, Wood WA, Yong A, Duncan CN, Flowers ME, Majhail NS. Secondary solid cancer screening following hematopoietic cell transplantation. Bone Marrow Transplant [print-electronic]. 2015 Aug; 50(8): 1013-23. PMID: 25822223, PII: bmt201563, DOI: 10.1038/bmt.2015.63, ISSN: 1476-5365.

Chakraborty R, Savani BN, Litzow M, Mohty M, Hashmi S. A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties. Cancer [print-electronic]. 2015 Jul 7/15/2015; 121(14): 2303-13. PMID: 25872879, DOI: 10.1002/cncr.29382, ISSN: 1097-0142.

Chakraborty R, Savani BN, Litzow M, Mohty M, Hashmi S. A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties. Cancer [print-electronic]. 2015 Jul 7/15/2015; 121(14): 2303-13. PMID: 25872879, DOI: 10.1002/cncr.29382, ISSN: 1097-0142.

Sengsayadeth S, Savani BN, Blaise D, Malard F, Nagler A, Mohty M. Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT. Haematologica. 2015 Jul; 100(7): 859-69. PMID: 26130513, PMCID: PMC4486220, PII: haematol.2015.123331, DOI: 10.3324/haematol.2015.123331, ISSN: 1592-8721.

Sengsayadeth S, Savani BN, Blaise D, Malard F, Nagler A, Mohty M. Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT. Haematologica. 2015 Jul; 100(7): 859-69. PMID: 26130513, PMCID: PMC4486220, PII: haematol.2015.123331, DOI: 10.3324/haematol.2015.123331, ISSN: 1592-8721.

Carpenter PA, Kitko CL, Elad S, Flowers ME, Gea-Banacloche JC, Halter JP, Hoodin F, Johnston L, Lawitschka A, McDonald GB, Opipari AW, Savani BN, Schultz KR, Smith SR, Syrjala KL, Treister N, Vogelsang GB, Williams KM, Pavletic SZ, Martin PJ, Lee SJ, Couriel DR. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report. Biol. Blood Marrow Transplant [print-electronic]. 2015 Jul; 21(7): 1167-87. PMID: 25838185, PMCID: PMC4821166, PII: S1083-8791(15)00224-4, DOI: 10.1016/j.bbmt.2015.03.024, ISSN: 1523-6536.

Harris AE, Styczynski J, Bodge M, Mohty M, Savani BN, Ljungman P. Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection?. Bone Marrow Transplant [print-electronic]. 2015 Jul; 50(7): 899-903. PMID: 25798674, PII: bmt201549, DOI: 10.1038/bmt.2015.49, ISSN: 1476-5365.

Shah N, Callander N, Ganguly S, Gul Z, Hamadani M, Costa L, Sengsayadeth S, Abidi M, Hari P, Mohty M, Chen YB, Koreth J, Landau H, Lazarus H, Leather H, Majhail N, Nath R, Osman K, Perales MA, Schriber J, Shaughnessy P, Vesole D, Vij R, Wingard J, Giralt S, Savani BN, . Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2015 Jul; 21(7): 1155-66. PMID: 25769794, PII: S1083-8791(15)00174-3, DOI: 10.1016/j.bbmt.2015.03.002.

Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Duarte RF, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Pagluica T, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Carreras E. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant [print-electronic]. 2015 Jun; 50(6): 781-9. PMID: 25798682, PMCID: PMC4456788, PII: bmt201552, DOI: 10.1038/bmt.2015.52, ISSN: 1476-5365.

Perales MA, Ceberio I, Armand P, Burns LJ, Chen R, Cole PD, Evens AM, Laport GG, Moskowitz CH, Popat U, Reddy NM, Shea TC, Vose JM, Schriber J, Savani BN, Carpenter PA, . Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2015 Jun; 21(6): 971-83. PMID: 25773017, PII: S1083-8791(15)00152-4, DOI: 10.1016/j.bbmt.2015.02.022.

Mohty M, Malard F, Savani BN. High-dose total body irradiation and myeloablative conditioning before allogeneic hematopoietic cell transplantation: time to rethink?. Biol. Blood Marrow Transplant [print-electronic]. 2015 Apr; 21(4): 620-4. PMID: 25246296, PII: S1083-8791(14)00565-5, DOI: 10.1016/j.bbmt.2014.09.010, ISSN: 1523-6536.

Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, Marks DI, Moreb JS, Olsson R, Saber W, Savani BN, Schiller GJ, Tay J, Vogl DT, Waller EK, Wiernik PH, Wirk B, Lonial S, Krishnan AY, Dispenzieri A, Brandenburg NA, Gale RP, Hari PN. New cancers after autotransplantations for multiple myeloma. Biol. Blood Marrow Transplant [print-electronic]. 2015 Apr; 21(4): 738-45. PMID: 25555448, PMCID: PMC4359647, PII: S1083-8791(14)01472-4, DOI: 10.1016/j.bbmt.2014.12.028, ISSN: 1523-6536.

Copelan EA, Avalos BR, Ahn KW, Zhu X, Gale RP, Grunwald MR, Hamadani M, Hamilton BK, Hale GA, Marks DI, Waller EK, Savani BN, Costa LJ, Ramanathan M, Cahn JY, Khoury HJ, Weisdorf DJ, Inamoto Y, Kamble RT, Schouten HC, Wirk B, Litzow MR, Aljurf MD, van Besien KW, Ustun C, Bolwell BJ, Bredeson CN, Fasan O, Ghosh N, Horowitz MM, Arora M, Szer J, Loren AW, Alyea EP, Cortes J, Maziarz RT, Kalaycio ME, Saber W. Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation. Biol. Blood Marrow Transplant [print-electronic]. 2015 Mar; 21(3): 552-8. PMID: 25528388, PMCID: PMC4329042, PII: S1083-8791(14)01410-4, DOI: 10.1016/j.bbmt.2014.12.010, ISSN: 1523-6536.

Hashmi S, Carpenter P, Khera N, Tichelli A, Savani BN. Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors. Biol. Blood Marrow Transplant [print-electronic]. 2015 Feb; 21(2): 225-32. PMID: 24999225, PII: S1083-8791(14)00402-9, DOI: 10.1016/j.bbmt.2014.06.035, ISSN: 1523-6536.

Ballinger TJ, Savani BN, Gupta V, Kroger N, Mohty M. How we manage JAK inhibition in allogeneic transplantation for myelofibrosis. Eur. J. Haematol [print-electronic]. 2015 Feb; 94(2): 115-9. PMID: 25256963, DOI: 10.1111/ejh.12455, ISSN: 1600-0609.

Bachanova V, Burns LJ, Wang T, Carreras J, Gale RP, Wiernik PH, Ballen KK, Wirk B, Munker R, Rizzieri DA, Chen YB, Gibson J, Akpek G, Costa LJ, Kamble RT, Aljurf MD, Hsu JW, Cairo MS, Schouten HC, Bacher U, Savani BN, Wingard JR, Lazarus HM, Laport GG, Montoto S, Maloney DG, Smith SM, Brunstein C, Saber W. Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor. Bone Marrow Transplant [print-electronic]. 2015 Feb; 50(2): 197-203. PMID: 25402415, PMCID: PMC4336786, PII: bmt2014259, DOI: 10.1038/bmt.2014.259, ISSN: 1476-5365.

Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, Prockup SE, Ringdén OT, Savani BN, Socié G, Schultz KR, Spitzer T, Teshima T, Bredeson CN, Jacobsohn DA, Hayashi RJ, Drobyski WR, Frangoul HA, Akpek G, Ho VT, Lewis VA, Gale RP, Koreth J, Chao NJ, Aljurf MD, Cooper BW, Laughlin MJ, Hsu JW, Hematti P, Verdonck LF, Solh MM, Norkin M, Reddy V, Martino R, Gadalla S, Goldberg JD, McCarthy PL, Pérez-Simón JA, Khera N, Lewis ID, Atsuta Y, Olsson RF, Saber W, Waller EK, Blaise D, Pidala JA, Martin PJ, Satwani P, Bornhäuser M, Inamoto Y, Weisdorf DJ, Horowitz MM, Pavletic SZ, . Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biol. Blood Marrow Transplant [print-electronic]. 2015 Feb; 21(2): 266-74. PMID: 25445023, PMCID: PMC4326247, PII: S1083-8791(14)00660-0, DOI: 10.1016/j.bbmt.2014.10.021, ISSN: 1523-6536.

Jain NA, Ito S, Tian X, Kurlander R, Battiwalla M, Lu K, Savani BN, Malkovska V, Rezvani K, Le RQ, Shenoy A, Hourigan CS, Keyvanfar K, Koklanaris E, Superata J, Muranski P, Barrett AJ, Yong ASM. Clinical and biological predictors of outcome following relapse of CML post-allo-SCT. Bone Marrow Transplant [print-electronic]. 2015 Feb; 50(2): 189-96. PMID: 25387087, PMCID: PMC4318796, DOI: 10.1038/bmt.2014.249, ISSN: 1476-5365.

Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, Pulsipher MA, Savani BN, Schears RM, Shaw BE, Confer DL. Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis. Biol. Blood Marrow Transplant [print-electronic]. 2015 Jan; 21(1): 165-71. PMID: 25316111, PMCID: PMC4272878, PII: S1083-8791(14)00632-6, DOI: 10.1016/j.bbmt.2014.10.007, ISSN: 1523-6536.

Duncan CN, Majhail NS, Brazauskas R, Wang Z, Cahn JY, Frangoul HA, Hayashi RJ, Hsu JW, Kamble RT, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Maziarz RT, Mehta P, Myers KC, Norkin M, Pidala JA, Porter DL, Reddy V, Saber W, Savani BN, Schouten HC, Steinberg A, Wall DA, Warwick AB, Wood WA, Yu LC, Jacobsohn DA, Sorror ML. Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes. Biol. Blood Marrow Transplant [print-electronic]. 2015 Jan; 21(1): 151-8. PMID: 25316109, PMCID: PMC4272862, PII: S1083-8791(14)00631-4, DOI: 10.1016/j.bbmt.2014.10.006, ISSN: 1523-6536.

Prince P, Mitchell SA, Wehrlen L, Childs R, Savani B, Yang L, Bevans M. Spiritual Well-Being in Hispanic and Non-Hispanic Survivors of Allogeneic Hematopoietic Stem Cell Transplantation. J Psychosoc Oncol. 2015; 33(6): 635-54. PMID: 26315721, PMCID: PMC4743042, DOI: 10.1080/07347332.2015.1082167, ISSN: 1540-7586.

Savani BN, Mohty M. Bone marrow transplantation. Preface. Hematol. Oncol. Clin. North Am [print-electronic]. 2014 Dec; 28(6): xiii-xv. PMID: 25459189, PII: S0889-8588(14)00122-1, DOI: 10.1016/j.hoc.2014.09.001, ISSN: 1558-1977.

Sharma M, Zhang MJ, Zhong X, Abidi MH, Akpek G, Bacher U, Callander NS, Dispenzieri A, Freytes CO, Fung HC, Gale RP, Gasparetto C, Gibson J, Holmberg LA, Kindwall-Keller TL, Klumpp TR, Krishnan AY, Landau HJ, Lazarus HM, Lonial S, Maiolino A, Marks DI, Mehta P, Mikhael Med JR, Nishihori T, Olsson R, Ramanathan M, Roy V, Savani BN, Schouten HC, Scott E, Tay J, To LB, Vesole DH, Vogl DT, Hari P. Older patients with myeloma derive similar benefit from autologous transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2014 Nov; 20(11): 1796-803. PMID: 25046833, PMCID: PMC4194262, PII: S1083-8791(14)00439-X, DOI: 10.1016/j.bbmt.2014.07.013, ISSN: 1523-6536.

Ringdén O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder D, Burns LJ, Cahn JY, Duncan C, Hale GA, Halter J, Hayashi RJ, Hsu JW, Jacobsohn DA, Kamble RT, Kamani NR, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Myers KC, Ramanathan M, Saber W, Savani BN, Schouten HC, Socie G, Sorror ML, Steinberg A, Popat U, Wingard JR, Mattsson J, Majhail NS. Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. Biol. Blood Marrow Transplant [print-electronic]. 2014 Nov; 20(11): 1777-84. PMID: 25042734, PMCID: PMC4194257, PII: S1083-8791(14)00435-2, DOI: 10.1016/j.bbmt.2014.07.009, ISSN: 1523-6536.

Hamadani M, Hari PN, Zhang Y, Carreras J, Akpek G, Aljurf MD, Ayala E, Bachanova V, Chen AI, Chen YB, Costa LJ, Fenske TS, Freytes CO, Ganguly S, Hertzberg MS, Holmberg LA, Inwards DJ, Kamble RT, Kanfer EJ, Lazarus HM, Marks DI, Nishihori T, Olsson R, Reddy NM, Rizzieri DA, Savani BN, Solh M, Vose JM, Wirk B, Maloney DG, Smith SM, Montoto S, Saber W, Alpdogan O, Cashen A, Dandoy C, Finke R, Gale R, Gibson J, Hsu JW, Janakiraman N, Laughlin MJ, Lill M, Cairo MS, Munker R, Rowlings PA, Schouten HC, Shea TC, Stiff PJ, Waller EK. Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2014 Nov; 20(11): 1729-36. PMID: 25008330, PMCID: PMC4194275, PII: S1083-8791(14)00403-0, DOI: 10.1016/j.bbmt.2014.06.036, ISSN: 1523-6536.

Das-Gupta E, Greinix H, Jacobs R, Zhou L, Savani BN, Engelhardt BG, Kassim A, Worel N, Knobler R, Russell N, Jagasia M. Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure. Haematologica [print-electronic]. 2014 Nov; 99(11): 1746-52. PMID: 25150260, PMCID: PMC4222474, PII: haematol.2014.108217, DOI: 10.3324/haematol.2014.108217, ISSN: 1592-8721.

Duong HK, Savani BN, Copelan E, Devine S, Costa LJ, Wingard JR, Shaughnessy P, Majhail N, Perales MA, Cutler CS, Bensinger W, Litzow MR, Mohty M, Champlin RE, Leather H, Giralt S, Carpenter PA. Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2014 Sep; 20(9): 1262-73. PMID: 24816581, PII: S1083-8791(14)00288-2, DOI: 10.1016/j.bbmt.2014.05.003, ISSN: 1523-6536.

Törlén J, Ringdén O, Le Rademacher J, Batiwalla M, Chen J, Erkers T, Ho V, Kebriaei P, Keever-Taylor C, Kindwall-Keller T, Lazarus HM, Laughlin MJ, Lill M, O'Brien T, Perales MA, Rocha V, Savani BN, Szwajcer D, Valcarcel D, Eapen M. Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome. Biol. Blood Marrow Transplant [print-electronic]. 2014 Sep; 20(9): 1418-25. PMID: 24892261, PMCID: PMC4127369, PII: S1083-8791(14)00319-X, DOI: 10.1016/j.bbmt.2014.05.021, ISSN: 1523-6536.

Hu B, Savani BN. Impact of risk score calculations in choosing front-line tyrosine kinase inhibitors for patients with newly diagnosed chronic myeloid leukemia in the chronic phase. Eur. J. Haematol [print-electronic]. 2014 Sep; 93(3): 179-86. PMID: 24766312, DOI: 10.1111/ejh.12356, ISSN: 1600-0609.

McClune BL, Ahn KW, Wang HL, Antin JH, Artz AS, Cahn JY, Deol A, Freytes CO, Hamadani M, Holmberg LA, Jagasia MH, Jakubowski AA, Kharfan-Dabaja MA, Lazarus HM, Miller AM, Olsson R, Pedersen TL, Pidala J, Pulsipher MA, Rowe JM, Saber W, van Besien KW, Waller EK, Aljurf MD, Akpek G, Bacher U, Chao NJ, Chen YB, Cooper BW, Dehn J, de Lima MJ, Hsu JW, Lewis ID, Marks DI, McGuirk J, Cairo MS, Schouten HC, Szer J, Ramanathan M, Savani BN, Seftel M, Socie G, Vij R, Warlick ED, Weisdorf DJ. Allotransplantation for patients age =40 years with non-Hodgkin lymphoma: encouraging progression-free survival. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jul; 20(7): 960-8. PMID: 24641829, PMCID: PMC4057955, PII: S1083-8791(14)00162-1, DOI: 10.1016/j.bbmt.2014.03.013, ISSN: 1523-6536.

Wirk B, Fenske TS, Hamadani M, Zhang MJ, Hu ZH, Akpek G, Aljurf MD, Armand P, Ayala E, Bachanova V, Bolwell B, Cairo MS, Cashen A, Chen YB, Costa LJ, Farhan S, Freytes CO, Gajewski JL, Gibson J, Hale GA, Holmberg LA, Hsu JW, Inwards DJ, Kamble RT, Maharaj D, Maziarz RT, Munker R, Nath R, Reddy NM, Reeder CB, Rizzieri DA, Sauter CS, Savani BN, Schouten HC, Sureda A, Vose JM, Waller EK, Wiernik PH, Gale RP, Burns LJ, Saber W. Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jul; 20(7): 951-9. PMID: 24641828, PMCID: PMC4060436, PII: S1083-8791(14)00163-3, DOI: 10.1016/j.bbmt.2014.03.014, ISSN: 1523-6536.

Bodge MN, Reddy S, Thompson MS, Savani BN. Preparative regimen dosing for hematopoietic stem cell transplantation in patients with chronic kidney disease: analysis of the literature and recommendations. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jul; 20(7): 908-19. PMID: 24565993, PII: S1083-8791(14)00100-1, DOI: 10.1016/j.bbmt.2014.02.013, ISSN: 1523-6536.

Sengsayadeth S, Wang T, Lee SJ, Haagenson MD, Spellman S, Fernandez Viña MA, Muller CR, Verneris MR, Savani BN, Jagasia M. Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jun; 20(6): 900-3. PMID: 24631737, PMCID: PMC4034271, PII: S1083-8791(14)00154-2, DOI: 10.1016/j.bbmt.2014.03.005, ISSN: 1523-6536.

Bodge MN, Culos KA, Haider SN, Thompson MS, Savani BN. Preparative regimen dosing for hematopoietic stem cell transplantation in patients with chronic hepatic impairment: analysis of the literature and recommendations. Biol. Blood Marrow Transplant [print-electronic]. 2014 May; 20(5): 622-9. PMID: 24492142, PII: S1083-8791(14)00074-3, DOI: 10.1016/j.bbmt.2014.01.029, ISSN: 1523-6536.

Bubalo J, Carpenter PA, Majhail N, Perales MA, Marks DI, Shaughnessy P, Pidala J, Leather HL, Wingard J, Savani BN, . Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee. Biol. Blood Marrow Transplant [print-electronic]. 2014 May; 20(5): 600-16. PMID: 24462742, PII: S1083-8791(14)00050-0, DOI: 10.1016/j.bbmt.2014.01.019.

Mathews V, Savani BN. Conditioning regimens in allo-SCT for thalassemia major. Bone Marrow Transplant [print-electronic]. 2014 May; 49(5): 607-10. PMID: 24442250, PII: bmt2013216, DOI: 10.1038/bmt.2013.216, ISSN: 1476-5365.

Kharfan-Dabaja MA, Hamadani M, Sibai H, Savani BN. Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all!. Bone Marrow Transplant [print-electronic]. 2014 May; 49(5): 599-606. PMID: 24442246, PII: bmt2013226, DOI: 10.1038/bmt.2013.226, ISSN: 1476-5365.

Goswami M, Hensel N, Smith BD, Prince GT, Qin L, Levitsky HI, Strickland SA, Jagasia M, Savani BN, Fraser JW, Sadrzadeh H, Rajkhowa T, Ito S, Jain NA, Battiwalla M, Fathi AT, Levis MJ, Barrett AJ, Hourigan CS. Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues [letter]. Leukemia [print-electronic]. 2014 May; 28(5): 1167-70. PMID: 24472813, PMCID: PMC4013200, PII: leu201414, DOI: 10.1038/leu.2014.14, ISSN: 1476-5551.

Li X, Brazauskas R, Wang Z, Al-Seraihy A, Baker KS, Cahn JY, Frangoul HA, Gajewski JL, Hale GA, Hsu JW, Kamble RT, Lazarus HM, Marks DI, Maziarz RT, Savani BN, Shah AJ, Shah N, Sorror ML, Wood WA, Majhail NS. Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents. Biol. Blood Marrow Transplant [print-electronic]. 2014 Apr; 20(4): 587-92. PMID: 24388803, PMCID: PMC3959243, PII: S1083-8791(13)01182-8, DOI: 10.1016/j.bbmt.2013.12.567, ISSN: 1523-6536.

Hu B, Vikas P, Mohty M, Savani BN. Allogeneic stem cell transplantation and targeted therapy for FLT3/ITD+ acute myeloid leukemia: an update. Expert Rev Hematol [print-electronic]. 2014 Apr; 7(2): 301-15. PMID: 24308526, DOI: 10.1586/17474086.2014.857596, ISSN: 1747-4094.

Joshi S, Savani BN, Chow EJ, Gilleece MH, Halter J, Jacobsohn DA, Pidala J, Quinn GP, Cahn JY, Jakubowski AA, Kamani NR, Lazarus HM, Rizzo JD, Schouten HC, Socie G, Stratton P, Sorror ML, Warwick AB, Wingard JR, Loren AW, Majhail NS. Clinical guide to fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant [print-electronic]. 2014 Apr; 49(4): 477-84. PMID: 24419521, PMCID: PMC4071767, PII: bmt2013211, DOI: 10.1038/bmt.2013.211, ISSN: 1476-5365.

Sengsayadeth S, Savani BN. Age is more than a number. Cytotherapy. 2014 Mar; 16(3): 287-8. PMID: 24503007, PII: S1465-3249(14)00022-X, DOI: 10.1016/j.jcyt.2014.01.002, ISSN: 1477-2566.

Saad A, Mahindra A, Zhang MJ, Zhong X, Costa LJ, Dispenzieri A, Drobyski WR, Freytes CO, Gale RP, Gasparetto CJ, Holmberg LA, Kamble RT, Krishnan AY, Kyle RA, Marks D, Nishihori T, Pasquini MC, Ramanathan M, Lonial S, Savani BN, Saber W, Sharma M, Sorror ML, Wirk BM, Hari PN. Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma. Biol. Blood Marrow Transplant [print-electronic]. 2014 Mar; 20(3): 402-408.e1. PMID: 24342394, PMCID: PMC3961011, PII: S1083-8791(13)01129-4, DOI: 10.1016/j.bbmt.2013.12.557, ISSN: 1523-6536.

Booth GS, Gehrie EA, Savani BN. Minor RBC Ab and allo-SCT [letter]. Bone Marrow Transplant [print-electronic]. 2014 Mar; 49(3): 456-7. PMID: 24317128, PII: bmt2013196, DOI: 10.1038/bmt.2013.196, ISSN: 1476-5365.

Mohty M, Malard F, Mohty B, Savani B, Moreau P, Terpos E. The effects of bortezomib on bone disease in patients with multiple myeloma. Cancer [print-electronic]. 2014 Mar 3/1/2014; 120(5): 618-23. PMID: 24249482, DOI: 10.1002/cncr.28481, ISSN: 1097-0142.

Bachanova V, Marks DI, Zhang MJ, Wang H, de Lima M, Aljurf MD, Arellano M, Artz AS, Bacher U, Cahn JY, Chen YB, Copelan EA, Drobyski WR, Gale RP, Greer JP, Gupta V, Hale GA, Kebriaei P, Lazarus HM, Lewis ID, Lewis VA, Liesveld JL, Litzow MR, Loren AW, Miller AM, Norkin M, Oran B, Pidala J, Rowe JM, Savani BN, Saber W, Vij R, Waller EK, Wiernik PH, Weisdorf DJ. Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease. Leukemia [print-electronic]. 2014 Mar; 28(3): 658-65. PMID: 23989431, PMCID: PMC3951192, PII: leu2013253, DOI: 10.1038/leu.2013.253, ISSN: 1476-5551.

Jain NA, Pophali PA, Klotz JK, Ito S, Koklanaris E, Chawla K, Hourigan CS, Gormley N, Savani BN, Barrett AJ, Battiwalla M. Repair of impaired pulmonary function is possible in very-long-term allogeneic stem cell transplantation survivors. Biol. Blood Marrow Transplant [print-electronic]. 2014 Feb; 20(2): 209-13. PMID: 24188917, PMCID: PMC3918472, PII: S1083-8791(13)00502-8, DOI: 10.1016/j.bbmt.2013.10.025, ISSN: 1523-6536.

Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn JY, Bornhauser M, Seftel M, Cairo MS, Laughlin MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen YB, Liesveld JL, Cutler CS, Ghobadi A, Uy GL, Eapen M, Weisdorf DJ, Litzow MR. Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. Biol. Blood Marrow Transplant [print-electronic]. 2014 Feb; 20(2): 202-8. PMID: 24184335, PMCID: PMC3924751, PII: S1083-8791(13)00500-4, DOI: 10.1016/j.bbmt.2013.10.023, ISSN: 1523-6536.

Pophali PA, Klotz JK, Ito S, Jain NA, Koklanaris E, Le RQ, Hourigan CS, Savani BN, Chawla K, Shanbhag S, Barrett AJ, Battiwalla M. Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events. Exp. Hematol [print-electronic]. 2014 Feb; 42(2): 83-9. PMID: 24141092, PMCID: PMC3929523, PII: S0301-472X(13)00759-5, DOI: 10.1016/j.exphem.2013.07.003, ISSN: 1873-2399.

Sengsayadeth S, Savani BN, Jagasia M, Goodman S, Greer JP, Chen H, Chinratanalab W, Kassim AA, Engelhardt BG. Six-month freedom from treatment failure is an important end point for acute GVHD clinical trials. Bone Marrow Transplant [print-electronic]. 2014 Feb; 49(2): 236-40. PMID: 24096824, PMCID: PMC3946331, PII: bmt2013157, DOI: 10.1038/bmt.2013.157, ISSN: 1476-5365.

Marks DI, Woo KA, Zhong X, Appelbaum FR, Bachanova V, Barker JN, Brunstein CG, Gibson J, Kebriaei P, Lazarus HM, Olsson R, Perales MA, Pidala J, Savani B, Rocha V, Eapen M. Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors. Haematologica [print-electronic]. 2014 Feb; 99(2): 322-8. PMID: 24056817, PMCID: PMC3912963, PII: haematol.2013.094193, DOI: 10.3324/haematol.2013.094193, ISSN: 1592-8721.

Reddy NM, Oluwole O, Greer JP, Engelhardt BG, Jagasia MH, Savani BN. Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma. Exp. Hematol [print-electronic]. 2014 Jan; 42(1): 39-45. PMID: 24096123, PII: S0301-472X(13)00747-9, DOI: 10.1016/j.exphem.2013.09.012, ISSN: 1873-2399.

Gupta V, Malone AK, Hari PN, Ahn KW, Hu ZH, Gale RP, Ballen KK, Hamadani M, Olavarria E, Gerds AT, Waller EK, Costa LJ, Antin JH, Kamble RT, van Besien KM, Savani BN, Schouten HC, Szer J, Cahn JY, de Lima MJ, Wirk B, Aljurf MD, Popat U, Bejanyan N, Litzow MR, Norkin M, Lewis ID, Hale GA, Woolfrey AE, Miller AM, Ustun C, Jagasia MH, Lill M, Maziarz RT, Cortes J, Kalaycio ME, Saber W. Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jan; 20(1): 89-97. PMID: 24161923, PMCID: PMC3886623, PII: S1083-8791(13)00495-3, DOI: 10.1016/j.bbmt.2013.10.018, ISSN: 1523-6536.

Ragon BK, Clifton C, Chen H, Savani BN, Engelhardt BG, Kassim AA, Vaughan LA, Lucid C, Jagasia M. Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jan; 20(1): 53-7. PMID: 24120525, PII: S1083-8791(13)00450-3, DOI: 10.1016/j.bbmt.2013.10.004, ISSN: 1523-6536.

Hamadani M, Abu Kar SM, Usmani SZ, Savani BN, Ayala E, Kharfan-Dabaja MA. Management of relapses after hematopoietic cell transplantation in T-cell non-Hodgkin lymphomas. Semin. Hematol [print-electronic]. 2014 Jan; 51(1): 73-86. PMID: 24468319, PII: S0037-1963(13)00155-8, DOI: 10.1053/j.seminhematol.2013.11.005, ISSN: 1532-8686.

Reddy NM, Savani BN. Management of T-cell lymphomas: overcoming challenges and choosing the best treatment [editorial]. Semin. Hematol [print-electronic]. 2014 Jan; 51(1): 1-4. PMID: 24468310, PII: S0037-1963(13)00159-5, DOI: 10.1053/j.seminhematol.2013.11.009, ISSN: 1532-8686.

Copelan EA, Hamilton BK, Avalos B, Ahn KW, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn JY, Costa LJ, de Lima M, Gale RP, Hale GA, Halter J, Hamadani M, Inamoto Y, Kamble RT, Litzow MR, Loren AW, Marks DI, Olavarria E, Roy V, Sabloff M, Savani BN, Seftel M, Schouten HC, Ustun C, Waller EK, Weisdorf DJ, Wirk B, Horowitz MM, Arora M, Szer J, Cortes J, Kalaycio ME, Maziarz RT, Saber W. Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Blood [print-electronic]. 2013 Dec 12/5/2013; 122(24): 3863-70. PMID: 24065243, PMCID: PMC3854108, PII: blood-2013-07-514448, DOI: 10.1182/blood-2013-07-514448, ISSN: 1528-0020.

Booth GS, Gehrie EA, Savani BN. Response to "What is the optimal approach to major ABO-incompatible allogeneic stem cell transplantation" [letter]. Biol. Blood Marrow Transplant [print-electronic]. 2013 Dec; 19(12): 1760-1. PMID: 24125949, PII: S1083-8791(13)00451-5, DOI: 10.1016/j.bbmt.2013.10.005, ISSN: 1523-6536.

Lee SJ, Storer B, Wang H, Lazarus HM, Waller EK, Isola LM, Klumpp TR, Umejiego JB, Savani BN, Loren AW, Cairo MS, Camitta BM, Cutler CS, George B, Jean Khoury H, Marks DI, Rizzieri DA, Copelan EA, Gupta V, Liesveld JL, Litzow MR, Miller AM, Schouten HC, Gale RP, Cahn JY, Weisdorf DJ. Providing personalized prognostic information for adult leukemia survivors. Biol. Blood Marrow Transplant [print-electronic]. 2013 Nov; 19(11): 1600-7. PMID: 24018394, PMCID: PMC3832127, PII: S1083-8791(13)00390-X, DOI: 10.1016/j.bbmt.2013.08.013, ISSN: 1523-6536.

Costa LJ, Zhang MJ, Zhong X, Dispenzieri A, Lonial S, Krishnan A, Freytes C, Vesole D, Gale RP, Anderson K, Wirk B, Savani BN, Waller EK, Schouten H, Lazarus H, Meehan K, Sharma M, Kamble R, Vij R, Kumar S, Nishihori T, Kindwall-Keller T, Saber W, Hari PN. Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma. Biol. Blood Marrow Transplant [print-electronic]. 2013 Nov; 19(11): 1615-24. PMID: 23939198, PMCID: PMC3952066, PII: S1083-8791(13)00351-0, DOI: 10.1016/j.bbmt.2013.08.002, ISSN: 1523-6536.

Vaughan LA, Vu M, Sengsayadeth S, Lucid C, Clifton C, McCarty K, Hagaman D, Domm J, Kassim A, Chinratanalab W, Goodman S, Greer J, Frangoul H, Engelhardt BG, Jagasia M, Savani BN. New allergies after cord blood transplantation. Cytotherapy. 2013 Oct; 15(10): 1259-65. PMID: 23993300, PII: S1465-3249(13)00550-1, DOI: 10.1016/j.jcyt.2013.05.018, ISSN: 1477-2566.

Mohty M, Brissot E, Savani BN, Gaugler B. Effects of bortezomib on the immune system: a focus on immune regulation. Biol. Blood Marrow Transplant [print-electronic]. 2013 Oct; 19(10): 1416-20. PMID: 23707853, PII: S1083-8791(13)00224-3, DOI: 10.1016/j.bbmt.2013.05.011, ISSN: 1523-6536.

Savani BN. Ferritin and FerriScan in HCT recipients. Blood. 2013 Aug 8/29/2013; 122(9): 1539-41. PMID: 23990615, PII: 122/9/1539, DOI: 10.1182/blood-2013-07-511014, ISSN: 1528-0020.

Booth GS, Gehrie EA, Bolan CD, Savani BN. Clinical guide to ABO-incompatible allogeneic stem cell transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2013 Aug; 19(8): 1152-8. PMID: 23571461, PII: S1083-8791(13)00145-6, DOI: 10.1016/j.bbmt.2013.03.018, ISSN: 1523-6536.

Wulff-Burchfield EM, Savani BN. Building a transplantation physician workforce for growing need: recruitment starts during residency. Biol. Blood Marrow Transplant [print-electronic]. 2013 Aug; 19(8): 1142-3. PMID: 23680471, PII: S1083-8791(13)00199-7, DOI: 10.1016/j.bbmt.2013.05.004, ISSN: 1523-6536.

Sengsayadeth SM, Savani BN. Umbilical cord blood transplant: expanding the options [editorial]. Expert Rev Hematol. 2013 Aug; 6(4): 341-2. PMID: 23991919, DOI: 10.1586/17474086.2013.816509, ISSN: 1747-4094.

Foran JM, Pavletic SZ, Logan BR, Agovi-Johnson MA, Pérez WS, Bolwell BJ, Bornhäuser M, Bredeson CN, Cairo MS, Camitta BM, Copelan EA, Dehn J, Gale RP, George B, Gupta V, Hale GA, Lazarus HM, Litzow MR, Maharaj D, Marks DI, Martino R, Maziarz RT, Rowe JM, Rowlings PA, Savani BN, Savoie ML, Szer J, Waller EK, Wiernik PH, Weisdorf DJ. Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research. Biol. Blood Marrow Transplant [print-electronic]. 2013 Jul; 19(7): 1102-8. PMID: 23632091, PMCID: PMC3691352, PII: S1083-8791(13)00190-0, DOI: 10.1016/j.bbmt.2013.04.022, ISSN: 1523-6536.

Jagasia M, Greinix H, Robin M, Das-Gupta E, Jacobs R, Savani BN, Engelhardt BG, Kassim A, Worel N, Knobler R, Russell N, Socie G. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis. Biol. Blood Marrow Transplant [print-electronic]. 2013 Jul; 19(7): 1129-33. PMID: 23623892, PII: S1083-8791(13)00186-9, DOI: 10.1016/j.bbmt.2013.04.018, ISSN: 1523-6536.

Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN, Hsu JW, Inwards DJ, Kamble RT, Klein A, Maharaj D, Marks DI, Rizzieri DA, Savani BN, Schouten HC, Waller EK, Wirk B, Laport GG, Montoto S, Maloney DG, Lazarus HM. Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma. Biol. Blood Marrow Transplant [print-electronic]. 2013 May; 19(5): 746-53. PMID: 23380340, PMCID: PMC3650915, PII: S1083-8791(13)00060-8, DOI: 10.1016/j.bbmt.2013.01.024, ISSN: 1523-6536.

Michaelis LC, Saad A, Zhong X, Le-Rademacher J, Freytes CO, Marks DI, Lazarus HM, Bird JM, Holmberg L, Kamble RT, Kumar S, Lill M, Meehan KR, Saber W, Schriber J, Tay J, Vogl DT, Wirk B, Savani BN, Gale RP, Vesole DH, Schiller GJ, Abidi M, Anderson KC, Nishihori T, Kalaycio ME, Vose JM, Moreb JS, Drobyski W, Munker R, Roy V, Ghobadi A, Holland HK, Nath R, To LB, Maiolino A, Kassim AA, Giralt SA, Landau H, Schouten HC, Maziarz RT, Mikhael J, Kindwall-Keller T, Stiff PJ, Gibson J, Lonial S, Krishnan A, Dispenzieri A, Hari P, . Salvage second hematopoietic cell transplantation in myeloma. Biol. Blood Marrow Transplant [print-electronic]. 2013 May; 19(5): 760-6. PMID: 23298856, PMCID: PMC3816739, PII: S1083-8791(13)00017-7, DOI: 10.1016/j.bbmt.2013.01.004, ISSN: 1523-6536.

Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN, Hsu JW, Inwards DJ, Kamble RT, Klein A, Maharaj D, Marks DI, Rizzieri DA, Savani BN, Schouten HC, Waller EK, Wirk B, Lazarus HM. Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research. Biol. Blood Marrow Transplant [print-electronic]. 2013 Apr; 19(4): 625-31. PMID: 23333532, PMCID: PMC3640440, PII: S1083-8791(13)00024-4, DOI: 10.1016/j.bbmt.2013.01.009, ISSN: 1523-6536.

Wulff-Burchfield EM, Jagasia M, Savani BN. Long-term follow-up of informal caregivers after allo-SCT: a systematic review. Bone Marrow Transplant [print-electronic]. 2013 Apr; 48(4): 469-73. PMID: 22732697, PII: bmt2012123, DOI: 10.1038/bmt.2012.123, ISSN: 1476-5365.

Danner-Koptik KE, Majhail NS, Brazauskas R, Wang Z, Buchbinder D, Cahn JY, Dilley KJ, Frangoul HA, Gross TG, Hale GA, Hayashi RJ, Hijiya N, Kamble RT, Lazarus HM, Marks DI, Reddy V, Savani BN, Warwick AB, Wingard JR, Wood WA, Sorror ML, Jacobsohn DA. Second malignancies after autologous hematopoietic cell transplantation in children. Bone Marrow Transplant [print-electronic]. 2013 Mar; 48(3): 363-8. PMID: 22964594, PMCID: PMC3525761, PII: bmt2012166, DOI: 10.1038/bmt.2012.166, ISSN: 1476-5365.

Logue M, Savani BN. Understanding basic steps to hematopoietic stem cell transplantation evaluation. Am J Blood Res [electronic-print]. 2013; 3(2): 102-6. PMID: 23675562, PMCID: PMC3649815, ISSN: 2160-1992.

Buchbinder D, Nugent DJ, Brazauskas R, Wang Z, Aljurf MD, Cairo MS, Chow R, Duncan C, Eldjerou LK, Gupta V, Hale GA, Halter J, Hayes-Lattin BM, Hsu JW, Jacobsohn DA, Kamble RT, Kasow KA, Lazarus HM, Mehta P, Myers KC, Parsons SK, Passweg JR, Pidala J, Reddy V, Sales-Bonfim CM, Savani BN, Seber A, Sorror ML, Steinberg A, Wood WA, Wall DA, Winiarski JH, Yu LC, Majhail NS. Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research. Biol. Blood Marrow Transplant [print-electronic]. 2012 Dec; 18(12): 1776-84. PMID: 22863842, PMCID: PMC3496823, PII: S1083-8791(12)00265-0, DOI: 10.1016/j.bbmt.2012.06.018, ISSN: 1523-6536.

Hart AJ, Jagasia MH, Kim AS, Mosse CA, Savani BN, Kassim A. Minimal residual disease in myeloma: are we there yet?. Biol. Blood Marrow Transplant [print-electronic]. 2012 Dec; 18(12): 1790-9. PMID: 22626785, PII: S1083-8791(12)00211-X, DOI: 10.1016/j.bbmt.2012.05.009, ISSN: 1523-6536.

Engelhardt BG, Sengsayadeth SM, Jagasia M, Savani BN, Kassim AA, Lu P, Shyr Y, Yoder SM, Rock MT, Crowe JE. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival. Exp. Hematol [print-electronic]. 2012 Dec; 40(12): 974-982.e1. PMID: 22885125, PMCID: PMC3611587, PII: S0301-472X(12)00343-8, DOI: 10.1016/j.exphem.2012.08.002, ISSN: 1873-2399.

Sengsayadeth SM, Jagasia M, Engelhardt BG, Kassim A, Strickland SA, Goodman S, Lucid C, Vnencak-Jones CL, Greer JP, Savani BN. Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. Bone Marrow Transplant [print-electronic]. 2012 Dec; 47(12): 1535-7. PMID: 22659680, PII: bmt201288, DOI: 10.1038/bmt.2012.88, ISSN: 1476-5365.

Reddy N, Oluwole O, Greer JP, Goodman S, Engelhardt B, Jagasia MH, Savani BN. Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation. Clin Lymphoma Myeloma Leuk [print-electronic]. 2012 Dec; 12(6): 406-11. PMID: 22981964, PII: S2152-2650(12)00136-X, DOI: 10.1016/j.clml.2012.07.003, ISSN: 2152-2669.

Jacobs R, Tran U, Chen H, Kassim A, Engelhardt BG, Greer JP, Goodman SG, Clifton C, Lucid C, Vaughan LA, Savani BN, Jagasia M. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant [print-electronic]. 2012 Nov; 47(11): 1470-3. PMID: 22484321, PII: bmt201256, DOI: 10.1038/bmt.2012.56, ISSN: 1476-5365.

Sengsayadeth SM, Srivastava S, Jagasia M, Savani BN. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2012 Oct; 18(10): 1479-87. PMID: 22449611, PII: S1083-8791(12)00120-6, DOI: 10.1016/j.bbmt.2012.03.008, ISSN: 1523-6536.

Reddy N, Greer JP, Goodman S, Engelhardt B, Oluwole O, Jagasia MH, Savani BN. Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma. Bone Marrow Transplant [print-electronic]. 2012 Oct; 47(10): 1318-20. PMID: 22327132, PII: bmt201210, DOI: 10.1038/bmt.2012.10, ISSN: 1476-5365.

Reddy N, Savani BN. Primary central nervous system lymphoma: implication of high-dose chemotherapy followed by auto-SCT. Bone Marrow Transplant [print-electronic]. 2012 Oct; 47(10): 1265-8. PMID: 22002486, PII: bmt2011204, DOI: 10.1038/bmt.2011.204, ISSN: 1476-5365.

Ballen KK, Woolfrey AE, Zhu X, Ahn KW, Wirk B, Arora M, George B, Savani BN, Bolwell B, Porter DL, Copelan E, Hale G, Schouten HC, Lewis I, Cahn JY, Halter J, Cortes J, Kalaycio ME, Antin J, Aljurf MD, Carabasi MH, Hamadani M, McCarthy P, Pavletic S, Gupta V, Deeg HJ, Maziarz RT, Horowitz MM, Saber W. Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia. Biol. Blood Marrow Transplant [print-electronic]. 2012 Sep; 18(9): 1446-54. PMID: 22449610, PMCID: PMC3499973, PII: S1083-8791(12)00121-8, DOI: 10.1016/j.bbmt.2012.03.009, ISSN: 1523-6536.

Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, Litzow MR, Nieto Y, Savani BN, Schriber JR, Shaughnessy PJ, Wall DA, Carpenter PA. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2012 Aug; 18(8): 1150-63. PMID: 22510384, PMCID: PMC3404151, PII: S1083-8791(12)00144-9, DOI: 10.1016/j.bbmt.2012.04.005, ISSN: 1523-6536.

Battiwalla M, Ellis K, Li P, Pavletic SZ, Akpek G, Hematti P, Klumpp TR, Maziarz RT, Savani BN, Aljurf MD, Cairo MS, Drobyski WR, George B, Hahn T, Khera N, Litzow MR, Loren AW, Saber W, Arora M, Urbano-Ispizua A, Cutler C, Flowers ME, Spellman SR. HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies. Biol. Blood Marrow Transplant [print-electronic]. 2012 Aug; 18(8): 1302-8. PMID: 22414493, PMCID: PMC3580851, PII: S1083-8791(12)00107-3, DOI: 10.1016/j.bbmt.2012.02.011, ISSN: 1523-6536.

Dunn D, Vikas P, Jagasia M, Savani BN. Plerixafor in AL amyloidosis: improved graft composition and faster lymphocyte recovery after auto-SCT in patient with end-stage renal-disease. Bone Marrow Transplant [print-electronic]. 2012 Aug; 47(8): 1136-7. PMID: 22080973, PII: bmt2011226, DOI: 10.1038/bmt.2011.226, ISSN: 1476-5365.

Johnson DB, Savani BN. How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation?. Exp. Hematol [print-electronic]. 2012 Jul; 40(7): 513-7. PMID: 22542577, PII: S0301-472X(12)00138-5, DOI: 10.1016/j.exphem.2012.04.004, ISSN: 1873-2399.

Rezvani K, Yong AS, Mielke S, Savani BN, Jafarpour B, Eniafe R, Le RQ, Musse L, Boss C, Childs R, John Barrett A. Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy. Cancer Immunol. Immunother [print-electronic]. 2012 Jul; 61(7): 1125-36. PMID: 22198310, PMCID: PMC4163946, DOI: 10.1007/s00262-011-1187-z, ISSN: 1432-0851.

Jagasia M, Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Chen H, Kassim A, Greer JP, Engelhardt BG, Savani BN. Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies. Biol. Blood Marrow Transplant [print-electronic]. 2012 Jul; 18(7): 1069-75. PMID: 22178694, PII: S1083-8791(11)01080-9, DOI: 10.1016/j.bbmt.2011.12.518, ISSN: 1523-6536.

Chinratanalab W, Reddy N, Greer JP, Morgan D, Engelhardt B, Kassim A, Brandt SJ, Jagasia M, Goodman S, Savani BN. Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies. Exp. Hematol [print-electronic]. 2012 Jun; 40(6): 431-5. PMID: 22269114, PMCID: PMC4067702, PII: S0301-472X(12)00016-1, DOI: 10.1016/j.exphem.2012.01.014, ISSN: 1873-2399.

Reddy N, Greer JP, Goodman S, Kassim A, Morgan DS, Chinratanalab W, Brandt S, Englehardt B, Oluwole O, Jagasia MH, Savani BN. Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen. Exp. Hematol [print-electronic]. 2012 May; 40(5): 359-66. PMID: 22269117, PII: S0301-472X(12)00014-8, DOI: 10.1016/j.exphem.2012.01.012, ISSN: 1873-2399.

Warlick E, Ahn KW, Pedersen TL, Artz A, de Lima M, Pulsipher M, Akpek G, Aljurf M, Cahn JY, Cairo M, Chen YB, Cooper B, Deol A, Giralt S, Gupta V, Khoury HJ, Kohrt H, Lazarus HM, Lewis I, Olsson R, Pidala J, Savani BN, Seftel M, Socié G, Tallman M, Ustun C, Vij R, Vindeløv L, Weisdorf D. Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era. Blood [print-electronic]. 2012 Apr 4/26/2012; 119(17): 4083-90. PMID: 22408257, PMCID: PMC3350369, PII: blood-2012-02-409763, DOI: 10.1182/blood-2012-02-409763, ISSN: 1528-0020.

Benrashid M, Moyers K, Mohty M, Savani BN. Vitamin D deficiency, autoimmunity, and graft-versus-host-disease risk: Implication for preventive therapy. Exp. Hematol [print-electronic]. 2012 Apr; 40(4): 263-7. PMID: 22265707, PII: S0301-472X(12)00008-2, DOI: 10.1016/j.exphem.2012.01.006, ISSN: 1873-2399.

Engelhardt BG, Jagasia SM, Crowe JE, Griffith ML, Savani BN, Kassim AA, Lu P, Weitkamp JH, Moore DJ, Yoder SM, Rock MT, Jagasia M. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood [print-electronic]. 2012 Mar 3/8/2012; 119(10): 2417-21. PMID: 22262764, PMCID: PMC3311262, PII: blood-2011-10-384750, DOI: 10.1182/blood-2011-10-384750, ISSN: 1528-0020.

Zatarain L, Savani BN. The role of nutrition and effects on the cytokine milieu in allogeneic hematopoietic stem cell transplantation. Cell. Immunol [print-electronic]. 2012 Mar; 276(1-2): 6-9. PMID: 22677562, PII: S0008-8749(12)00100-1, DOI: 10.1016/j.cellimm.2012.05.003, ISSN: 1090-2163.

Armand P, Kim HT, Zhang MJ, Perez WS, Dal Cin PS, Klumpp TR, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz AS, Gupta V, Savani BN, McCarthy PL, Cahn JY, Schouten HC, Finke J, Ball ED, Aljurf MD, Cutler CS, Rowe JM, Antin JH, Isola LM, Di Bartolomeo P, Camitta BM, Miller AM, Cairo MS, Stockerl-Goldstein K, Sierra J, Savoie ML, Halter J, Stiff PJ, Nabhan C, Jakubowski AA, Bunjes DW, Petersdorf EW, Devine SM, Maziarz RT, Bornhauser M, Lewis VA, Marks DI, Bredeson CN, Soiffer RJ, Weisdorf DJ. Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. Biol. Blood Marrow Transplant [print-electronic]. 2012 Feb; 18(2): 280-8. PMID: 21810400, PMCID: PMC3224672, PII: S1083-8791(11)00324-7, DOI: 10.1016/j.bbmt.2011.07.024, ISSN: 1523-6536.

Stover DG, Reddy VK, Shyr Y, Savani BN, Reddy N. Long-term impact of prior rituximab therapy and early lymphocyte recovery on auto-SCT outcome for diffuse large B-cell lymphoma. Bone Marrow Transplant [print-electronic]. 2012 Jan; 47(1): 82-7. PMID: 21358691, PII: bmt201129, DOI: 10.1038/bmt.2011.29, ISSN: 1476-5365.

Savani BN. How can we improve life expectancy and quality of life in long-term survivors after allogeneic stem cell transplantation?. Semin. Hematol. 2012 Jan; 49(1): 1-3. PMID: 22221778, PII: S0037-1963(11)00108-9, DOI: 10.1053/j.seminhematol.2011.10.014, ISSN: 1532-8686.

Shanis D, Merideth M, Pulanic TK, Savani BN, Battiwalla M, Stratton P. Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management. Semin. Hematol. 2012 Jan; 49(1): 83-93. PMID: 22221788, PMCID: PMC3257831, PII: S0037-1963(11)00096-5, DOI: 10.1053/j.seminhematol.2011.10.002, ISSN: 1532-8686.

Brissot E, Savani BN, Mohty M. Management of high ferritin in long-term survivors after hematopoietic stem cell transplantation. Semin. Hematol. 2012 Jan; 49(1): 35-42. PMID: 22221783, PII: S0037-1963(11)00097-7, DOI: 10.1053/j.seminhematol.2011.10.003, ISSN: 1532-8686.

Mielke S, McIver ZA, Shenoy A, Fellowes V, Khuu H, Stroncek DF, Leitman SF, Childs R, Battiwalla M, Koklanaris E, Haggerty J, Savani BN, Rezvani K, Barrett AJ. Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies. Biol. Blood Marrow Transplant [print-electronic]. 2011 Dec; 17(12): 1855-61. PMID: 21684344, PMCID: PMC3179818, PII: S1083-8791(11)00238-2, DOI: 10.1016/j.bbmt.2011.05.019, ISSN: 1523-6536.

Savani BN. Can we modify transplant outcome by improving lymphocyte recovery?. Cytotherapy. 2011 Sep; 13(8): 900-2. PMID: 21846297, DOI: 10.3109/14653249.2011.603220, ISSN: 1477-2566.

Reddy N, Savani BN. Treatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approach. Biol. Blood Marrow Transplant [print-electronic]. 2011 Sep; 17(9): 1265-72. PMID: 21621630, PMCID: PMC3156833, PII: S1083-8791(11)00208-4, DOI: 10.1016/j.bbmt.2011.05.002, ISSN: 1523-6536.

Jagasia MH, Savani BN, Neff A, Dixon S, Chen H, Pickard AS. Outcome, toxicity profile and cost analysis of autologous stem cell mobilization. Bone Marrow Transplant [print-electronic]. 2011 Aug; 46(8): 1084-8. PMID: 21042307, PII: bmt2010254, DOI: 10.1038/bmt.2010.254, ISSN: 1476-5365.

Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Snavely J, Chen H, Savani BN, Kassim A, Greer JP, Schuening FG, Engelhardt BG, Jagasia MH. Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD. Blood [print-electronic]. 2011 Jul 7/28/2011; 118(4): 1140-4. PMID: 21628416, PII: blood-2010-09-310011, DOI: 10.1182/blood-2010-09-310011, ISSN: 1528-0020.

Tedesco J, Qualtieri J, Head D, Savani BN, Reddy N. High Prevalence of Obesity in Acute Promyelocytic Leukemia (APL): Implications for Differentiating Agents in APL and Metabolic Syndrome. Ther Adv Hematol. 2011 Jun; 2(3): 141-5. PMID: 23556085, PMCID: PMC3573402, PII: 10.1177_2040620711408490, DOI: 10.1177/2040620711408490, ISSN: 2040-6207.

Le RQ, Melenhorst JJ, Battiwalla M, Hill B, Memon S, Savani BN, Shenoy A, Hensel NF, Koklanaris EK, Keyvanfar K, Hakim FT, Douek DC, Barrett AJ. Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation. Blood [print-electronic]. 2011 May 5/12/2011; 117(19): 5250-6. PMID: 21421838, PMCID: PMC3109546, PII: blood-2011-01-329706, DOI: 10.1182/blood-2011-01-329706, ISSN: 1528-0020.

Reddy N, Rezvani K, Barrett AJ, Savani BN. Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients. Biol. Blood Marrow Transplant [print-electronic]. 2011 May; 17(5): 591-7. PMID: 20732435, PMCID: PMC3763478, PII: S1083-8791(10)00346-0, DOI: 10.1016/j.bbmt.2010.08.007, ISSN: 1523-6536.

Yong AS, Stephens N, Weber G, Li Y, Savani BN, Eniafe R, Keyvanfar K, Kurlander R, Rezvani K, Barrett AJ. Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein. Leukemia [print-electronic]. 2011 Apr; 25(4): 629-37. PMID: 21252986, PMCID: PMC3076540, PII: leu2010325, DOI: 10.1038/leu.2010.325, ISSN: 1476-5551.

Savani BN, Griffith ML, Jagasia S, Lee SJ. How I treat late effects in adults after allogeneic stem cell transplantation. Blood [print-electronic]. 2011 Mar 3/17/2011; 117(11): 3002-9. PMID: 21193694, PMCID: PMC3062306, PII: blood-2010-10-263095, DOI: 10.1182/blood-2010-10-263095, ISSN: 1528-0020.

Rezvani K, Yong AS, Mielke S, Jafarpour B, Savani BN, Le RQ, Eniafe R, Musse L, Boss C, Kurlander R, Barrett AJ. Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies. Haematologica [print-electronic]. 2011 Mar; 96(3): 432-40. PMID: 21134985, PMCID: PMC3046275, PII: haematol.2010.031674, DOI: 10.3324/haematol.2010.031674, ISSN: 1592-8721.

Lucid CE, Savani BN, Engelhardt BG, Shah P, Clifton C, Greenhut SL, Vaughan LA, Kassim A, Schuening F, Jagasia M. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Bone Marrow Transplant [print-electronic]. 2011 Mar; 46(3): 426-9. PMID: 20581885, PII: bmt2010152, DOI: 10.1038/bmt.2010.152, ISSN: 1476-5365.

Engelhardt BG, Jagasia M, Savani BN, Bratcher NL, Greer JP, Jiang A, Kassim AA, Lu P, Schuening F, Yoder SM, Rock MT, Crowe JE. Regulatory T cell expression of CLA or a(4)ß(7) and skin or gut acute GVHD outcomes. Bone Marrow Transplant [print-electronic]. 2011 Mar; 46(3): 436-42. PMID: 20577222, PMCID: PMC3217583, PII: bmt2010127, DOI: 10.1038/bmt.2010.127, ISSN: 1476-5365.

Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, Wang Z, Sobocinski KA, Gupta V, Hale GA, Marks DI, Stadtmauer EA, Apperley J, Cahn JY, Schouten HC, Lazarus HM, Savani BN, McCarthy PL, Jakubowski AA, Kamani NR, Hayes-Lattin B, Maziarz RT, Warwick AB, Sorror ML, Bolwell BJ, Socié G, Wingard JR, Rizzo JD, Majhail NS. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol. Blood Marrow Transplant [print-electronic]. 2011 Feb; 17(2): 157-66. PMID: 20659574, PMCID: PMC3017731, PII: S1083-8791(10)00300-9, DOI: 10.1016/j.bbmt.2010.07.009, ISSN: 1523-6536.

Tedeschi SK, Jagasia M, Engelhardt BG, Domm J, Kassim AA, Chinratanalab W, Greenhut SL, Goodman S, Greer JP, Schuening F, Frangoul H, Savani BN. Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation. Cytotherapy [print-electronic]. 2011 Jan; 13(1): 78-82. PMID: 20586668, DOI: 10.3109/14653249.2010.495114, ISSN: 1477-2566.

Griffith ML, Jagasia MH, Misfeldt AA, Chen H, Engelhardt BG, Kassim A, Savani BN, Survant M, Jagasia SM. Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2011 Jan; 17(1): 86-92. PMID: 20561594, PII: S1083-8791(10)00254-5, DOI: 10.1016/j.bbmt.2010.06.010, ISSN: 1523-6536.

Venepalli N, Rezvani K, Mielke S, Savani BN. Role of allo-SCT for CML in 2010. Bone Marrow Transplant [print-electronic]. 2010 Nov; 45(11): 1579-86. PMID: 20531284, PII: bmt2010138, DOI: 10.1038/bmt.2010.138, ISSN: 1476-5365.

Savani BN. Transplantation in AML CR1. Blood. 2010 Sep 9/16/2010; 116(11): 1822-3. PMID: 20847206, PII: 116/11/1822, DOI: 10.1182/blood-2010-06-291500, ISSN: 1528-0020.

Stringaris K, Adams S, Uribe M, Eniafe R, Wu CO, Savani BN, Barrett AJ. Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies. Biol. Blood Marrow Transplant [print-electronic]. 2010 Sep; 16(9): 1257-64. PMID: 20302958, PMCID: PMC3801172, PII: S1083-8791(10)00109-6, DOI: 10.1016/j.bbmt.2010.03.004, ISSN: 1523-6536.

Griffith ML, Savani BN, Boord JB. Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management. Blood [print-electronic]. 2010 Aug 8/26/2010; 116(8): 1197-204. PMID: 20439623, PII: blood-2010-03-276576, DOI: 10.1182/blood-2010-03-276576, ISSN: 1528-0020.

Tedeschi SK, Savani BN, Jagasia M, Engelhardt B, Anasetti C, Barrett AJ, Lee S. Time to consider HPV vaccination after allogeneic stem cell transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2010 Aug; 16(8): 1033-6. PMID: 20302962, PMCID: PMC3750708, PII: S1083-8791(10)00112-6, DOI: 10.1016/j.bbmt.2010.03.007, ISSN: 1523-6536.

Le RQ, Bevans M, Savani BN, Mitchell SA, Stringaris K, Koklanaris E, Barrett AJ. Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Biol. Blood Marrow Transplant [print-electronic]. 2010 Aug; 16(8): 1162-70. PMID: 20302959, PMCID: PMC2897903, PII: S1083-8791(10)00110-2, DOI: 10.1016/j.bbmt.2010.03.005, ISSN: 1523-6536.

Clark WB, Strickland SA, Barrett AJ, Savani BN. Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome [editorial]. Haematologica. 2010 Jun; 95(6): 860-3. PMID: 20513805, PMCID: PMC2878780, PII: 95/6/860, DOI: 10.3324/haematol.2010.025890, ISSN: 1592-8721.

Savani BN, Mielke S, Reddy N, Goodman S, Jagasia M, Rezvani K. Management of relapse after allo-SCT for AML and the role of second transplantation. Bone Marrow Transplant [print-electronic]. 2009 Dec; 44(12): 769-77. PMID: 19855439, PII: bmt2009300, DOI: 10.1038/bmt.2009.300, ISSN: 1476-5365.

Jagasia MH, Savani BN, Stricklin G, Engelhardt B, Kassim A, Dixon S, Chen H, Chinratanalab W, Goodman S, Greer JP, Schuening F. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol. Blood Marrow Transplant [print-electronic]. 2009 Oct; 15(10): 1288-95. PMID: 19747637, PMCID: PMC3159406, PII: S1083-8791(09)00289-4, DOI: 10.1016/j.bbmt.2009.06.007, ISSN: 1523-6536.

Le Q, Shenoy A, Koklanaris E, Childs R, John Barrett A, Savani BN. Lamivudine prophylaxis and hepatitis B vaccination for prevention of hepatitis B virus reverse seroconversion in long-term survivors after allogeneic stem cell transplantation [letter]. Biol. Blood Marrow Transplant. 2009 Jul; 15(7): 886-7. PMID: 19539222, PMCID: PMC3759997, PII: S1083-8791(09)00182-7, DOI: 10.1016/j.bbmt.2009.03.024, ISSN: 1523-6536.

Savani BN, Pohlmann PR, Jagasia M, Chinratanalab W, Kassim A, Engelhardt B, Greer J, Schuening F, Goodman S. Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD? [letter]. Blood. 2009 Jun 6/11/2009; 113(24): 6263-4. PMID: 19520823, PII: 113/24/6263, DOI: 10.1182/blood-2009-04-213892, ISSN: 1528-0020.

Reddy N, Goodman S, Savani BN. Prophylactic intravenous immunoglobulin does not have a role in hematopoietic stem-cell transplantation: is the evidence clear? [letter]. J. Clin. Oncol [print-electronic]. 2009 May 5/1/2009; 27(13): 2296-7; author reply 2297. PMID: 19307488, PII: JCO.2009.22.0897, DOI: 10.1200/JCO.2009.22.0897, ISSN: 1527-7755.

Savani BN, Goodman S, Barrett AJ. Can routine posttransplant HPV vaccination prevent commonly occurring epithelial cancers after allogeneic stem cell transplantation?. Clin. Cancer Res [print-electronic]. 2009 Apr 4/1/2009; 15(7): 2219-21. PMID: 19293253, PMCID: PMC3819600, PII: 1078-0432.CCR-08-3099, DOI: 10.1158/1078-0432.CCR-08-3099, ISSN: 1078-0432.

Savani BN, Goodman S, Reddy N. Does extra alemtuzumab remove the graft-versus-leukemia effect after allogeneic stem cell transplantation in chronic lymphocytic leukemia? [letter]. Biol. Blood Marrow Transplant. 2009 Apr; 15(4): 517-8. PMID: 19285641, PII: S1083-8791(09)00004-4, DOI: 10.1016/j.bbmt.2008.12.511, ISSN: 1523-6536.

Rezvani K, Yong AS, Tawab A, Jafarpour B, Eniafe R, Mielke S, Savani BN, Keyvanfar K, Li Y, Kurlander R, Barrett AJ. Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia. Blood [print-electronic]. 2009 Mar 3/5/2009; 113(10): 2245-55. PMID: 18988867, PMCID: PMC2652370, PII: blood-2008-03-144071, DOI: 10.1182/blood-2008-03-144071, ISSN: 1528-0020.

Savani BN, Koklanaris EK, Le Q, Shenoy A, Goodman S, Barrett AJ. Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies. Biol. Blood Marrow Transplant. 2009 Mar; 15(3): 377-81. PMID: 19203730, PMCID: PMC3768008, PII: S1083-8791(08)00582-X, DOI: 10.1016/j.bbmt.2008.11.032, ISSN: 1523-6536.

Yong AS, Keyvanfar K, Hensel N, Eniafe R, Savani BN, Berg M, Lundqvist A, Adams S, Sloand EM, Goldman JM, Childs R, Barrett AJ. Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib. Blood [print-electronic]. 2009 Jan 1/22/2009; 113(4): 875-82. PMID: 18922853, PMCID: PMC2630272, PII: blood-2008-05-158253, DOI: 10.1182/blood-2008-05-158253, ISSN: 1528-0020.

Barrett AJ, Savani BN. Does chemotherapy modify the immune surveillance of hematological malignancies?. Leukemia [print-electronic]. 2009 Jan; 23(1): 53-8. PMID: 18830260, PMCID: PMC4170943, PII: leu2008273, DOI: 10.1038/leu.2008.273, ISSN: 1476-5551.

Savani K, Markus HR, Conner AL. Let your preference be your guide? Preferences and choices are more tightly linked for North Americans than for Indians. J Pers Soc Psychol. 2008 Oct; 95(4): 861-76. PMID: 18808264, PII: 2008-12903-007, DOI: 10.1037/a0011618, ISSN: 0022-3514.

Savani BN, Stratton P, Shenoy A, Kozanas E, Goodman S, Barrett AJ. Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination. Biol. Blood Marrow Transplant. 2008 Sep; 14(9): 1072-5. PMID: 18721771, PMCID: PMC2946417, PII: S1083-8791(08)00294-2, DOI: 10.1016/j.bbmt.2008.07.005, ISSN: 1523-6536.

Yong AS, Keyvanfar K, Eniafe R, Savani BN, Rezvani K, Sloand EM, Goldman JM, Barrett AJ. Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy. Leukemia [print-electronic]. 2008 Sep; 22(9): 1721-7. PMID: 18548092, PMCID: PMC2574650, PII: leu2008161, DOI: 10.1038/leu.2008.161, ISSN: 1476-5551.

Schubert J, Hillmen P, Röth A, Young NS, Elebute MO, Szer J, Gianfaldoni G, Socié G, Browne P, Geller R, Rother RP, Muus P, . Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria. Br. J. Haematol [print-electronic]. 2008 Jun; 142(2): 263-72. PMID: 18503589, PII: BJH7183, DOI: 10.1111/j.1365-2141.2008.07183.x, ISSN: 1365-2141.

Melenhorst JJ, Scheinberg P, Lu J, Ambrozak DR, Sosa E, Zhao L, Hensel NF, Savani BN, Douek DC, Price DA, Barrett AJ. Regulatory T-cell depletion does not prevent emergence of new CD25+ FOXP3+ lymphocytes after antigen stimulation in culture. Cytotherapy. 2008; 10(2): 152-64. PMID: 18368594, PII: 790471313, DOI: 10.1080/14653240701853536, ISSN: 1477-2566.

Barrett AJ, Savani BN. Allogeneic stem cell transplantation for myelodysplastic syndrome. Semin. Hematol. 2008 Jan; 45(1): 49-59. PMID: 18179969, PII: S0037-1963(07)00156-4, DOI: 10.1053/j.seminhematol.2007.10.005, ISSN: 0037-1963.

Rezvani K, Yong AS, Mielke S, Savani BN, Musse L, Superata J, Jafarpour B, Boss C, Barrett AJ. Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies. Blood [print-electronic]. 2008 Jan 1/1/2008; 111(1): 236-42. PMID: 17875804, PMCID: PMC2200809, PII: blood-2007-08-108241, DOI: 10.1182/blood-2007-08-108241, ISSN: 0006-4971.

Savani BN, Mielke S, Adams S, Uribe M, Rezvani K, Yong AS, Zeilah J, Kurlander R, Srinivasan R, Childs R, Hensel N, Barrett AJ. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia. Leukemia [print-electronic]. 2007 Oct; 21(10): 2145-52. PMID: 17673900, PII: 2404892, DOI: 10.1038/sj.leu.2404892, ISSN: 0887-6924.

Savani BN, Mielke S, Rezvani K, Montero A, Yong AS, Wish L, Superata J, Kurlander R, Singh A, Childs R, Barrett AJ. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2007 Oct; 13(10): 1216-23. PMID: 17889359, PMCID: PMC3426353, PII: S1083-8791(07)00335-7, DOI: 10.1016/j.bbmt.2007.07.005, ISSN: 1083-8791.

Rezvani K, Yong AS, Savani BN, Mielke S, Keyvanfar K, Gostick E, Price DA, Douek DC, Barrett AJ. Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia. Blood [print-electronic]. 2007 Sep 9/15/2007; 110(6): 1924-32. PMID: 17505014, PMCID: PMC1976363, PII: blood-2007-03-076844, DOI: 10.1182/blood-2007-03-076844, ISSN: 0006-4971.

Mielke S, Rezvani K, Savani BN, Nunes R, Yong AS, Schindler J, Kurlander R, Ghetie V, Read EJ, Solomon SR, Vitetta ES, Barrett AJ. Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease. Blood [print-electronic]. 2007 Sep 9/1/2007; 110(5): 1689-97. PMID: 17478639, PMCID: PMC1975850, PII: blood-2007-03-079160, DOI: 10.1182/blood-2007-03-079160, ISSN: 0006-4971.

Soule BP, Simone NL, Savani BN, Ning H, Albert PS, Barrett AJ, Singh AK. Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant. Bone Marrow Transplant [print-electronic]. 2007 Sep; 40(6): 573-8. PMID: 17637691, PII: 1705771, DOI: 10.1038/sj.bmt.1705771, ISSN: 0268-3369.

Yong AS, Rezvani K, Savani BN, Eniafe R, Mielke S, Goldman JM, Barrett AJ. High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects. Blood [print-electronic]. 2007 Jul 7/15/2007; 110(2): 770-5. PMID: 17412886, PMCID: PMC1924474, PII: blood-2007-02-071738, DOI: 10.1182/blood-2007-02-071738, ISSN: 0006-4971.

Shenoy A, Savani BN, Barrett AJ. Recombinant factor VIIa to treat diffuse alveolar hemorrhage following allogeneic stem cell transplantation. Biol. Blood Marrow Transplant. 2007 May; 13(5): 622-3. PMID: 17448923, PII: S1083-8791(07)00116-4, DOI: 10.1016/j.bbmt.2007.01.070, ISSN: 1083-8791.

Savani BN, Donohue T, Kozanas E, Shenoy A, Singh AK, Childs RW, Barrett AJ. Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation. Biol. Blood Marrow Transplant. 2007 May; 13(5): 517-20. PMID: 17448910, PII: S1083-8791(07)00144-9, DOI: 10.1016/j.bbmt.2007.01.085, ISSN: 1083-8791.

Singh AK, Savani BN, Albert PS, Barrett AJ. Efficacy of CD34+ stem cell dose in patients undergoing allogeneic peripheral blood stem cell transplantation after total body irradiation. Biol. Blood Marrow Transplant. 2007 Mar; 13(3): 339-44. PMID: 17317587, PII: S1083-8791(06)00752-X, DOI: 10.1016/j.bbmt.2006.10.029, ISSN: 1083-8791.

Savani BN, Kozanas E, Shenoy A, Barrett AJ. Recovery of spermatogenesis after total-body irradiation [letter]. Blood. 2006 Dec 12/15/2006; 108(13): 4292-3; author reply 4293. PMID: 17148595, PII: 108/13/4292, DOI: 10.1182/blood-2006-08-044289, ISSN: 0006-4971.

Savani BN, Montero A, Srinivasan R, Singh A, Shenoy A, Mielke S, Rezvani K, Karimpour S, Childs R, Barrett AJ. Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. Biol. Blood Marrow Transplant. 2006 Dec; 12(12): 1261-9. PMID: 17162207, PMCID: PMC1849949, PII: S1083-8791(06)00647-1, DOI: 10.1016/j.bbmt.2006.07.016, ISSN: 1083-8791.

Montero A, Savani BN, Shenoy A, Read EJ, Carter CS, Leitman SF, Mielke S, Rezvani K, Childs R, Barrett AJ. T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome. Biol. Blood Marrow Transplant. 2006 Dec; 12(12): 1318-25. PMID: 17162214, PII: S1083-8791(06)00577-5, DOI: 10.1016/j.bbmt.2006.08.034, ISSN: 1083-8791.

Singh AK, Karimpour SE, Savani BN, Guion P, Hope AJ, Mansueti JR, Ning H, Altemus RM, Wu CO, Barrett AJ. Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant. Int. J. Radiat. Oncol. Biol. Phys. 2006 Oct 10/1/2006; 66(2): 520-7. PMID: 16965994, PII: S0360-3016(06)00942-4, DOI: 10.1016/j.ijrobp.2006.05.023, ISSN: 0360-3016.

Barrett AJ, Savani BN. Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents. Leukemia [print-electronic]. 2006 Oct; 20(10): 1661-72. PMID: 16871277, PII: 2404334, DOI: 10.1038/sj.leu.2404334, ISSN: 0887-6924.

Rezvani K, Mielke S, Ahmadzadeh M, Kilical Y, Savani BN, Zeilah J, Keyvanfar K, Montero A, Hensel N, Kurlander R, Barrett AJ. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood [print-electronic]. 2006 Aug 8/15/2006; 108(4): 1291-7. PMID: 16627754, PMCID: PMC1895877, PII: blood-2006-02-003996, DOI: 10.1182/blood-2006-02-003996, ISSN: 0006-4971.

Savani BN, Dunbar CE, Rick ME. Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization. Am. J. Hematol. 2006 Mar; 81(3): 218-9. PMID: 16493611, DOI: 10.1002/ajh.20506, ISSN: 0361-8609.

Savani BN, Rezvani K, Mielke S, Montero A, Kurlander R, Carter CS, Leitman S, Read EJ, Childs R, Barrett AJ. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood [print-electronic]. 2006 Feb 2/15/2006; 107(4): 1688-95. PMID: 16131570, PMCID: PMC1895415, PII: 2005-05-1897, DOI: 10.1182/blood-2005-05-1897, ISSN: 0006-4971.

Savani BN, Montero A, Kurlander R, Childs R, Hensel N, Barrett AJ. Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation. Bone Marrow Transplant. 2005 Dec; 36(11): 1009-15. PMID: 16205732, PII: 1705167, DOI: 10.1038/sj.bmt.1705167, ISSN: 0268-3369.

Savani BN, Srinivasan R, Espinoza-Delgado I, Dorrance C, Takahashi Y, Igarashi T, Rezvani K, Lundqvist A, Barrett AJ, Childs RW. Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib. Lancet Oncol. 2005 Oct; 6(10): 809-12. PMID: 16198987, PII: S1470-2045(05)70391-0, DOI: 10.1016/S1470-2045(05)70391-0, ISSN: 1470-2045.

Montero A, Savani BN, Kurlander R, Read EJ, Leitman SF, Childs R, Solomon SR, Barrett AJ. Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning. Br. J. Haematol. 2005 Sep; 130(5): 733-9. PMID: 16115130, PII: BJH5665, DOI: 10.1111/j.1365-2141.2005.05665.x, ISSN: 0007-1048.

Solomon SR, Savani BN, Childs R, Montero A, Boss C, Read EJ, Leitman SF, Barrett AJ. Improved outcome for peripheral blood stem cell transplantation for advanced primary myelodysplastic syndrome. Biol. Blood Marrow Transplant. 2005 Aug; 11(8): 619-26. PMID: 16041312, PII: S1083879105002909, DOI: 10.1016/j.bbmt.2005.05.004, ISSN: 1083-8791.

Solomon SR, Mielke S, Savani BN, Montero A, Wisch L, Childs R, Hensel N, Schindler J, Ghetie V, Leitman SF, Mai T, Carter CS, Kurlander R, Read EJ, Vitetta ES, Barrett AJ. Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation. Blood [print-electronic]. 2005 Aug 8/1/2005; 106(3): 1123-9. PMID: 15817673, PMCID: PMC1895160, PII: 2005-01-0393, DOI: 10.1182/blood-2005-01-0393, ISSN: 0006-4971.

Savani BN, Montero A, Wu C, Nlonda N, Read E, Dunbar C, Childs R, Solomon S, Barrett AJ. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol. Blood Marrow Transplant. 2005 Mar; 11(3): 223-30. PMID: 15744241, PII: S1083879104009814, DOI: 10.1016/j.bbmt.2004.12.328, ISSN: 1083-8791.

Chun NS, Savani B, Seder RH, Taplin ME. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura. Am. J. Hematol. 2003 Dec; 74(4): 276-9. PMID: 14635210, DOI: 10.1002/ajh.10432, ISSN: 0361-8609.

Al Bahar S, Pandita R, Bavishi K, Savani B. Sequential standard dose mitoxantrone and cytosine arabinoside for newly diagnosed adult acute myeloblastic leukemia. Neoplasma. 1999; 46(1): 61-5. PMID: 10355536, ISSN: 0028-2685.

Patel AP, Patel KM, Shukla SN, Savani BN, Gopal N, Bavishi KN, Madan PL, Anand A, Parikh BJ, Shah PM. Splenic infiltrates in acute lymphoblastic leukemia. Am. J. Hematol. 1994 Apr; 45(4): 349-50. PMID: 8178811, DOI: 10.1002/ajh.2830450420, ISSN: 0361-8609.